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ABSTRACT 
Human interleukin 6 (hIL6) is a multifunctional cytokine effecting the 
function and proliferation of many cell types. The further understanding of 
hIL6 and its possible medical applications rely on the availability of this 
protein. The filamentous fungus Aspergillus oryzae is an important industrial 
organism and is used for the large scale production of many enzymes. As this 
fungus has an impressive secretory output it was decided to attempt to 
produce hIL6 in this organism. 
The initial work was based on the development of a gene transfer 
system for A. oryzae in order that the hIL6 gene could be introduced to the 
organism. A transformation system based on the homologous nitrate 
reductase gene is described. This system yielded up to 800 transformants per µg 
plasmid DNA. Additionally, the adaptation of the transformation system 
based on the A. nidulans anuiS gene and the use of other transformation 
systems is reported. 
In order to ensure that the hIL6 gene was efficiently transcribed it was 
considered important that homologous control regions from highly produced 
and regulated A. oryzae genes were linked to the hIL6 gene. Therefore the 
genes encoding glucoamylase and a-amylase were isolated from A. oryzae. A 
method for the purification of A. oryzae Si nuclease is described and the 
amino acid sequence of the N terminus is reported. 
A. oryzae produces large amounts of extracellular proteases, a feature 
unlikely to be attractive in a heterologous host. Therefore the production of 
protease production in A. oryzae was studied. A method is described for the 
selection of protease deficient mutants. Using this method two protease 
mutants were isolated and these have been characterized. One mutation 
designated prtA2 protects against the degradation of hJL6 in vitro. The A. 
oryzae alkaline protease gene was isolated and mutagenised and the attempts 
made to produce specific protease mutant by reverse genetics are described. 
A system is described where by A. oryzae can be engineered to produce 
relatively high levels of hIL6. Using gene fusion constructs transformants 
producing in the range of 1 mg per Litre have been isolated. This system is 
heterologous, recommendations for increasing hIL6 production are included. 
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ABBREVIATIONS 
A Angstrom 
A adenine 
ATP adenosine triphosphate 
ß beta 
bp base pair(s) 
BSA bovine serum albumin 
ßME beta mercaptoethanol 
C cytosine 
cm centimetres 
°C degrees centigrade 
Da Dalton 
DEP diethylpyrocarbonate 
DNA deoxyribose nucleic acid 
DNase deoxyribonudease 
DNSA dinitrosalicylic acid 
dsDNA double stranded DNA 
DTT dithiothreitol 
dpm disintigrations per minute 
EDTA ethylene diamine tetra-acetic acid 
et al. et alia (and others) 
ER endoplasmic reticulum 
I gamma 
g gram(s) 
G guanine 
hlL6 human interleukin 6 
IPTG isopropyl ß-thiogalactoside 
vii 
xg times force of gravity (centrifugation) 
k 1 thousand 
kb kilobase(s) (pairs) 
kbp kilobare pairs 
kDa kiloDalton 
kV kilovolts 
lambda 
1 litres 
LB Luria broth 
M molar 
µCi microcuries 
µg micrograms 
µl microlitre(s) 
mm millimolar 
mm millimetre(s) 
mg milligram(s) 
ml millilitre(s) 
MM minimal media 
Mr relative molecular weight 
mRNA messenger RNA 
N any nucleotide 
nm nanometres 
OD600 optical density at 600 nanometres 
(wavelength) 
PAGE polyacrylamide gel electrphoresis 
PEG 6000 polyethylene glycol of molecular 
weight 6000 
pers. comm. personnal communication 
vii' 
pg picograms 
R any purine 
RNA ribose nucleic acid 
RNase ribonuclease 
rpm revolutions per minute 
ssDNA single stranded DNA 
SDS sodium dodecyl sulphate 
SDW sterile distilled water 
SRP signal recognition protein 
T thymine 
TE 10 mM Tris-HC1 pH 7.5,1 mM EDTA 
Tris Tris (hydroxymethyl) aminomethane 
u units 
UV ultraviolet light 
V volts 
v/v volume per volume 
w/v weight per volume 
X-gal 5'-bromo-4'-chloro-3'-indolyl-5-D- 
galactopyranoside 
Y any pyrimidine 
Chemical symbols have their conventional meaning. 
ix 
Amino acids are abbreviated in text and figures as follows: 
Amino acid One letter code Three letter code 
Alanine A Ala 
Arginine R Arg 
Asparagine N Asn 
Aspartic add D Asp 
Cysteine C Cys 
Glutamine Q Gln 
Glutamic acid E Glu 
Glycine G Gly 
Histidine H His 
Isoleucine I Ile 
Leucine L Leu 
Lysine K Lys 
Methionine M Met 
Phenylalanine F Phe 
Proline P Pro 
Serine S Ser 
Threonine T Thr 
Tryptophan W Trp 
Tyrosine Y Tyr 
Valine V Val 
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Chapter 1 
Introduction 
1.1 General introduction 
Heterologous expression can be defined as the production by 
an organism of a protein encoded by a DNA sequence foreign to that 
organism. The process of heterologous expression involves introducing 
such a sequence of DNA, or gene, which encodes a protein in one 
particular organism, into another organism, known as the host, in such 
away that the gene is recognised and expressed by the host. The process of 
introducing this DNA into an organism and its subsequent inheritance is 
called transformation. As transformation systems become available for 
more organisms, the applications of recombinant DNA technology 
become greater. Developments in genetics and nucleic acid chemistry 
now enable genes coding for natural biologically active proteins to be 
identified, analysed, transferred between organisms and expressed under 
controlled conditions so as to achieve the synthesis of the polypeptide for 
which they encode. 
Heterologous expression opens exciting new prospects for 
industrial microorganisms. For example, microorganisms can be 
genetically programmed to grow on previously unsuitable substrates. For 
instance, many workers are currently attempting to express heterologous 
starch degradation enzymes in brewers strains of Saccharomyces 
cerevisiae in order to make the brewing process more efficient (Cole et. al. 
1988). The possibilities of altering substrate utilization offers many 
exciting opportunities; biological wastes could be used for primary 
product formation and industrial wastes could be detoxified; it has 
1 
already been shown for the latter that many microorganisms can remove 
heavy metals from aqueous effluent to a 99% efficiency level (Ross 1986). 
The yields of commercial microbiological fermentations 
could be improved by adding extra copies of gene(s) encoding rate 
limiting step enzymes. This approach has increased Cephalosporium 
acremonium antibiotic production (Skatrud et al. 1989). Existing 
industries could be made more economical with the production of 
secondary products after the primary fermentation, for example from 
yeast after the brewing process 
The ability to synthesize and manipulate nucleic acids 
allows the construction of altered genes, encoding modified products, 
which possess enhanced biological activity and/or diminished adverse 
biological characteristics. For instance, alteration in the specificity of the 
Streptomyces subtilisin inhibitor (Kojima et al. 1990), and the production 
of vaccines from heterologously expressed viral antigens such as foot and 
mouth disease virus (FMDV) coat protein (Kleid et al. 1981) and 
Hepatitus B core antigen (HBcAg) (Beesley et al. 1990). Additionally, 
quantities of useful medicinal products which were hitherto difficult to 
prepare, can now be manufactured using heterologous hosts. For 
example, human growth hormone can now be produced in the 
prokaryotic bacteria Esherichia coli (Goeddel et al. 1979); previously it was 
only available from post-mortem tissue, requiring the pituitary glands 
from twelve corpses to obtain sufficient hormone to treat one pituitary 
dwarf. Further inroads into the understanding of protein structure will 
allow a priori the design of entirely novel polypeptides and their 
production by recombinant DNA technology. New enzymes could be 
designed to be more specific and able to function at temperatures and pH 
more suitable to industrial processes. 
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As techniques become more sophisticated, one may expect 
further possibilities to improve existing industries. For example 
transgenic plants can be made resistant to herbicides (Comai et al. 1985) or 
virus attack (Abel et al. 1986). With the recent reports of transgenic 
animals (Gordon et al. 1987, Meade et al. 1990, Clark et al. 1989, Archibald 
et al. 1990, Rancourt et al. 1990) it may soon be possible to produce drugs 
in the milk of farm animals. Recombinant DNA technology is a rapidly 
expanding industry; it took just five years from the first reports of cloning 
human hormone genes to the approval of the clinical use of recombinant 
insulin as a licensed product by the U. S. A. Food and Drug 
Administration (FDA) (Khosrovi and Gray 1988). Techniques are 
becoming more precise and understanding of gene structure and function 
is becoming clearer. Only time will tell the future applications of 
recombinant DNA technology. 
1.2 Introduction to Aspergillus oryzae 
The genus Aspergillus, included in the class Ascomycetes, 
was described as early as 1729 in Michel is Nova Plantarum Genera. 
Classified as a member of the A. Flavus-oryzae group by Thom and Raper 
(1945), A. oryzae is described as a fungus with vegetative mycelium, 
largely sub-merged, supporting a deep loose textured surface growth of 
long-stalked conidial structures and intermixed with aerial mycelium. 
When grown on Czapeks medium it ranges in colour from pale greenish 
yellow through to olive-buff shifting to light to dull brown shades with 
age. The reverse side is un-coloured and odour is lacking or non- 
distinctive. Conidial heads are radiate, mostly 150-300 µ in diameter. No 
ascosporic form is known (Raper and Fennell 1965). 
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A. oryzae is an important industrial organism and is used 
for the commercial production of oriental fermented foods including soy 
sauce, miso and sake (Hesseltine 1983, Frost 1988). Fermentation 
procedures for this organism are well established, the first process 
describing the production of A. oryzae enzymes for starch hydrolysis, 
"Takadiase" was patented in 1894 (Takamine 1894). A. oryzae has been 
widely used for the production of a number of secreted enzymes most 
notably a-amylase (Cannel and Moo-Young 1980), lactase (Kiuchi and 
Tanaka 1975) and protease (Yoshida and Ichishma 1964). The enzymes 
produced commercially by A. oryzae and their industrial applications are 
detailed in Table 1.1. 
Owing to its long history of food use, A. oryzae has received 
"Generally Regarded as Safe" status (Category 1) from the FDA and World 
Health Authority (WHO) (WHO report 1987). Enzymes produced from A. 
oryzae have a Group A classification from the Association of 
Manufacturers of Animal and Plant Food Enzymes (AMFEP), meaning 
that due to the traditional use of this organism in food, or food 
processing, in general no testing is required (AMFEP report 1980). 
The phylogenetically related filamentous fungus A. 
nidulans has been widely studied and analysed genetically. There is a 
considerable amount of knowledge available on the structure and 
function of its genetic material (Clutterbuck 1974, Smith and Pateman 
1977). A. nidulans has a relatively small genome (2.6 x 107 bp) with low 
repetitive DNA content (Timberlake 1978) making molecular genetical 
techniques easier to apply. 
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Table 1.1 A. oe Enzymes Produced Commercially a 
Enzyme IUB numberb 
1 
Examples of Application c 
a- amylase 3.2.1.1 C, H, I, J, L, N, 0 
glucoamylase 3.2.1.3 C, I, J, L, N, 0, R 
cellulase 3.2.1.4 I, J, R 
endo-ß-glucanase 3.2.1.6 J 
hemicellulase 3.2.1.78 M 
lipase 3.1.1.3 B, C 
maltase 3.2.1.20 H 
pectinase 3.2.1.15 C, I, F 
protease 3.4.23.4 B, E, F, H, I, J, K, 0, Q, R, P, S, T, 
U 
tannase 3.1.1.20 J 
lactase 3.2.1.23 A, B, D, R 
a: -Taken from Denner 1983, Frost 1988, Anstrup 1979 and references 
therein. 
b: - EC numbering 1978 
c: A: Milk, B: Cheese, C: Fats and Oils, D: Edible Ices, E: Meat, F: Fish, H: 
Cereal and Starch, I: Fruit and Vegetables, J: Beverages (Soft drinks, beer 
and wine), K: Soups and Broths, L: Sugar and Honey, M: Cocoa and 
Chocolate, N: Confectionery, 0: Bakery, P: Photography, Q. Spices and 
Flavours, R: Dietary food, S: Leather, T: Animal feeds, U: 
Pharmaceuticals. 
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1.3 Requirements for heterologous protein expression 
The production process for proteins begins similarly in all 
cells. A gene, ie. an organizational unit of genetic DNA, is transcribed 
into message RNA (mRNA). In turn, the mRNA is translated into a 
polypeptide chain by a , process in which the content of the RNA is 
transferred to a sequence of amino acids that is polymerized into a single 
chain. In order for a gene encoding a heterologous protein to be expressed 
in another organism, a number of criteria must be met. First, the 
heterologous gene must be introduced into the host cell. Thus, the host 
organism must have a gene transfer system. Second, once the gene is in 
the host cell it must be recognised by the host's cellular apparatus and 
transcribed into mRNA by a RNA polymerase and then translated into 
protein. The host therefore must be able to recognise the transcriptional 
and translational control regions on the heterologous gene. 
Additionally, a number of other features are desirable in a 
host organism. For example, the benefits of the host cell secreting the 
heterologous protein are out-lined in Table 1.2. Ideally the host cell 
should not produce proteases which would degrade the heterologous 
product, and if the protein has post-translational modifications such as 
glycosylation the host cell should have the apparatus to process the 
protein correctly. The final application of the heterologous product may 
also influence the choice of host organism. For example, if the protein is 
for medical use there may be benefits in selecting a host organism that is 
non-pathogenic. The 'scalability' of the recombinant culture may also be 
important, as the commercial success of any recombinant expression 
system relies upon the ability of that system to be scaled up, economically, 
to a production level at which satisfactory yields of the protein can be 
obtained consistently. Thus the value of the protein, the ease of 
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Table 12 Advantages of secretion for the production of heterologous 
proteins a 
1 1) No need for cell lysis in product recovery allowing continuous 
fermentation in addition to batch culture. 
1 2) Avoids the formation of inclusion bodies. 
13) Proteins are not subject to internal proteolysis. (Although they are 
not protected from external proteases). 
14) Allows for glycosylation and post secretory modification. 
5) Purification of protein is easier. 
6) Reduces any harmful effects on the host organism caused by 
intracellular accumulation of the potentially toxic product. 
a: -reproduced from Saunders et al. 1989 
purification, cost of media components and many other factors must be 
taken into consideration (reviewed in Sofer and Mason 1987). 
The requirement for these criteria will obviously influence 
the selection of host organism. These criteria and the choice of host 
organism are discussed in more detail below. 
1.4 Gene transcription factors 
In order to be expressed in the host, the foreign gene has to 
be recognised and transcribed into RNA by an RNA polymerase. In 
bacteria the RNA polymerase recognises certain sequences in the DNA, 
the operator and the promoter, that instruct it to bind to the DNA and 
initiate transcription. Such bacterial promoters have been relatively well 
defined and have highly conserved consensus sequences, the -35 region 
(TTGACA) and the -10 region or pribnow box (TATAAT) (Hawley and 
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McClure 1983). In eukaryotes, gene promoters do not have a discrete 
consensus sequence, rather the RNA polymerase is thought to recognise 
several discrete motifs that facilitate transcription. The most common of 
these has a consensus sequence TATAT/AA, abbreviated to TATA and is 
analogous to the pribnow box in prokaryotes (Dobson et al. 1982). The 
TATA box, when present, in filamentous fungal and mammalian genes 
is a single copy, located 30 to 60 base pairs away from the transcriptional 
initiation site. In contrast, TATA boxes are often multicopy and variable 
in position in S. cerevisiae genes. Another common promoter region is 
the so called CAAT box, the consensus sequence for which is CCAAT. 
This sequence is rare in S. cerevisiae, but is located, if present, between -70 
to -90 base pairs in higher eukaryotes and -60 to -120 in filamentous fungi. 
Eukaryotic promoters often have a pyrimidine rich area immediately 5' 
from the transcriptional initiation site. This is usual in S. cerevisiae 
particularly if the TATA and CAAT boxes are missing and also in highly 
expressed genes (La Thangue and Rigby 1988). 
In addition to these trans-acting promoter elements there 
are other, cis-acting, regions known as enhancers which may be several 
kilobases away from the gene, either up or down stream, or located 
within the gene itself (Hatzopolous et al. 1988). These regions may be 
specific or effect a wide range of genes. The position of some of these cis- 
acting elements, in relation to the gene, effects the efficiency of 
transcription. The precise method by which these enhancers work is not 
known. It is known however that some of them increase the number of 
RNA polymerase molecules binding to the DNA (Hatzopolous et al. 
1988). There are also trans-acting proteins that bind to the DNA and effect 
transcription initiation either in a positive or negative manner. The 
DNA binding domains of these proteins are usually at the N-terminus of 
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the gene and are often characterized by one of the following structures; 
the helix-turn-helix, zinc finger(s), leucine zipper(s) and helix-loop-helix 
(for a review, see Glover 1989) 
It is thought that these cis- and trans- elements interact to 
change the conformation of the DNA and/or alter the chromatin 
structure, in order to facilitate the binding of the RNA polymerase and 
target it to the start of initiation. Thus, in eukaryotes, promoter strength 
may be determined by the mosaic arrangement of several promoter 
motifs that work together with an abundance of trans-acting transcription 
factors to produce a particular level of transcription. Although S. 
cerevisiae transcriptional control regions have been shown to work 
efficiently in animal cells (Struhl 1983) the reverse may not always be true 
(Henikoff et al. 1981), suggesting that one or more of the signals for gene 
expression may frequently differ between S. cerevisiae and higher 
eukaryotes. It may therefore be advantageous in heterologous protein 
expression to use a promoter that is homologous to the organism. 
Certain heterologously produced, mammalian proteins 
have been shown to be toxic to their host cells (Belsham et al. 1986), 
particularly when fermentations are scaled up beyond laboratory scale. 
For example, a recombinant yeast that constitutively expressed Epstein 
Barr virus gp550 could not be scaled up to a volume of more than a few 
ml without complete loss of expression (Schultz et al. 1987). A way to 
circumvent this problem is to employ a system where transcription of the 
gene can be initiated after the host cell biomass is established, by using an 
inducible promoter. 
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1.5 Translation 
The efficiency of translation and the stability of the zRNA 
affect the level of protein production. In prokaryotic organisms the RNA 
is translated directly into protein by a ribosome. The ribosome attaches to 
the RNA at a specific sequence, up stream of the initiation site, known as 
the Shine Delgarno site (Shine and Delgarno 1974). The position of this 
ribosomal binding site relative to the initiation codon and the 
intervening DNA sequence is considered, to effect the translational 
efficiency (Shepard et al. 1982). Additional regions 5' to the ribosomal 
binding site have been shown to enhance translation (McCarthy et al. 
1986). However, in eukaryotes the processing of the RNA must first take 
place. The protein coding regions, or exons, of many eukaryotic gene 
sequences are interrupted by areas of non-coding DNA known as 
intervening sequences or introns. Introns are transcribed into RNA. 
Before the mRNA is passed into the cytoplasm for translation it is 
processed. Processing includes the addition of a 7-methylguanine cap on 
the 5' end and the addition of a polyadenylated tail on the 3' end. The 
addition of these structures is thought to increase mRNA stability 
(Furiuchi et al. 1977, Nevins 1983) and it has long been suggested that the 
cap may play a role in translation. Methylation of internal adenine 
residues has been observed in higher eukaryotes (Adams and Cory 1975), 
but not in yeast mRNA (De Kloet and Andrean 1976) 
During processing, introns are removed by a splicing 
mechanism. A particular sequence of RNA is recognised at the 5' and 3' 
junctions of the introns and the intervening DNA is removed. These 
sequences are conserved and similar in yeast and higher eukaryotes 
(Mount 1982). However, in S. cerevisiae there is an absolute requirement 
10 
for the sequence TACTAACA close to the 3' end of the yeast intron 
(Langford et al. 1984) and S. cerevisiae appears to be unable to process 
introns from higher eukaryotic organisms (Beggs et al. 1980, Innis et al. 
1985, Penttilae et al. 1987). The intron splicing sequences of filamentous 
fungi have been shown to have similarities those of higher eukaryotes 
(Gurr et al. 1987). The exons of mammalian genes are short and often 
interrupted by many, long introns. This is in contrast to the genes of 
filamentous fungi, where the introns are generally few and less than 100 
bp in length. Introns are less common in yeasts and completely absent in 
prokaryotes, which are incapable of processing mRNA. 
Different species have different preferred codons for highly 
expressed genes. Even within species, codon usage differs for genes that 
are expressed at different levels. Very different codon usage between a 
cloned gene and the host cell may contribute to instability of the mRNA 
(reviewed in King et al. 1986). The codon selection preference is different 
in prokaryotes and eukaryotic genes and this may effect the translation 
efficiency, structure and therefore stability of the mRNA (Ernst 1988a, 
Brown and Lithgow 1987). The codon bias in yeast is often very 
pronounced and there is evidence that it could prevent efficient 
transcription (Bennetzen and Hall 1982). Egel-Mitani and co-workers 
(1988) report that codon usage effects the ability of the gene to compete for 
expression and Ernst and Kawashima (1988) report that changing rare 
codons for more common ones can increase translation efficiency two to 
three times. Filamentous fungi may not be as selective in its codon usage 
as S. cerevisiae (Marauyama et al. 1986). 
1.6 Si ng al sequences 
The advantages of secreting foreign proteins are outlined in 
Table 1.2. In order for proteins to be secreted they have to be translocated 
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across membranes. In bacteria this transport occurs across the cell 
membrane and in eukaryotes it is across the endoplasmic reticulum (ER). 
Secretion is dependent on two factors; the structure of the newly 
synthesized polypeptide and the existence in the host cell of a secretion 
system. Secreted proteins are generally synthesized with a signal sequence 
at their N terminal end, which is usually removed during the process of 
secretion. However, the genes for human Interleukin 1 and human 
fibroblast growth factors do not include classical sequences usually 
associated with secreted proteins (Barr et al. 1988). Signal sequences are 
commonly between 15 and 30 amino acids long and have three distinct 
regions. The N terminal end is hydrophilic and thought to be involved 
in interaction with the docking protein on the ER. There is a central 
region which is hydrophobic and a more polar C terminal that seems to 
define cleavage (von Heijne 1985). The amino acids in the signal 
sequence follow the -1, -3 rule; at the cleavage site amino acids -1 and -3 
have small uncharged side chains. These amino acids are rare in 
positions -2, -4, -5 and +1 (von Heijne 1983); thus a definite structure is 
formed that interacts with the cleavage protease that removes the signal 
sequence. There is thought to be no consensus sequence for a signal 
sequence, apart from the -1, -3 rule, and indeed many random amino acid 
sequences have been shown to functionally replace signal sequences in 
yeast. (Kaiser et a1.1987) 
During secretion the signal sequence is recognised by, and 
bound to, by the signal recognition particle (SRP), a cytosolic ribonuclear 
protein, similar to the heat shock proteins (Chirico et al 1988). These 
proteins have been found in every organism studied to date and are 
highly conserved throughout evolution (Dehaies et al. 1988). Binding of 
the SRP usually occurs while the protein is still being translated, after 
12 
approximately 80 amino acids have been assembled. This includes the 40 
which are associated with the ribosome and 25 which are the signal 
sequence (Wiedmann et al. 1987). However, in some cases the protein is 
completed (Eilers and Schatz 1988). Binding of the SRP arrests ribosomal 
transcription until a place is found for the SRP-protein complex on the 
membrane (Walters and Blobel 1981). It is thought that the SRP brings 
about, or stabilizes, a translocation competent formation in the protein 
(Sanz and Meyer 1988). Dehaies and co-workers (1988) consider the 
possibility that the SRP acts as an unfoldase, unfolding the protein. It has 
been shown Mandell and Hardy 1986) that proteins associated with SRP 
were more susceptible to proteolysis; indicating that protein unfolding 
had occurred. This process requires ATP (Chen and Tai 1985). The loosely 
folded structure is thought to be maintained by soluble factors that have 
been termed "molecular chaperons" (Kumomoto 1991). 
The SRP-protein complex interacts with a docking protein 
on the ER membrane. The SRP is released and protein elongation 
continues. The signal sequence then interacts with the signal sequence 
recognition protein (SSR) and passes through the ER wall into the 
lumen. The exact mechanism of this is not fully understood. It could be 
that the SSR assists the signal sequence in interaction with the lipid 
moiety of the membrane or that the SSR forms part of a channel that the 
protein can pass through (Wiedmann et al. 1987). Once in the ER lumen 
the protein is glycosylated and sorted before being targeted to one of the 
organelles or secreted. 
Most eukaryotic cells contain secretory systems as described 
above whilst prokaryotic cells such as bacteria do not. Consequently, 
eukaryotic systems such as yeast and mammalian cells have been used for 
secreting recombinant proteins. Secretion is often a limiting step in the 
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production of heterologous proteins. Smith and co-workers (1985) report 
that secretion is limiting in S. cerevisiae and Upshall and colleagues 
(1987) suggest that the build up of heterologous products in the ER in A. 
nidulans swamps the secretion pathway and causes hypoglycosylation. A 
report by Kelly (1989) suggests that proteins that are incorrectly folded 
become lodged in the ER because they associate with BiP, a 78 kDa heavy 
chain binding protein. This implies that secretion is dependent on the 
protein itself, either a sequence in the protein, or the structure of the 
protein. Tsonis and co-workers (1988) also suggest that there is a sequence 
in the protein that is required for secretion. Another report suggests that, 
since the signal sequence is removed during the passage of the protein 
into the lumen of the ER, it must be the protein itself that directs sorting 
in the golgi and not enough information within the heterologous protein 
could lead to misdirection (Robinson et al. 1988). This could also explain 
the reports by Lee and co-workers (1989) and Benson et al. (1985) of a 
nonsecretory protein fused to the signal sequence and coding region of a 
normally secreted protein not being secreted. 
1.7 Post-translational modification 
Proteins destined for secretion, for the cell surface, and for 
cellular destinations branching from the secretory pathway, fold and 
undergo significant co- and post-translational modification within the 
lumen of the endoplasmic reticulum. Some of these- modifications are 
almost universal; for example proteolytic cleavage of the hydrophobic N- 
terminal signal peptide, the formation of di-sulphide bonds, glycosylation 
of the Asn residues in the sequence -Asn-X-Thr(Ser)-, while others are 
specific for certain classes of protein, such as the hydroxylation of Pro and 
Lys residues in procollagens, and the y-carboxylation of Glu residues in 
blood clotting and other W+-binding proteins. Several of the enzymes 
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involved in these processes are integral proteins of the endoplasmic 
reticulum membrane, and this has limited their characterization. As a 
result, no detailed picture can be formed of the processes undergone by a 
newly synthesized protein in the stages between its translocation across 
the membrane and its exit from the endoplasmic reticulum lumenal 
compartment. These processes are complex and interdependent and 
include conformational changes (folding), covalent changes (post- 
translational modifications) and changes in quaternary interactions 
(assembly) (reviewed in Chou and Fasman 1978, Rossman and Argos 
1981, Chothia 1984). For example, insulin has two polypeptide chains that 
are linked by di-sulphide bridges, however, it does not display this 
structure at the moment of synthesis. Instead, the precursor is comprised 
of a single large polypeptide, proinsulin, which is subsequently cross- 
linked by intramolecular di-sulphide bridges and later modified by the 
removal of peptide segments (Steiner and Oyer, 1967). A further example 
is the cleavage of pepsinogen to yield pepsin, the principle proteolytic 
enzyme in the gastric juice of vertebrates (van Vunakis and Herriot, 
1956). 
Of these post-translational modifications one of the most 
common is N-glycosylation, the attachment of oligosaccharides to the 
polypeptide through an N-glycosidic bond (Montreuil 1982, Wagh and 
Bahl 1981). In animal glycoproteins, the carbohydrate is bound to the 
protein; either via the N-glycosdic linkage to asparagine or through the 
0-glycosidic linkage to serine, threonine or hydroxylysine and 
hydroxyproline. The N-glycosidic oligosaccharides fall into three classes; 
the high mannose, hybrid and complex type glycans. Each of them 
contains a core (Man)3(Glc NAc)2 that is bound to asparagine. The. core 
pentasaccharide is substituted in high mannose type glycans with 2-6 
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mannose residues and in complex type glycans with 
fructose and an 
antennae composed of sialic acid, galactose and N-acetyl glucosamine. In 
animal cells the 0-glycosidic glycans are usually bound via N-acetyl 
galactosamine to the peptide chain but mannose can also form this 
linkage. In S. cerevisiae the N-linked glycans are basically of the high 
mannose type however they are usually much longer than those of 
animal cells ranging from 8-100 residues. The processing of N-linked 
oligosaccharides in yeast differs greatly from that in animal cells. In S. 
cerevisiae the O-linked oligosaccharides are linked to serine or threonine 
and composed only of mannose. Reports indicate that many of the 
mammalian proteins heterologously expressed in yeast cells are over 
glycosylated and that there is some heterogenicity in the glycosylation 
states of the recombinant proteins (Innis et al. 1985, Rothstein et al. 1984, 
Smith et al. 1985). Byrd and co-workers (1982) suggest that S. cerevisiae 
lacks a Man8GlcNAc2 carbohydrate trimming enzyme. There is evidence 
that filamentous fungi glycosylate proteins in the same manner as 
animal cells. The N-glycosidic glycans in Trichoderma reesei resemble the 
high mannose chains of animal glycoproteins (Salovuori et al. 1987). 
The oligosaccharide moiety can have a significant effect on 
the physical/ chemical properties of the protein, including thermal 
stability and solubility (West 1986). The oligosaccharide moieties also 
affect the biological properties of the glycoprotein. For example it has been 
demonstrated in vivo that oligosaccharides (particularly terminal sialic 
acid groups) play an important role in defining the immunogenicity of a 
glycoprotein (reviewed in Feizi and Childs 1987 and Schauer 1988). 
Protein clearance in the circulatory system is primarily mediated by 
recognition of specific oligosaccharide moieties (for reviews see Ashwell 
and Hartford 1982, McFarlene 1983, also Hotchkiss et al. 1988, Fukuda et 
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al. 1989, Freedman 1989). Therefore, difference in oligosaccharide 
structure can dramatically influence the clearance rate of an injected 
glycoprotein. Certain oligosaccharides can determine the in vivo 
distribution and therefore the final destination of the protein. 
Thus clearly post-translational modifications play an 
important role in the structure and function of many proteins, many are 
species-specific, some are even cell specific. A recombinant protein will 
have, in many cases, non-physiological post-translational modification. 
The capability of the various host cells to perform these modifications 
varies phylogenetically. Bacterial cells being prokaryotic and 
evolutionarily the most primitive, are generally incapable of performing 
most post-translational modifications (Fieschko 1989). 
1.8 Gene transfer systems 
A gene transfer system is a prerequisite for the introduction 
of heterologous genes into an organism. There are many systems of gene 
transfer including; viral mediated systems used in plant cells, 
microinjection of DNA into oocytes and bombardment of cells with 
accelerated particles coated in DNA, but the most widely used system is 
transformation. In addition to introducing the heterologous gene into an 
organism, transformation also provides a useful tool to enable further 
understanding of the genetics of an organism. 
Certain organisms such as B. subtilis are naturally 
competent, that is they can readily uptake DNA, and consequently the 
understanding of the genetics of this organism is well advanced. Early 
attempts to achieve transformation in E. coli were unsuccessful and it 
was generally believed that E. soli was refractory to transformation. 
However, Mandel and Higa (1970) found that treatment with CaC12 
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allowed E. coli to take up DNA from bacteriophage X. The requirement 
for the treatment with CaC12 for transformation in E. coli is probably due 
to structural rearrangements in the cell wall which it mediates. 
Transformation of S. cerevisiae was first described by Hinnen and co- 
workers 1978 employing spheroplasts (wall free cells) and mediated by 
polyethylene glycol and CaCl2 
Most of the transformation systems used with bacteria and 
yeasts involve self-replicating plasmids based on naturally occurring 
plasmids or chromosomal replicons. However, naturally occurring 
plasmids are not common in filamentous fungi, a few have been isolated 
and transformation systems have been developed based upon these 
(Paietta and Marzluf 1985). However, the copy number of the self- 
replicating plasmids has been shown to remain at one per cell. The more 
usual method of transformation is where the DNA integrates into the 
chromosome often in multiple copies producing a higher gene dosage 
(Kelly and Hynes 1985, Beri and Turner 1987, Skatrud et at 1987). Higher 
gene copy number has been shown to increase the amount of gene 
product produced (Gwynne et al. 1987, Finklestein 1987). 
The first reports of integrative transformation in 
filamentous fungi were from Mishra and co-workers (1973), using 
inositol requiring auxotrophs of Neurospora crassa. The cell wall of the 
auxotrophs was supposed to be more permeable to the uptake of DNA. 
However, due to a high revertent rate of the auxotrophs their data was 
not conclusive. More definitive evidence was provided later, when the 
same workers showed that auxotrophic mutants when transformed with 
DNA from temperature sensitive cells also became temperature sensitive 
(Mishra 1979). The real break through came when the transformation 
protocols developed in S. cerevisiae (Hinnen et al. 1978, Beggs 1978), were 
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applied to N. crassa (Case et al. 1979) and A. nidulans (Tilburn et al. 1983, 
Ballance et at. 1983, John and Peberdy 1984, Yelton et at. 1984). Since then 
several types of transformation systems have been developed for many 
species of filamentous fungi (Table 1.3 and reviewed in Fincham 1989). 
There are basically three types of transformation system; those where 
auxotrophic mutants are complemented, those that permit growth on a 
substrate hitherto unavailable to the organism and those based on 
resistance to an antibiotic or toxin. Drug resistance is particularly useful 
in poorly genetically characterised fungi as the wild type strains can be 
used as recipients. The ability to transform wild type strains is especially 
important in the study of plant pathogens or industrial fungal strains, as 
random mutations in the genome may cause deleterious effects, such as 
drop in yield in production strains or changes in pathogenicity. 
Mutagenesis to auxotrophy may also cause disturbances to the general 
metabolism, which is not desirable in industrial strains or in the study of 
pathogens. However, using drug resistance as a means of selection for 
transformation means the introduction of a foreign gene, usually of 
bacterial origin, into the fungus. This may be a severe disadvantage as 
expensive and time consuming clinical trials may be required, before a 
product could be accepted for use in the food or pharmaceutical industry, 
particularly if the antibiotic is in clinical use. Additionally, many fungi 
have a natural resistance to antibiotics, for example A. oryzae is sensitive 
to phleomycin at 50 µg/ml but hygromycin at 5 mg/ml (Mattern and 
Punt 1988). 
Screening for auxotrophic mutants is often tedious and time 
consuming. There are however, a few systems with positive selection 
methods where an auxotrophic mutant leads to concomitant resistance to 
an otherwise toxic metabolic analogue; which allows large numbers of 
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Taille 1.3 Transformation selection systems for filamentous fungi 
System Organism Reference 
Acetate Aspergillus nidulans Turner et al. 1985, Ballance 
utilization & Turner 1986 
Acetamide Aspergillus nidulans Kelly & Hynes 1985, 
utilization Tilburn et al. 1983 
Aspergillus niger Kelly & Hynes 1985 
Aspergillus terrus Upshall 1986a 
Penicillium chrysogenum Beri & Turner 1987 
Cochliobolus heterotrophous Turgeon et al. 1985 
Adenine Neurospora crassa Alic et al. 1990 
auxotrophy Phanenchaete chrysogenum Alic et al . 1990 
Arginine Aspergillus nidulans John & Peberdy 1984, 
auxotrophy Johnstone 1985, Upshall et 
al. 1986 Upshall 1986b 
Aspergillus niger Buxton et al. 1985 
Aspergillus oryzae Hahm & Batt 1988 
Neurospora crassa Weiss et al 1985 
Inositol Neurospora crassa Feher et al. 1986 
auxotrophy 
Glutamate Neurospora crassa Kinsey & Rambosek 1984, 
auxotrophy Grant et al. 1984 
Methionine Aspergillus oryzae limura et al. 1987 
auxotrophy 
Nitrate Aspergillus nidulans Stewart & Vollmer 1986 
utilization 
Aspergillus niger Unkles et al. 1989a, 
Campbell et 'al. 1989 
Penicillium chrysogenum Whitehead et al. 1989 
Fusarium oxysporum Malardier et al 1989, 
Daboussi et al. 1989, Langin 
et al. 1990 
Colletotrichum lindemuthianum Daboussi et al. 1989 
Nectria haematcocca Daboussi et al. 1989 
Pyricularia oryzae Daboussi et al. 1989 
Aphonocladium album Daboussi et al. 1989 
Beauveria bassiana Daboussi et al. 1989 
Penicillium caseicolum Daboussi et al. 1989 
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Table 1, Transformation systems for filamentous fungi (continued) 
System Organism Reference 
Proline Aspergillus nidulans Durrens et al. 1986 
auxotrophy 
Quinic acid Neurospora crassa Case et al. 1979, Case 1982 
utilization 
Aspergillus nidulans Da Silva et al. 1986 
Tryptophan Aspergillus nidulans Yelton et al. 1984,1985 
auxotrophy 
Neurospora crassa Kim & Marzluf 1988, Case 
et al 1979 
Coprinus cinereus Binninger et al. 1987 
Penicillium chrysogenum Sanchez et al. 1987, Picket et 
al. 1987 
Uracil Aspergillus niger Goosen et al. 1987, van 
auxotrophy Hartingsvelt et al 1987 
Aspergillus nidulans Ballance & Turner 1985, 
Ballance et al. 1983 
Aspergillus oryzae de Ruiter-Jacobs et al. 1989 
Neurospora crassa Buxton & Radford 1983 
Penicillium chrysogenum Beri & Turner 1987, 
Cantoral et al. 1987, Diez et 
al. 1987 
Trichoderma reesei Smith et al. 1991, Gruber et 
al. 1990 
Podospora anserina Tudzynski et al. 1980, Perrot 
et al. 1987 
Benomyl Aspergillus nidulans Dunne & Oakley 1988 
resistance 
Neurospora crassa Orbach et al. 1986, Vollmer 
& Yanofsky 1986 
Gaeumannomyces graminis Henson et al. 1988 
G418 Neurospora crassa Bull & Wootton 1984 
resistance Ce halos orium acremonium Penalva et al. 1985 
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Table 1 3 Transformation systems for filame ntous fungi (Continued) . 
System 
[Organism 
Reference 
Hygromycin Aspergillus nidulans Cullen et al. 1987 
resistance 
Aspergillus niger Punt et al. 1987 
Cephalosporium acremonium Queener et al. 1985 
Fusarium oxysporum Kistler & Benny 1988 
Fulvia fulva Oliver et al. 1987 
Colletrotrichum lindemuthianum Rodriguez & Yoder 1987 
Ustilago maydis Leong et al. 1987, Wang et 
al. 1988 
Kanamycin Ustilago maydis Suarez & Eslava 1988 
resistance 
Oligomycin Aspergillus nidulans Ward et al. 1986 
resistance 
Aspergillus niger Ward et al. 1988 
Penicillium chr so enum Bull et al. 1988 
mutagenised cells to be screened. Mutants in orotide 5'-phosphate 
decarboxylase can be selected by growth on 5-fluro orotic acid, a 
compound toxic to strains with normal uridine metabolism. This system 
was first developed in S. cerevisiae (Boeke et al. 1984) and has been used 
to select for mutants in a variety of fungi (Table 1.3). Mutants defective in 
acetate utilization can be screened for in the same way through 
fluroacetate resistance (Apirion 1965) and lysine auxotrophs through a- 
aminoadipate resistance. Spontaneously arising mutants defective in 
nitrate reductase activity can be selected by growth on chlorate and 
characterized from other mutants in nitrogen metabolism by simple 
growth tests (Chapter 3). This system has been applied to a variety of 
fungal species (Unkles et al. 1989a, Malardier et al. 1989, Langin et al. 1990). 
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Another form of selection that does not require the 
generation of mutants is to transform the fungi with a gene which will 
allow it to grow on a novel substrate. One such system utilizes the A. 
nidulans amdS gene, encoding for the enzyme acetamidase (Hynes et al. 
1983). Acetamidase permits growth on medium containing acetamide as 
the sole nitrogen source. However, this method of transformation is 
limited as some fungi can naturally utilize acetamide. 
If the heterologous protein is to be used in the food or 
pharmaceutical industry the introduction of foreign DNA may cause 
expensive clinical trials to be required. This is one reason why a 
homologous transformation system employing genes from the same 
organism as a selection method, may be advantageous. Evidence also 
shows that homologous transformation systems are more efficient; 
giving a higher transformation frequency, ie: more transformants per gg 
of plasmid DNA (van Hartingsveldt et al 1987, Goosen et al. 1987, 
Campbell et al. 1989). This is thought to be due to the increased ability of 
the plasmid DNA to align with the homologous chromosomal DNA and 
integrate into the genome. There are three ways in which DNA can 
integrate into the genome first described in yeast by Hinnen and co- 
workers (1978) (Figure 1). Type I integration results in tandemly arranged 
genes with the vector sequence between, caused by homologous cross 
over between the incoming gene and the resident gene (Figure 1 A). This 
type of event may be called homologous additive integration. In Type II 
integration (Figure 1 B) there is no change in the vicinity of the resident 
gene as the plasmid vector has integrated else where in the genome. This 
occurs as a result of non-homologous recombination between the 
plasmid and the chromosome and is known as ectopic integration. Type 
III (Figure 1 C) integration results in no visible changes in the genome as 
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the resident gene is simply replaced by the incoming gene. All three types 
of integration profile have been observed in filamentous fungi. However, 
there is no clear evidence to say in what proportions these arise. In 
general ectopic transformation is more likely to arise in a heterologous 
transformation system and Type I and III integration events are more 
likely to occur in a homologous transformation system. (Goosen et al. 
1987, Campbell et al. 1989, Unkles et al. 1989ab). Kim and Marzluf (1988) 
reported that when N. crassa was transformed with linearized plasmid 
cleaved within the trpl gene only Type I transformants arose. However, 
they also reported differences dependent on the host strain of N. crassa 
used, and Yelton and co-workers (1984) reported no differences in the 
types of integration events with linear trp C DNA. 
Most fungal transformation systems are based on the 
generation of protoplasts, however some systems have been developed 
using electroporation (Richey et al. 1989) or high concentrations of 
alkaline metal ions, such as lithium chloride (Dhawale et at. 1984, 
Binninger et al. 1987) to induce permeability to DNA in intact cells. 
Usually protoplasts are generated by an enzyme preparation derived from 
T. viride, Novozyme 234, although some workers have used more 
characterised enzyme preparations. For example, to produce protoplasts 
in Coprinus cinerus, Binninger and co-workers (1987) used cellulase and 
chitinase. Protoplasts can be derived from a variety of fungal cells; 
conidia, young mycelium, basidiospores or oidia; choice seems to be a 
matter of convenience. Osmotic stabilizers also vary, the commonest 
choice is 0.8-1.2 M sorbitol but 0.8 M mannitol (Binninger et al. 1987), 0.6 
or 0.7 M sodium chloride (Ballance and Turner 1985, Diez et al. 1987, 
Picard et al. 1987) and 1.2 M magnesium sulphate (Tilburn et al. 1983) 
have also been used. The mechanism by which the DNA enters the 
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protoplasts is unclear but involves treating the protoplasts with DNA and 
calcium ions followed by a high concentration of polyethelyne glycol 
(PEG). The effect of PEG is to cause the cells to clump, which may facilitate 
the trapping of DNA. An alternative way of delivering DNA to the cells 
was devised by Radford and co-workers (1981). They encapsulated the 
DNA into liposomes and induced them to fuse with protoplasts. 
Various physical methods have been employed to improve 
the transformation frequency including; size fractioning the protoplasts 
to remove the larger vacuolate protoplasts and altering the time in 
Novozyme as presence of cell wall materials may effect the uptake of 
DNA (Shawcross et al. 1988). There have also been reports that purity of 
the plasmid is important in increasing transformation efficiency (Case 
1981, Shawcross et al. 1988). Johnstone and co-workers (1985) reported that 
bacterial sequences of some vectors can interfere with the uptake of DNA, 
a phenomenon also observed in tissue culture transformation (Lusky and 
Botchan 1981). Linearization of the plasmid DNA is reported to greatly 
increase transformation frequency in some cases (Dhawale and Marzluf 
1985, Skatrud et al. 1987, Wang et al. 1988, Campbell et al. 1989, Unkles et 
al. 1989b) although in others it is reported to have no effect (Yelton et al. 
1984). This effect seems to be dependent of the position of the cut; if the 
plasmid was linearized within the vector DNA no increase in 
transformation frequency occurred (Yelton et al. 1984). However, if the 
plasmid was linearized within the fungal DNA insert, but outside the 
gene transformation frequency increased (Campbell et al. 1989, Unkles et 
al. 1989b). 
In S. cerevisiae autonomously replicating sequences (ARS) 
have been shown to greatly increase transformation frequencies and 
many workers have searched for ARS in other species. However, no such 
25 
sequences have been found in filamentous fungi yet (Buxton and 
Radford 1984). Another sequence, ansl, from A. nidulans (Ballance and 
Turner 1985) has been shown to increase integration in pyrG 
transformations by up to 100 times. However, the effect of this sequence 
in other fungi is variable, from no effect in A. niger (van Hartingsveldt et 
al. 1987) to a three fold increase in P. chrysogenum (Cantoral et al. 1987). 
Wernars and co-workers (1986) deduce that the affects of the ansl 
sequence to be gene and location specific. 
In situations where a transforming gene cannot be selected 
for, it is possible to look for its entry along with a more readily selectable 
marker, a process called co-transformation, first exploited by Wernars and 
co-workers (1987). Co-transformation can be explained by the fact that not 
all protoplasts take up DNA as readily as others. Those that do take up 
DNA often take up more than one molecule simultaneously. Frequency 
of co-transformation seems to be dependent on the selection system and 
the species used. For example, co-transformation with the A. oryzae pyrG 
transformation system is around 25 % We Ruiter-Jacobs et al. 1989), where 
as using the niaD transformation system co-transformation efficiency 
reduces to only 4-9 % (Chapter 3, Unkles et al. 1989b) and using the niaD 
system in A. niger efficiency is 4-16 % (Campbell et al. 1989). However, 
changing the molar ratios of the two plasmids also seems to affect co- 
transformation efficiency. 
Thus it would appear to be advantageous from a point of 
view of expressing heterologous proteins if the transformation system 
used was homologous, efficient, did not cause disturbances in the general 
metabolism and if the recipient strain could be produced from an 
industrial strain without the use of general mutagenesis. 
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1 .9 Choice of host organism 
A multitude of different host organisms have been described 
for the expression of heterologous proteins. I have attempted to describe 
some of the advantages and disadvantages of these systems in the 
sections that follow. This does not attempt to be a comprehensive review 
of all heterologously expressed proteins in all organisms, but just to 
indicate the common advantages and failings of each group of organisms, 
and the rationale for selecting A. oryzae as the choice of host organism for 
this thesis. 
Heterologous expression in E. coli 
The first report of the designed heterologous expression of a 
eukaryotic gene was the production of the small peptide hormone 
somatostatin in E. coli (Itakura et al. 1977). The choice of organism in 
early recombinant DNA work was invariably this gram negative 
bacterium because the genetics of E. coli are well characterized and the 
regulation of expression is understood. Promoter elements from E. coli 
genes have been isolated and characterized and many have been used for 
heterologous protein expression. These include the constitutive 
lactamase promoter (Bernard and Helinski, 1980) or, more usually, 
regulated promoters; such as those from lac (Goeddel et al. 1979), trp 
(Nugent et al. 1983) and tac (Chernajovsky et al. 1983). Another advantage 
of E. coli is that it has a fast specific growth rate relative to mammalian 
and yeast cells. 
Many hundreds of heterologous proteins have been 
expressed in E. coli (reviewed in Harris 1983). However over produced 
foreign proteins tend to accumulate in the cytoplasm and form inclusion 
bodies; insoluble, amorphous aggregates containing not only the 
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heterologous protein but also many of the host proteins, DNA and RNA. 
Purification of the recombinant protein from these inclusion bodies is 
difficult, expensive and sometimes even impossible for large proteins 
(Schein 1989). These purification procedures and many other problems 
would be minimised if the protein was secreted from the cell into the 
media (Table 1.2). Some work has been done using the signal sequences 
from the secreted E. coli proteins; ß lactamase, membrane protein ompA 
and alkaline phosphatase coupled to heterologous genes (Villa-Komaroff 
et al. 1978, Ghrayeb et al. 1984, Lord 1985). Additionally, secretion has been 
achieved using the signal sequence native to the protein for example, 
urokinase (Jacobs et al. 1985) and human growth hormone (Gray et al. 
1982). Oka and co-workers reported the secretion of human epidermal 
growth factor into the periplasmic space using its native signal sequence 
(Oka et al. 1985), however this system is not always successful (Little et al. 
1989). 
There are further disadvantages in using E. coli as a host for 
the expression of heterologous proteins including, the production of 
pyrogenic lipopolysaccharides and the lack of cellular apparatus to 
perform post transcriptional modification. The lack of post 
transcriptional modification of products may lead to the formation of 
biologically inactive proteins as glycosylation, amidation and acetylation 
may be important for specific activity, protein recognition and clearance 
rate (Goochee and Monica 1990). Additionally incorrect processing may 
affect protein structure (West 1986). Prokaryotes such as E. coli cannot 
process eukaryotic introns or recognise higher eukaryotic transcriptional 
sequences. The codons used in mRNA coding for highly expressed genes 
are not random. There is a marked preference for particular codons. This 
codon selection preference is different in prokaryotic and eukaryotic 
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genes and may effect the translation, structure and thus the stability of the 
mRNA (Brown and Lithgow 1987, Ernst 1988a). The breakdown of 
heterologous protein by native proteases may also be a disadvantage in 
using E. coli as a host organism for heterologous expression (Little et al. 
1989). Additionally E. coli can be subject to lysogeny in large scale 
fermentation (Fieschko 1989). 
Heterologous expression in other bacteria 
Attention was thus turned to other organisms amenable to 
classical genetical analysis, such as the gram positive bacterium Bacillus 
subtilis. B. subtilis is naturally competent (Errington and Mountain 1990) 
and has been well characterised biochemically and genetically. The 
genetic map of B. subtilis has been determined (Henner and Hoch 1980). 
B. subtilis is a food grade organism and has F. D. A., G. R. A. S. status. It 
produces high yields of extracellular enzymes; 45 % of the world enzyme 
market is supplied by Bacillus exoenzymes (Volesky and Luong 1985), and 
has established fermentation procedures (Priest 1977) which makes it 
attractive for the expression of heterologous proteins. Several eukaryotic 
genes have been expressed and secreted by B. subtilis; including mature 
human growth hormone (Nakayama et al. 1988), interferon a (Schein et 
al. 1986, Wagner et al. 1989). However, secretion does not always occur 
and seems to be dependent on the protein, for example hBcAg and FMDV 
(Hardy et al. 1981) and membrane protein El from Semiliki Forest virus 
(Garoff et al. 1983) were not excreted. Errington and Mountain (1990) 
consider that this inconsistency in secretion is due to the nature of the 
secretion mechanism. They postulate that prokaryotic organisms have 
more stringent requirements for secretion than eukaryotes, and possibly 
need a more rigid maintenance of the unfolded conformation. This 
problem was overcome by Stephens and co-workers (1986) by the use of a 
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fusion protein. These workers fused native a-amylase to the human 
atriopeptin gene and produced recombinant protein at levels of up to 1g 
per litre of culture fluid. 
Other problems have also been encountered. For instance B. 
subtilis secretes high amounts of proteases which leave the heterologous 
proteins. This problem has been overcome by the use of protease 
defective mutants, where the protease gene has been cloned and 
inactivated (Kawamura and Doi 1984, Stahl and Ferrari 1984). However, 
minor residual proteases continue to remain a problem (Fahnestock and 
Fisher 1987). Another disadvantage of B. subtilis as a host organism is 
that its RNA polymerase is very specific and will not recognise ribosomal 
binding sites of even closely related organisms (Doi 1982, McLaughlin et 
al. 1981, Moran et al. 1982). Additionally, B. subtitlis, like E. coli, is a 
prokaryotic organism and therefore has limited post-translational 
modification of proteins. 
Exploitation of B. subtilis as a host organism for 
heterologous expression has been disappointing due to plasmid 
instability (Errington 1988), frequent deletion of cloned genes (Hahn and 
Dubnau 1985) and to lower levels of expression than might be expected 
(Errington and Mountain 1990). However, better results in terms of yield 
have been achieved with other bacilli and with the filamentous 
bacterium Streptomyces. For example B. lichenaformis, B. amylofaciens 
and B. stearothermophilis all show higher native protein secretion levels 
than B. subtilis. B. pumilis has been shown to be a more stable host for 
heterologoys gene expression than B. subtilis (Chen et al. 1989) and some 
success has been had with B. brevis (Takagi et al. 1989) and B. megaterium 
(Meinhardt et al. 1989). The sporulation characteristics of Bacillus species 
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Bacillus species are an additional disadvantage, however this has been 
nearly eliminated with the development of asporogenic strains. 
Streptomyces species also secrete relatively large amounts of 
proteins. S. albogriseolus S3253 can secrete up to 200 mg per litre of 
Streptomyces subtilisin inhibitor (SSI) (Koijma et al. 1990). Streptomyces 
are not pathogenic to man and have an established fermentation 
procedure as they are used for the large scale production of several 
secondary metabolites. Additionally Streptomyces recognise control 
regions of genes from a wide range of organisms. Recent reports indicate 
that Streptomyces may be a very useful host for the expression of 
heterologous proteins. Taguchi and co-workers (1989) report the 
expression of a sex pheromone from Enterococcus faecalis , in S. lividans 
at levels equal to native SSI. 
Heterologous expression in yeasts 
Saccharomyces cerevisiae has been utilized extensively for 
the expression of heterologous proteins; including mammalian proteins 
(reviewed by Kingsman et al. 1987) and proteins from animals (Mellor et 
al. 1983, Oberto and Davidson 1985), plants (Rothstein et al. 1984, Huang 
et 41.1990) and viral origin (Hitzman et 41.1981,1983, Kniskern et al. 1986, 
Miyanohara et al. 1983). Most of the genes expressed were cDNA copies as, 
despite being a eukaryotic organism, S. cerevisiae appears to be unable to 
process the introns from higher eukaryotic organisms (Beggs et 41.1980, 
Innis et al. 1985, Penttila et al. 1987), due to the absolute requirement for 
the sequence TACTAACA dose to the 3' end of the yeast intron. 
The majority of the systems developed for the heterologous 
expression of proteins in S. cerevisiae employ transcriptional control 
elements derived from strong promoters of the yeast glycolytic pathway 
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genes, alcohol dehydrogenase I (Williamson et al. 1980), endolase 
(Holland et al. 1981), glyceraldehyde-3-phosphate dehydrogenase (Holland 
and Holland 1979,1980) phosphoglucokinase (Hitzman et al. 1982) and 
pyruvate kinase (Burke et al. 1983). The limitations of these promoters 
rapidly became evident when the synthesis of heterologous products 
advanced from expression in small shake flasks to multilitre production 
plants. The promoters directed the synthesis of the products in a 
relatively unregulated way (reviewed in Shuster 1989); the heterologous 
gene was expressed at all stages of the yeast host growth. The negative 
effects of this unregulated expression often led to problems with the 
stability of the expressing cultures, due to selection against the expressing 
cells in culture. Regulated promoters have been derived from regulatory 
upstream control activation sequences, isolated from genes involved in 
carbon metabolism (Guarente et al. 1982), and also from genes involved 
in phosphate metabolism (Krammer et al. 1984, Lemontt et al. 1985) and 
the mating system (Brake et al. 1984, Zapf et al. 1981). 
The majority of heterologous proteins were produced 
intracellularly in S. cerevisiae. However, intracellular production often 
leads to the accumulation of insoluble proteins (Cousens et al. 1987) and 
the various problems outlined in Table 1.2. Some use has been made of 
the signal sequences from the native yeast proteins; a mating factor 
(aMF) (Brake et al. 1984, Barr et al. 1988, Payette et al. 1990), alkaline 
phosphatase (Hinnen et al. 1983, Smith et al. 1985, Chang et al. 1986, Sato 
of al. 1989). Also signal sequences native to the heterologous proteins 
have been employed; Mucor mehei aspartic protease (Hiramatsu et al. 
1989), human interferons (Hitzman et al. 1983), Aspergillus awamori 
glucoamylase (Innis et al. 1985) and wheat a-amylase (Rothstein et al. 
1984). However, expression has remained low compared to that of native 
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proteins. Sato and co-workers (1989) compared different signal sequences 
on human a-amylase and reported that secretion was dependent on the 
protein, not on the signal sequence. Smith and co-workers (1985) 
concluded that, S. cerevisiae is not an inherently efficient secretor and 
that the rate limiting step in secretion was either, transfer of protein 
through the endoplasmic reticulum into the golgi apparatus, passage- of 
protein through the golgi, or the addition of outerchain carbohydrates in 
the golgi. 
Occasionally, workers have reported incorrect processing of 
the amino terminus (Brake et al. 1984, Barr et al. 1988) and the carboxy 
terminus (Vlasuk et al. 1986). It has been suggested that S. cerevisiae 
contains insufficient dipeptidyl amino peptidase to process large amounts 
of foreign proteins (Brake et al. 1984). 
There have been several reports of S. cerevisiae 
hyperglycosylating foreign proteins (Ballou 1982, McKay 1987, Moonen et 
al. 1987, Van Arsdell et al. 1987). In animal glycoproteins, carbohydrate is 
bound to the protein either via the N-glycosidic linkage to asparagine or 
the 0-glycosidic linkage to serine, threonine or hydroxylysine and 
hydroxyproline. The N-glycosidic oligosaccharides can be grouped into 
three classes; the high mannose, hybrid and complex type glycans. Each of 
them contains a core (Man)3(Glc NAc)2 that is bound to asparagine. The 
core pentasaccharide is substituted in high mannose type glycans with 2-6 
mannose residues and in complex type glycans with fructose and an 
antennae composed of sialic acid, galactose and N-acetyl glucosamine. 
The O-glycosidic glycans of animal cells are usually bound via N-acetyl 
galactosamine to the peptide chain, but mannose can also form this 
linkage. In yeasts the N-linked glycans are basically of the high mannose 
type however, they are usually much longer than those of animal cells 
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ranging from 8-100 residues. The processing of N-linked oligosaccharides 
in yeast differs greatly from that In animal cells. In yeast the O-linked 
oligosaccharides are linked via serine or threonine and composed only of 
mannose. Several reports indicate that many of the mammalian proteins 
are over glycosylated in S. cerevisiae and that there is some heterogenicity 
in the glycosylation states of the recombinant proteins (Innis et al. 1985, 
Rothstein et al. 1984, Smith et al. 1985). Byrd and co-workers (1982) 
suggest that S. cerevisiae lacks a Man8GlcNAc2 carbohydrate trimming 
enzyme. Possibly as a consequence of this hypoglycosylation, many 
proteins cannot pass through the cell wall and remain trapped in the 
periplasmic space. There have also been reports of proteolysis of 
recombinant products in S. cerevisiae (Siegal and Brierley 1990, Stepien et 
al 1983). 
The codon bias in S. cerevisiae is often very pronounced and 
there is evidence that it could prevent efficient transcription (Bennetzen 
and Hall 1982). Egel-Mitani and co-workers (1988) report that codon usage 
effects the ability of the gene to compete for expression and Ernst (1988b) 
reports that changing rare codons for more common ones can increase 
translation efficiency two to three times. 
Thus S. cerevisiae has proved to be a disappointing host for 
the production of some heterologous proteins. In general internal 
production is high but secretion is very poor, as it seems that the 
secretion process is limiting (Smith et al. 1985). However, other yeasts 
naturally secrete more proteins than S. cerevisiae. Kluyveromyces lactis 
has produced higher levels of calf chymosin than S. cerevisiae (van den 
Berg et al. 1990). Transformation systems have been developed for 
Schwanniomyces occidentalis (Dohmen et al. 1989) and Yarrowia 
lipolytica (Nicaud et al. 1989). A report of heterologous expression of 
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tumour necrosis factor in Pichia pastoris describes levels reaching 
6- 10 g 
per litre (Sreekrisha et al. 1988). P. pastoris does not hypoglycosylate 
glycoproteins in the same excessive manner as S. cerevisiae (Grinna and 
Tschopp 1989, Tschopp et al. 1987). The P. pastoris genome has a tightly 
regulated highly expressed promoter, the alcohol oxidase I gene promoter 
(Cregg et al. 1989) and these workers feel that P. pastoris has a promising 
outlook for the expression of heterologous proteins. 
Heterologous expression in animal cells 
Mammalian tissue culture 
Mammalian tissue culture is used extensively for the 
production of monoclonal antibodies and the production of vaccines 
(Backer 1989). Heterologous genes are usually introduced via transfection 
with viruses such as SV40. However, mammalian tissue culture is not 
without its problems; it is technically difficult as the regulation of 
mammalian cells is not fully understood. There are over 300 different 
human cell lines listed in the American Type Culture Collection (ATCC 
Rockville, MD, USA) Cell line catalogue. However, only a few of these 
retain normal characteristics when immortalised (Crow 1989). Yet normal 
cells are required for producing FDA-approvable pharmaceutical products 
(Van Brunt 1989). Because of the difficulties in immortalising human 
cells most of the monoclonal antibodies produced arise from Chinese 
Hamster Ovary (CHO) cells (Parekh et al. 1989). There has also been 
concern expressed about using virus-infected human cells for the 
production of medical products. As some post-translational modifications 
are species and even cell type specific, the best guarantee that a 
heterologous protein produced is authentic is to use the natural cells of 
origin. This is usually not feasible because the cells cannot be 
conveniently cultured and other cell lines do not always produce 
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correctly processed product for example human protein C (Yan et al. 
1990). Mammalian cell culture requires expensive media constituents. 
van Leen and co-workers (1991) reported that the heterologous 
production of interleukin 3 in mammalian cells was 5-10 times more 
expensive than microbial production even if the same levels of 
heterologous protein could be achieved by the mammalian cells. 
Whole animals 
Processes using transgenic live stock to secrete proteins into 
biological fluids such as blood, milk, egg yolk/white are still in the 
developmental stages. DNA is introduced into the embryonic tissue or 
egg cells via microinjection (Hammer et al. 1985). Several proteins have 
been produced in transgenic animals including the human blood clotting 
factor IX in the milk of sheep (Clark et al. 1989), human urokinase (Meade 
et al. 1990) and tissue plasminogen factor (Gordon et al. 1989) in murine 
milk. As more is understood about the targeting of genes in mammalian 
systems an increase in transgenic livestock producing pharmaceutical 
products can be expected. 
Insect tissue culture 
The most widely used cell line in insect tissue culture is that 
of the Fall Army Worm, Spodoptera frugiperda, cultured ovary cells 
(Vaughn et al. 1977) used in conjunction with a Baculovirus expression 
system. Based on the late hyper-expressed gene, polyhydrin protein, the 
system is relatively easy to use, non-pathogenic to vertebrates or plants, 
and has eukaryotic post-translational modification (reviewed in Cameron 
et al. 1989). The expression levels of heterologous proteins produced by 
this system have reached native levels of the polyhydrin protein (50 % of 
total protein) (Luckow and Summers 1988, Miller 1988, Maiorella et al. 
1990). However, these levels seem to be dependent on the type of protein 
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produced, glycoprotein yields appear to be lower (Takehara et al. 1988, Hu 
et al. 1987). As with mammalian cell tissue culture the media required is 
complex; the most common containing 5-10 % calf serum, which 
produces purification difficulties. Additionally heterologous expression 
directed by a Baculovirus expression system occurs during lytic infection 
resulting in cell death. 
Whole insects 
Using the Silk worm virus Bombyx mori (Bm) NPV as a 
vector Maeda and co-workers (1985) achieved expression of interferon-y at 
30 mg per litre of silk worm haemolymph and 1.5-5 mg of wolf fish 
antifreeze protein has been produced in Drosophila (Rancourt et al. 1990). 
The purification of these proteins was complicated and expertise in insect 
rearing was required (Marumoto et al. 1987.. Maeda 1989). 
Heterologous expression in plant cells 
Methods to transform cultured plant tissues, cells and 
protoplasts include; transfer of DNA via the Ti plasmid of Agrobacterium 
tumefaciens and the Ri plasmid of A. rhizogenes, direct delivery of DNA 
into protoplasts using PEG or electroporation, microinjection, and 
bombardment with accelerated particles coated in DNA (reviewed by 
Gasser and Fraley 1989, Davey et al. 1989). Plant cell culture appears to be 
technically difficult, especially on a large scale as the plant cells are 
sensitive to mechanical, osmotic and nutritional stress in addition to 
temperature, pH and oxygen tension (Morris et at. 1985). Plant cell 
suspensions require a high inocculum density to obtain growth (10-30 %) 
and their clumped growth morphology creates problems in mixing and 
sampling. Plant cells are much slower growing than their microbial 
counterparts (1-4 weeks) thereby tying -up reactors and causing potential 
sterility problems (Morris et al. 1985). For these reasons, the only 
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molecule that has been produced, on a large scale, from plant cell culture 
is the homologous secondary metabolite, Shikonin (Vasil 1990). Whole 
plants have been transformed to be resistant to herbicides (Padgette et al. 
1989) insect attack (Vaeck et al. 1989, Delanny et al. 1989) and virus 
infection (Hemenway et al. 1989, Stark and Beachy 1989). A number of 
mammalian proteins have been expressed in plants (Eichholtz et al. 1987, 
Lefebvre et at. 1987, Barta et al. 1986. ) Additionally, a number of 
pharmaceutically active compounds have been produced in plants 
including enkephelins (Vandelekerckhove et at. 1989, Hiatt et al. 1989). 
The advances in plant genetic engineering will depend on regulatory 
approval, proprietary protection and public perception but could provide 
an economically attractive means of production of health care products 
(Gasser and Fraley 1989). 
The case for heterologous expression in filamentous fungi 
Filamentous fungi are eukaryotic organisms that can be 
grown and genetically manipulated with the ease of prokaryotic 
microorganisms. The genus Aspergillus is included in the class 
Ascomycetes and consists of a number of species that have been 
investigated at both the biochemical and genetic level. They have a 
relatively small genome size (2.6 x 107 bp), with low repetitive DNA 
content, which gives advantages over higher eukaryotes, by enabling 
simple DNA manipulation (Timberlake 1975). Filamentous fungi also 
secrete large amounts of native proteins and they represent a great many 
industrial important organisms (Table 1.4). The enzyme glucoamylase 
reaches levels that can exceed 20 g per litre of culture fluid and citric acid 
levels can reach 200 g per litre in fermentations of A. awamori and A. 
niger (Rambosek and Leach 1987). 
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Table 1.4 Industrial products of filamentous funeia 
Product 
[ Organism 
Organic adds-citric, Aspergillus niger, Aspergillus 
itaconic, gluconic terrus 
Vitamins-ß-carotene, riboflavin Blakeslea trispora, Eremothecium 
ashbyii, Ashbya gossypii 
Polysaccharides- Aureobasidium pullulans, 
pullulan, scleroglucan Sclerotium rolfsii 
Antibiotics-penicillin, Penicillium chrysogenum, 
cephalosporins griseofulvin, Cephlasporium acremonium, 
fusidanes Penicillium griseofulvin, 
Fusidium coccineum 
Plant and animal growth Gibberella fujikuroi, Gibberella 
hormones zeae 
Other drugs-alkaloids, cyclosporin Claviceps purpurea, Trichoderma 
polysporium 
Enzymes- 
cc-amylases Aspergillus niger, Aspergillus 
oryzae, Aspergillus awamori 
glucoamylase Aspergillus niger, Aspergillus 
awamori, Rhizopus sp. 
ß -glucanase Aspergillus niger 
cellulases Trichoderma viride, Trichoderma 
reesei 
Acid protease Aspergillus niger, Aspergillus 
oryzae, Mucor pusillus, Mucor 
miehei 
pectinase Aspergillus niger 
lipases Rhizopus sp, Mucor 
miehei, Aspergillus niger 
catalase As er illus niger 
39 
Table 1.4 Industrial products of filamentous fun¢ia (continued) 
Product Organism 
glucose oxidase Aspergillus niger, Penicillium 
amagasakiense 
lactase Aspergillus niger, Aspergillus 
oryzae 
invertase Aspergillus niger, Aspergillus 
oryzae 
fungal rennin Mucor miehei, Mucor pusillus 
Foods- 
mushrooms Agricus bisporus, Pleurotus 
ostreatus, Lentinus edodes, 
Volvariella volvacea 
oriental food fermentations Aspergillus oryzae, Rhizopus sp. 
mould-ripened cheeses Penicillium roquefortii, 
Penicillium camembertii 
Single cell protein Fusarium, Paecilomyces 
Bioconversions- 
steriod hormones Rhizopus sp., Fusarium solani, 
Aspergillus ochraceus, Cürvularia 
lunata 
6-amoinopenicillic acid Penicillium chrysogenum, 
Cephalosporium sp., Fusarium sp. 
Insecticides- 
colarado beetle control Beauveria bassiana 
aphid control Verticillium lecanii 
citrus mite control Hirsutella thompsonii 
spittle-bust control Metarrhizium anisovliae 
a: - from Bigelis (1985), Benett (1985), Montenecourt and Eveleigh (1985), 
Brown et al. (1987) 
As discussed earlier, post-translational modification, and in particular 
glycosylation, is important for the correct structure and function of many 
proteins (Section 1.6). There is evidence that filamentous fungi 
glycosylate proteins in the same manner as animal cells. The N-glycosidic 
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glycans in T. reesei resemble the high mannose chains of animal 
glycoproteins (Salovuori et al. 1987). It is not known yet whether 
filamentous fungi would recognise mammalian intron splicing signals, 
but this is an interesting possibility in view of the similarities of fungal 
introns to those of higher eukaryotes (Gurr et al. 1987). Furthermore, it 
has been shown that Schizosaccharomyces pombe, a fisson yeast which is 
thought to be phylogenetically closer to Aspergillus than to 
Saccharomyces (Ballance 1987) can accurately remove introns from a 
mammalian transcript (Kaufer et al. 1985). Additionally filamentous 
fungi and in particular the Aspergilli may not be as selective in codon 
usage as S. cerevisiae (Marauyama et al. 1986). It has been shown that 
T. reesei has very similar glycosylation and down stream processing 
patterns to mammalian systems (Salovuori et al. 1987). 
The selection of a host for heterologous expression is not 
straight forward as the available systems have their disadvantages as well 
as advantages. Selection of a system is dictated by convenience, cost, 
yields, type of protein and safety of the product. In some cases the need to 
produce a fully authentic product takes priority. For example, many of the 
blood proteins require complex post-translational modifications which 
may only occur in mammalian cells. The best guarantee that an authentic 
protein is produced is to use the natural cells of origin. This is usually not 
feasible because the cells cannot be conveniently cultured, and other cell 
lines do not always produce correctly processed product for example 
human protein C (Yan et al. 1990). Mammalian cell culture is difficult 
and, as previously discussed, requires expensive media constituents, thus 
the heterologous protein needs to be of high value to make the process 
economic. Despite all their disadvantages E. coli is the only organism 
licensed for the commercial production of recombinant proteins; insulin, 
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interferon a and human growth factor are in clinical use and interleukin 
2, interferon ß, interferon y and tissue necrosis factor are under going 
clinical trials (Ellis 1989). 
It is the intention of this project is to assess the usefulness of 
the filamentous fungi A. oryzae as a host for the expression of 
mammalian proteins. 
1.10 Heterologous protein expression in filamentous fungi: An overview 
Many workers are attempting to develop filamentous fungi 
as hosts for the expression of heterologous proteins (Table 1.5). Due to the 
commercial applications of many of the heterologous proteins, the exact 
levels of protein are often unpublished or obscure, for this reason Table 
1.5 is incomplete. For example Allelix Biopharmaceuticals are working 
on the expression of human proteins in Aspergillus nidulans. They have 
achieved secretion of epidermal growth factor, growth hormone and 
corticosteroid binding protein, but have not disclosed the quantity of 
proteins obtained (Devchaud and Gwynne 1991). A number of proteins 
have been expressed in filamentous fungi, however, levels of 
mammalian proteins still remain much lower than expected. It would 
appear that fungal and yeast genes when expressed heterologously in 
filamentous fungi are produced at much greater levels than mammalian 
proteins. The same conclusion holds for heterologous expression in yeast, 
heterologous mammalian proteins are generally produced in much 
smaller amounts than native proteins. Several explanations have been 
put forward for this phenomenon including, proteolysis of the product. 
Many workers consider that the foreign protein is recognised as such by 
the host proteases and is rapidly broken down. (Carrez et at. 1990, 
Turnbull et at. 1989, Ward et al. 1990, Barr et at. 1988). 
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Table 1.4 Heterologous Protein Expression in Filamentous Fungi 
Organism Protein Source Yielda Reference 
Aspergillus enterotoxin sub unit B Esherichia. not Turnbull et al.. 1989 
nidulans coli detected 
tissue plasminogen human 1 mg/l Upshall et al. 1987 
activator 
chymosin calf 1-2 mg/lb Cullen et al. 1987 
a-interferon human 1 mg/l Gwynne et al. 1987 
endoglucanase Cellulomas 20 mg/l Gwynne et al. 1987 
fimi 
aspartic protease Mucor NI Gray et al. 1986 
miehei 
interleukin 6 human 25 µ /i Carrez et al. 1990 
Aspergillus pancreatic ribonuclease rat NI Finkelstein et al. 
niger 1989 
lysozyme hen egg 12 mg/l Archer et al. 1990 
glucoamylase Aspergillus 3 g/l Finklestein et al. 
awamori 1986 
interleukin 6 human not Carrez et al. 1990 
detectable 
Aspergillus chymosin calf 14.6 mg/f Ward 1989 
awamori 140 m /l Ward et al. 1990 
Aspergillus aspartic protease Mucor 3.3 g/l Christensen et al. 
or zae miehei 1988 
Trichoderma chymosin calf 40 mg/l Harkki et al. 1987, 
reesei 1989, Knowles et al 
1987 
Achlya interferon y human NI Leung 1987 
ambisexualis Leun et al. 1987 
a: Yield expressed as amount of secreted protein per litre of culture fluid. 
b: Yield originally expressed as gg protein/g mycelia converted to m/1 on 
the basis that 1g dry weight mycelia is produced per litre of media 
c: yield increased to 100 mg/1 with mutagenesis and screening for over 
producers. 
NI: Data not included 
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As the amount of recombinant protein is often increased by the 
formation of a fusion protein (Marston 1986, Ward et al. 1990, Cousens et 
al. 1987), these workers suggest that it is the tertiary structure of the 
protein that makes it liable to proteolysis. However, fusion proteins also 
affect translation of the mRNA, the mRNA configuration and therefore 
the mRNA stability, which could also affect the amounts of protein 
expressed. There are also reports of the termination of transcription 
affecting the RNA stability (Mellor et al. 1983, Zaret 1984). Other workers 
suggest that inefficient secretions allow the proteins to be in contact with 
internal proteases ý for too long (Rothstein et al. 1984). The inefficient 
secretion could be caused by the recombinant protein not having enough 
information to facilitate correct sorting (Smith et al. 1985). This is 
supported by evidence that heterologous proteins from closely related 
organisms are produced in high amounts. 
1.11 Proteases in A. oryzae 
Proteases of microbial origin have a wide industrial usage. 
They are extensively used in the food industry, for such purposes as to 
condition dough and to improve the texture and colour of crusts in the 
baking industry; 30 % of all the bread eaten, in the USA is treated with 
proteases of microbial origin (Khosrovi and Gray 1985). In the brewing 
industry, proteases are used for reducing the haze in beer and proteases 
are also used in cheese making, meat tenderizing and improvement of 
the available nutrition in animal feed stuffs (Lyons 1988). The use of 
protease in food manufacture is not a recent development; fungal 
proteases have been traditionally used in oriental fermentations for 
thousands of years. Proteases are also used in tanning leather and in the 
manufacture of biological detergents. Additionally fungal proteases have 
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clinical usage; proteases from A. oryzae and A. awamori have been found 
to have a fibrinolytic activity and may be of use in the treatment of 
thrombosis (Larsson et al. 1988). 
There are many ways of classifying proteases but the most 
common is that based on Hartley (1960) and improved by Barrett (1986). 
In this method proteases are classified according to their mode of action, 
determined by their sensitivity to inhibitors. This method is used as 
standard by the Enzyme Commission. The four different types of 
enzymes overlap with other classification methods for example, aspartic 
proteases tend to have a pH optimum in the acidic range, 
metalloproteases operate best at neutral pH and serine protease at 
alkaline pH values. 
Most aspartic proteases have a broad specificity but 
preferentially hydrolyze peptide bonds between two bulky amino acids. 
There is amino acid sequence homology between fungal aspartic 
proteases and mammalian aspartic proteases suggesting a common 
ancestry (Tang 1979). Aspartic proteases are generally produced by fungi 
that acidify the media as many enzymes are unstable at pH values above 
neutral (Matsushima et al. 1981) Milk clotting enzymes belong to this 
group. Fungal enzymes such as the aspartic protease produced by M. 
mehei cleave casein between the Phe-Met bond in the same manner as 
does rennin. 
There have only been a few examples of metalloproteases 
reported in fungi, mainly based on the zinc ion. Some workers have 
suggested that this group is in fact 2 sub-groups, as a group of 
metalloproteases characterized by low molecular weight (19-20 kDa) and 
slightly acidic pH optima (pH 5-6) has been found in contrast to those that 
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operate best at neutrality and have a molecular weight around 41 
kDa 
(Gripon et al. 1980). 
Non acid producing fungi tend to secrete high levels of 
serine protease (Matsushima et al. 1981). Fungal serine proteases are 
found to have a molecular weight between 18.5 and 35 kDa, usually 
around 25 kDa. They are sometimes glycosylated and generally have a 
broad specificity (North 1982). The occurrence of cysteine proteases in 
fungi is very low. Although an extracellular enzyme that was inhibited by 
thiol reagents and enhanced by reducing agents has been reported in A. 
oryzae (Kandu and Mana 1975). 
Generally it is the P1 site that is most important in 
determining protease specificity. However, this may not be the case for 
fungal proteases, Lida and co-workers (1988) report that the serine protease 
from A. sojae has low recognition specificity towards the side chain of the 
P1 position of amide substrates. Majima and co-workers (1988) report that 
aspartic proteases of fungal origin have different specificities to animal 
proteases. They also suggest that it is the P4 position that is the most 
important in aspartic proteases, as this enzyme cannot hydrolyse small 
synthetic peptides. However, specificities may change according to 
environmental conditions, different pH optima are exhibited by the same 
enzyme when challenged by different protein substrates (North 1982). 
Poulsen and Hau (1986) report that one enzyme can be active at two 
different pH. 
Proteases are synthesized in inactive forms rapidly, in 
response to de-repression and in some cases protein induction. Cohen 
(1973a) reports that fungal protease production occurs in response to 
starvation to any one of carbon, nitrogen or sulphur. In a further study he 
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observes, that in A. nidulans an external source of protein is not required 
(Cohen 1973b). However, induction by protein is necessary for protease 
production in N. crassa (Hanson and Marzluf 1975), A. nidulans (Gill and 
Modi 1981), A. niger (Pourrot et al. 1988) and Microsporum canis 
(O'Sullivan and Mathieson 1971). Evidently this requirement is strain 
specific. 
In A. oryzae there are at least five extracellular proteases. A 
serine protease molecular weight 29 kDa which has a pH optimum of 10.5 
(Nakadai et al. 1973a). Two metalloproteases; neutral protease I which has 
a molecular weight of 41 kDa and a optimum pH of 7.0 (Nakadai et al. 
1973b) and neutral protease II a 19.3 kDa protein with an optimum pH of 
5.5 to 6.0 (Nakadai et al. 1973c), leucine aminopeptidase III, optimum pH 
8.0 (Nakadai et al 1973d), and an acid protease (Davidson et al. 1975). A 
mutant has been selected for in A. nidulans that is deficient in all three of 
its external proteases (Cohen 1973a), indicating that these proteases are 
not required for normal growth. 
Degradation of heterologous products by extracellular 
proteases is not a desirable feature in a host organism, thus it is the aim of 
this project to minimise this. It is my intention to study the effect of the 
proteases of A. oryzae on recombinant proteins and if necessary to 
develop a protease defective or protease reduced mutant and to assess its 
usefulness in the expression of recombinant products. 
1.12 Mammalian protein - Human interleukin 6 
Human interleukin 6 (hIL6) is a multifunctional cytokine, 
originally identified as interferon ß2 (Zilberstein et al. 1986). It has been 
described under several other names including; B cell stimulation factor 
(Hirano et al. 1986), B cell hybridoma/plasmacytoma growth factor (van 
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Damme et al. 1987, Tosato et at. 1988), hybridoma growth 
factor (Aarden 
et al.. 1985) and hepatocyte stimulating factor 
(Gauldie et al. 1987). It 
affects the function and proliferation of many cells including; B cells 
(Tosato et al. 1988), T cells (Lownthal et a!. 1989), fibroblasts (Haegman et 
al. 1986), nerve cells (Satoh et al. 1988) and hepatocytes (Gauldie et al. 
1987). It is produced in response to a variety of noxious stimuli such as 
tissue injury and bacterial infection (Helfgott et a!.. 1987) or to viral 
infection (Ray et al 1988), or in response to inflammatory lymphokines 
derived from interleukin 1 and tumour necrosis factor (Kohase et a!. 
1987). When produced hIL6 has pleotrophic functions (Kishimoto and 
Hirano 1988), in the liver it negatively regulates the expression of 
albumen and stimulates the expression of several genes including, the 
acute phase reactants, al-antichymotrypsin, heptoglobulin, haemopexin, 
a2-macroglobulin, complement factor B, al-acid glycoprotein and C 
reactive protein. (Bauman et al. 1987, Gauldie et al. 1987, Castell et al. 
1988, Morrone et al. 1988). Thus hIL6 plays a major role in inflammation 
and remodelling of tissues. hIL6 has been identified as the major inducer 
of liver specific gene expression during inflammation (Gauldie et al. 1987) 
and is produced by a variety of cells including; fibroblasts, lymphocytes, 
promelocytes and macrophages (reviewed by Kishimoto and Hirano 1988, 
Hirano et al. 1990). 
The molecular weight of hIL6 is between 23-30 kDa, with at 
least five different molecular weight proteins being recognised. The three 
largest of these proteins are not produced in the presence of tunicamycin 
suggesting that they are glycosylated (May et al. 1988). It would appear that 
only a small fraction of the molecules are N-glycosylated, despite there 
being two N-glycosylation sites at positions 46 and 145. The number of 0- 
linked carbohydrate side-chains per molecule and the exact binding of 
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sialic acid remains unknown (Gross et al. 1989). In addition to the two 
potential N-glycosylation sites in the protein sequence of hIL6 there are a 
number of cysteine residues suggesting that di-sulphide bond formation 
may play a part in the folding of this protein (Hirano et al. 1986). The gene 
is situated on human chromosome 7 (Sehgal et al. 1986) and has 4 introns 
(Zilberstein et al. 1986, Yasakawa et al. 1987). The protein is synthesized as 
a 212 amino acid precursor from which a 34 amino acid signal sequence is 
cleaved (May et al. 1988). The protein has been expressed in mammalian 
and bacterial cells (Zilberstein et al. 1986, Hirano et al. 1986, Brakenhoff et 
al. 1987, May et al. 1988, Seigal et al. 1988,1989,1990), however it has been 
difficult and expensive to purify. 
It has been suggested that the different forms of hIL6 are 
actively regulated by a series of controlled post translational 
modifications, which could determine the activity of this protein. For 
example, some workers synthesized hIlb in mammalian cell lines and 
expressed a protein that had a high antiviral activity but a weak effect on 
B cells (Zilberstein et al. 1986). However, other workers produced a 21 kDa 
protein in E. coli that had no antiviral action but a strong effect on B cell 
activity (Hirano et al 1986). Thus the structure and glycosylation state of 
this protein are of paramount importance to its activity. Jambou and co- 
workers (1988) report that certain hIL6 activities are altered if cysteine 
residues are removed to maximise protein expression in bacteria. Oka 
and co-workers (1985) made an unsuccessful attempt to secrete hIL6 in E. 
coli using the pho A signal sequence. 
Further detailed investigations of the multiple functions of 
hIL6 depends on the availability of a pure and biologically active product, 
hIL6 also has future implication in medical usage for vaccines, 
immunostimulents and, when linked to a toxin, immunosuppressents. 
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(Smith 1989). The hIL6-toxin conjugate may also be of use in the 
treatment of myelomas, cervical cancers, cardiac myxomas and bladder 
carcinomas (Seigal et al. 1988). Since these tumour cells produce a high 
concentration of hIL6 receptors. There is also some evidence to show that 
topological application of hIL6 may promote wound healing, especially in 
immunosuppressed patients (Pierce et al. 1989). 
A recent report (Guisez et al. 1990) details the production of 
hIL6 in the yeast S. cerevisiae. The protein is secreted but not glycosylated, 
which may be of importance to its function. It is the intention of this 
study to attempt to produce this valuable protein, in an active state in A. 
oryzae and to assess whether this organism can process the protein 
correctly. 
1.12 Aims 
The focus of this thesis is to assess the suitability of A. oryzae 
for the high level expression a mammalian protein such as hIL6. To 
achieve this aim I intend to: - 
(A) Develop methods of gene transfer for A. oryzae that will enable 
introduction of the hIL6 gene in an efficient way. In this regard, I shall 
assess the usefulness of transformation systems developed for A. oryzae 
and certain other filamentous fungi and attempt to develop a 
homologous transformation system. 
(B) Isolate and study the effects of the promoters and signal sequences of 
several highly expressed native genes both induced and constitutive on 
the expression and secretion of hIL6 in A. oryzae. 
(C) Study the production of the extracellular proteases of A. oryzae and 
their effects on heterologous protein production and attempt to generate 
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a protease reduced strain that will protect against proteolysis of the hIL6 
protein. 
(D) Using the efficient methods and protease reduced strains that I 
propose to develop and expression cassettes employing the control 
regions isolated I hope to achieve expression of biologically active hIL6 in 
A. oryzae. 
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(A) Type I Integration 
(B) Type II Integration 
plasmid 
chromosome 
chromosome 
Plasmid sequences integrated into 
chromosome 
............ ................. ............ ................. 
Integration elsewhere in genome 
chromosome 
(C) Type III Integration 
plasmid 
homologous gene replaced 
Figure 1.1 Transformation integration type (Hinnen et al. 1978) 
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chromosome 
Chapter 2 
Materials and methods 
2.1 Plasmids and strains 
2.1.1 Bacterial strains: E. coli strains used for the maintenance and 
propagation of plasmids were: 
E. coli JM101 supE thie (lac-proAB) F [traD36 proAB+ lac19 lacZ 
AM15] (Sambrook et al, 1989) 
E. coli DH5 supE44 hsdRl7 recAl endAl gyrA96 thi-1 relAl 
(Sambrook et al, 1989). 
E. coli DHSa supE44, AlacU169, (480 lacZ AM15), hsdR17, recAl, 
endAl, gyrA96, thi-1, relAL. (Sambrook et al., 1989). 
The host strain for bacteriophage ). gtlO propagation was: 
E. coli NM538 supF hsdR trpR lacY (Sambrook et al, 1989) 
These strains were stored in glycerol at -70 °C. 
2.1.2 Fungal strains: The A. oryzae wild type strain IMI144242 (=ATCC91002, 
a-amylase over producing) was used for mutant selection. Mutants were 
designated the following strain numbers: - 
Strain number Mutation Source 
AO1.1 niaD14 This work, Chapter 3 
SAO200 prtAl This work, Chapter 9 
SAO201 prtAl, pyrG2 This work, Chapter 4 
SA0202 prtAl, pyrG3 This work, Chapter 4 
SA0203 prtAl, pyrG4 This work, Chapter 4 
SA0204 prtA2, niaD14 This work, Chapter 9 L 
A04.1 pyrGlniaDl4 Mattern et 41.1987 
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A. oryzae strains 1560-6 (NOVO Industries, Denmark) an a-amylase over 
producing, arg B- mutant and YTH-13 (argB-) from Dr. C. A. Batt, Cornell 
University, New York were used for arg B transformations. 
2.1.3 Vectors: The vectors used in this work are outlined below. 
lasmid gene marker source 
pSTA8 A. nidulans nitrate Johnstone et al. 
nitrate reductase utilization 1990 
pSTA10 A. niger nitrate nitrate Unkles et al. 
reductase utilization 1989a 
pILJ16 A. nidulans argB arginine Johnstone et al. 
auxotro h 1985 
plLJ141 A. nidulans nitrate Johnstone et al 
nitrate reductase utilization 1989 
p3SR2 A. niu la ns acetamide Kelly and Hynes 
amdS utilization 1985 
pANS-1 E. coli phleomycin van den Hondel, 
phleomycin resistance TNO 
resistance linked Laboratories, 
to A. nidulans pers. comm. 
promoter 
pSTA13 A. oryzae nitrate nitrate Unkles et al 
reductase utilization 1989b and 
Cha ter 3 
pSTA14 A. oryzae nitrate nitrate Unkles et al 
reductase utilization 1989b and 
Chapter 3 
pFGA2 A. niger Carrez et al. 1990 
lucoam lase 
pSTA1000 A. oryzae This work, 
glucoamylase Chapter 6 
pSTA15 DHFR gene Methotrexate Unkles 
linked to A. resistance University of St. 
niger niaD Andrews pers. 
promoter comm. 
pGA3L DHFR gene Methotrexate Contreras, 
linked to A. resistance University of 
nidulans glaA Gent, pers. 
promoter comm. 
HW300 A. oryzae a- Christiansen et 
amylase cDNA al 1988 
pA04-2 A. oryzae pyrG uridine de Ruiter-Jacobs 
auxotro h et a11989 
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lasmid gene marker source 
pFGA3HIL6TArg hIL6 gene and 
Arginine Contreras, 
signal sequence auxotrophy University of 
linked to A. Gent, pers. 
nidulans comm. 
glucoamylase 
promoter 
pFGA5HIL6T2Arg hIL6 gene linked Arginine 
Contreras, 
to A. nidulans auxotrophy University of 
glucoamylase Gent, pers. 
promoter and comm. 
signal suence 
pFGA6F11L6T2Arg hIL6 gene linked Arginine Contreras, 
to A. nidulans auxotrophy University of 
glucoamylase Gent, pers. 
promoter, signal comm. 
sequence and 
pro peptide 
pSTA1001 A. oryzae This work, 
alkaline protease Chapter 9 
pSTA1002 A. oryzae This work, 
alkaline protease Chapter 9 
mutant 
pSTA1003 A. oryzae This work, 
alkaline protease Chapter 9 
mutant 
pSTA900 A. oryzae This work, 
cc-amylase Chapter 7 
pNOM102 A. nidulans gpd- ß-glucuronidase Roberts et al 1989 
E. coli uidA production fusion construct 
pBT3 N. crassa tu b2 benomyl Orbachet al. 1986 
resistance 
pAOML61 hIL6 gene linked acetamide Broekhuijsen, 
to A. nidulans utilization TNO 
gpdA promoter Laboratories 
pers. comm. 
pAOHIL63* hIL6 gene acetamide Broekhuijsen, 
linked to A. utilization TNO 
nidulans gpdA Laboratories 
promoter pers. comm. 
pGLAhIL6T hIL6 gene linked Contreras, 
to A. niger University of 
glucoamylase Gent, pers. 
comm. 
pSp64GcML6 hIL6 Contreras, 
University of 
Gent, pers. 
comm. 
pGPDGLAhIL6T hIL6 gene linked Contreras, 
to A. niger University of 
glucoamylase Gent, pers. 
and gpdA comm. 
promoter 
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Additionally pUC13, pUC18 and pSU20 were used for ligations. 
2.2 Chemicals and equipment 
Chemicals of at least Analar grade were purchased from BDH or SIGMA 
chemical corporation (unless indicated otherwise), media components were 
metabolites and salts purchased from SIGMA or Lab M, as general purpose 
reagents and agar was obtained from BDH. Novozyme 234, batch number 
PPM2415 was provided by Novobiolabs, Novo Industri, A/S DK 2880 
Bagsvaerd, Denmark. Restriction enzymes and DNA modifying enzymes 
were purchased from Northumbria Biologicals Ltd. plc. or Boehringer 
Corporation Ltd. with the exception of CP ligase and Ba131 which were 
obtained from Pharmacia. Radioisotope was supplied by ICN Biomedicals 
Inc. 
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Centrifugation: Protoplast manipulations were performed using the MSE 
benchtop centrifuge with a swing out rotor. Large scale, medium and low 
speed centrifugation utilized the Sorvall models RC-5B or RC-5C (DuPont) 
and the Wifug 500E. For caesium chloride gradients the Sorvall ultra- 
centrifuge with a fixed angle rotor was employed. Bacterial phage lambda 
DNA was prepared using a Beckman ultra-centrifuge with swing out rotor 
SW45. Small scale centrifugation (less than 1.5 ml) was performed using a 
MSE microcentaur microfuge. 
Shaking cultures: Conical flasks (unbaffled) from Gibco were used in a New 
Brunswick Scientific controlled environment incubator shaker (model G25). 
The liquid media used, time of incubation and temperature were varied 
according to the type of experiment. 
Spectrophotometery: Absorbance was measured with a Pye Unicam SP6-500 
UV/VIS spectrophotometer. 
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pH measurements were made using a Pye Unicam pH meter model 
292MK2. 
Lyophilization of protein and RNA samples and removal of ethanol from 
nucleic acid preparations was carried out using the Edwards Pirani 501 
freeze dryer. 
Electrophoresis was carried out in horizontal gel rigs (models H4-H6) 
purchased from Bethesda Research Laboratories (BRL) with power supplied 
from ATTA, AE3121 or ST1082 models. Gels were stained with ethidium 
bromide and viewed using a transilluminator (Ultraviolet products Inc. 
model TM40). Photographs were taken with a Polaroid MP4 Land Camera 
using dark slides or Polaroid film. Acrylarnide gel electrophoresis used a 
Biorad vertical gel rig, PROTEAN II Slab Cell. Gels were stained with either 
Coomassie Blue G250 or monochromatic silver staining (Wray et al.. 1981). 
HPLC protein purification: S1 nuclease (Sigma) was passed down an 
Brownlee reverse-phase 300 cartridge or anion exchange column, AX300, 
using a spectraphysics sp88000 ternary HPLC pump and a Waters Mode 1441 
absorbance detector. Alternatively a Applied Biosystems FPLC was used. 
Blotting: Agarose gels were prepared, with appropriate solutions, by gentle 
shaking utilizing a Rotatest shaker (Luckham, model R100). Nucleic acids 
were transferred to nitrocellulose (Hybond C) or nylon membrane (Hybond 
N) from Amersham. Protein was transferred to nitrocellulose (0.2µm) 
(Scheicher and Schull, BA83) using the Mutliphor II Nova Blot system, LKB 
2117-005/250. 
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Autoradiographs were performed using Fuji RX or Kodak XAR5 X-ray film 
and films were processed by a Fuji (RGU) X-ray film processor. 
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2.3 Media and Qrowth conditions 
2.3.1 Bacterial 
Luria Broth (Maniatis et al. 1982): 
1% Tryptone 
0.5 % Yeast extract 
1% NaCl 
adjusted to pH 7.5 with NaOH 
SOC (Maniatis et al. 1982): 
2% Tryptone 
0.5 % Yeast extract 
10 mM MgC12 
10 mM MgSO4 
2.5 mM KC1 
5 mM NaCl 
20 mM Glucose (filter sterilized) 
adjusted to pH 7.5 with NaOH. 
All phage manipulations used NZYDT media (BRL) at the recommended 
concentration of 21 g/1 
2.3.2 Fungal 
Media: (modified from Cove, 1966 and Clutterbuck, 1974) 
Salt solution: 
20.8 g KCL 
20.8 g MgS04.7H20 
60.8 g KH2P04 
add dH2O to 11 
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Hunter's Trace elements solution (Hunter et al., 1950) 
1.1 g Na2MoO4.2H20 
11.2 g H3B04 
1.6 g CoC12.6H20 
1.6 g CuSO4.5H20 
5O g EDTA 
5.0 g FeSO4.7H2O 
5.0 g MnCl3.4H20 
22.2 g ZnSO4.7H20 
made up to 11 with dH2O, heated to boiling, cooled to 60 °C and pH adjusted 
to 6.8 with IM KOH. Storage was in the dark at 4 °C. 
Vitamin solution: per litre 
1.5 g Aneurine 
2.5 g Biotin 
2.5 g Nicotinic acid 
20.0 g Choline HCL 
0.8 g p-amino benzoic acid (PABA) 
1.0 g Pyridoxine HCL 
2.5 g Riboflavin 
2.0 g Pantothenate (Ca salt) 
Minimal media: 
10 g D-glucose 
25 ml Salt solution 
I ml Trace element solution 
1 ml Vitamin solution 
made up to 11 with dH2O and the pH was adjusted to 6.5 with NaOH. 
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Complete media: 
10 g D-glucose 
2g Mycological peptone 
Ig Yeast extract 
Ig Casein hydrolysate 
25 ml Salt solution 
1 ml Vitamin solution 
1 ml Trace element solution 
made up to l1 with dH2O and the pH was adjusted to 6.5 with NaOH. 
Nitrogen sources were made to 1M stock solutions and added at the 
following final concentrations: 
Ammonium tartrate 10 mM 
Ammonium nitrate 10 mM 
Acetamide 10 mm 
Glutamate 5 mM 
Additional supplements required for growth were filter sterilized and added 
at the following final concentrations: 
Arginine lo mm 
Uridine lo mm 
Ampicillin was made as a stock solution, 10 mg/ml in 10 mM Tris: HC1 pH 
7.5 and added when required to a final concentration of 10 gg/ml. 
Chloramphenical was made up in 96 % ethanol as a1 mg/ml stock solution 
and added to media as required to 20 µg/ml final concentration. Stock 
solutions of antibiotics were stored at 4 °C and were viable for at least 2 
weeks. 
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All the above solutions were sterilized by autoclaving at 120 °C, 15 pounds 
per square inch, for 20 minutes, except for heat labile solutions which were 
filter sterilized using a 0.2 µm Dynaguard filter (Microgon) 
2.4 General techniques 
2.4.1 Tris saturation of phenol 
A quantity of 500 ml crystalline phenol was melted at 60 °C and 
0.1 % hydroxyquinoline added in order to prevent oxidation. Extractions 
with 500 ml of 1M Tris HCl pH 8.0 were conducted in a separating funnel 
until the aqueous phase became dear and the pH of the phenol was pH 8.0. 
Finally, two extractions with 0.1 M Tris HCl pH 8.0 were performed before 
the phenol was stored at 4 °C, overlaid with 0.1 M Tris HCl pH 8.0. 
2.4.2 Preparation of phenol : chloroform 
The chloroform contained 4% (v/v) iso amyl alcohol (IAA) to 
permit separation of the phases. The phenol and chloroform were mixed in 
the appropriate ratio well before use to allow clearing. 
2.4.3 Deionisation of formamide 
To every 100 ml of formamide to be deionised 25 g of amberlite 
monobed resin was added. The mixture was stirred in the dark for 30 
minutes and filtered twice through Whatman No. 1. Storage was in the 
dark at -20 °C. 
2.5 E. coli techniques 
2.5.1 Preparation of competent cells and DNA transformation. 
Competent cells were prepared according to the method 
described by Hanahan (1983). 
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A single colony of the appropriate strain of E. coli was 
inoculated into 5 ml Luria and grown overnight at 37 °C, 200 rpm. This 
culture was subsequently used to seed 100 ml of Luria broth, at 100 x 
dilution, This was grown as before until cell density at O. D. 600= 0.1-0.2 (for 
recA- strains this corresponds to 1-2 x 107 cells/ml). Cells were chilled on ice 
for 10 minutes and pelleted rapidly at 10 k rpm, 4 °C, 10 seconds in the 
Sorvall GS3 rotor. The resulting pellet was resuspended gently in 25 ml of 
ice cold 100 MM MgC12. This protects the transforming DNA from bacterial 
DNases. The cells were pelleted as before and resuspended in 25 ml of ice 
cold 100 mM CaC12 and kept on ice for at least 15 minutes. The positively 
charged calcium ions act as an attractent for the negatively charged DNA 
during transformation. Cells were pelleted as before and resuspended in 5 
ml ice cold 100 mM CaC12,14 % v/v glycerol solution. The cell suspension 
was then aliquoted in 200 µl volumes into precooled microfuge tubes. These 
were stored at -70 °C and were viable for at least one month. 
An aliquot of cells were thawed on wet ice and added to a 
precooled microfuge tube containing the DNA sample, in a volume not 
greater than 10 µl. After mixing gently, the reaction was left on ice for 20 
minutes and then heat shocked by incubating at 42 °C for 45 seconds and 
then returned to ice for 2 minutes. SOC was added to 1 ml and the cells were 
incubated at 37 °C for 1 hour to allow full expression of antibiotic resistance. 
Cells were serially diluted and spread (maximum volume 200 µl) onto Luria 
agar containing antibiotic to estimate transformation efficiencies which was 
normally approximately 107 transformants per µg of DNA. 
Several plasrnid vectors, in addition to the antibiotic resistance 
gene, contain the E. coli lacZ gene, encoding for ß-galactosidase. The 
transformation of such a vector into a lac- bacterial strain, for example 
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JM101, will yield blue colonies on plates containing 250 µg/ml isopropyl ß- 
thiogalactoside. (IPTG), 250 µg/ml 5-Bromo-4-Chloro-3-indolyl-ß-D 
galactoside (X-gal) and the appropriate concentration of antibiotic. The 
antibiotic selects for transformed bacteria, IPTG induces the expression of 
the 1acZ gene and X-gal provides a chromographic assay for the presence of 
ß-galactosidase (a blue coloration). This system can be used to investigate the 
success of a ligation. The multiple cloning site of the IacZ plasmids occurs 
within the lacZ gene. Therefore, any DNA fragment ligated into these 
vectors disrupts the lacZ gene and prevents ß-glucosidase activity. This 
results in white colonies easily distinguished from the blue colonies 
housing vectors without inserts. 
2.5.2 Plasmid isolation and purification 
The alkaline method of plasmid isolation was according to 
Sambrook et al. (1989). The bacterial chromosome is selectively denatured 
with the alkali under conditions where the plasmid DNA remains native. 
Most protein and rRNA is removed by precipitation with SDS and high salt. 
The plasmid DNA can then be precipitated from the supernatant. 
A5 ml overnight culture of plasmid containing E. co1i was 
used to inoculate 500 ml of Luria broth containing antibiotic. Cells were 
grown overnight (about 16 hours) at 37 °C, 200 rpm and were harvested by 
centrifugation in the Sorvall GS3 rotor at 8k rpm, 4 °C, 10 minutes. The cell 
pellet was resuspended in 4 ml of solution I (50 mM glucose, 25 mM Tris- 
HCl pH 8.0,10 mM EDTA) and left at room temperature for 5 minutes. To 
this, 8 ml of freshly prepared solution 11(0.2 M NaOH, 1% SDS) was added 
and incubated on ice for 5 minutes to allow lysis of the cells. Then 6 ml of 
ice cold solution III (3 M KoAC pH 4.8) was added and the mixture was left 
to stand on ice for at least 15 minutes, before being centrifuged for 40 
minutes at 12 k rpm, 4 °C in the Sorvall SS34 rotor. The supernatant was 
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extracted with an equal volume of phenol: chloroform: isoamyl alcohol 
(25: 24: 1), before an equal volume of isopropanol was added to precipitate the 
DNA. The precipitated nucleic acid was pelleted at 11 k rpm, 4 °C in the 
Sorvall SS34 rotor, air dried and resuspended in TE (10 mM Tris-HCI pH 7.5, 
1 mM EDTA). The plasmid DNA was then purified using one of the two 
following methods: - 
Caesium chloride purification 
This method was as according to Maniatis et at. (1982). For 
every 1 ml of DNA solution, 1.1 g of CsC1 was added followed by 75 µl of a 20 
mg/ml ethidium bromide solution. The solution was then transfered to a 
Sorvall ultracentrifuge tube. The tubes were filled to the base of the neck 
and then topped up with liquid paraffin, balanced to within two decimal 
places, capped and spun at 35 k rpm, 4 °C for 48 hours. The supercoiled 
plasmid band (lower band) was removed using a needle and syringe. 
Ethidium bromide was removed by extracting with n-butanol several times 
and the DNA was dialysed against TE buffer overnight. The purified 
plasmid DNA was then ethanol precipitated and resuspended in TE. 
Tagen Rack-500 Purification 
This method employed a Quiagen pack-500 (Quiagen Inc. ), 
based on an anion-exchange resin, and was according to the protocol out- 
lined in The Quiagenologist (1989). DNA was prepared as above and 
resuspended in 4 ml of TE and RNAse was added to a final concentration of 
10 gg/ml. The solution was incubated at 37 °C for 1-2 hours. The salt 
concentration was adjusted with the addition of 880 µl 5M NaCl and 800 µl 
1M MOPS pH 7.0. The Quiagen pack-500 was assembled with a syringe and 
equilibrated with 5 ml solution A (400 mM NaCl, 50 mM MOPS pH 7.0,15 % 
ethanol). The plasmid solution was then poured into the barrel of the 
syringe and pushed through the pack at a flow rate of 2 ml/ minute, to 
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allow binding of the DNA to the resin. The pack was the washed with 20 ml 
solution C (1 M NaCl, 50 mM MOPS pH 7.0,15 % ethanol) at a flow rate of 3 
ml/minute to remove contaminating proteins, polysaccharides etc. DNA 
was eluted with 5 ml solution F (1.5 M NaCl, 50 mM MOPS pH 7.5,15 % 
ethanol) and then precipitated with 0.8 volume isopropanol. 
A similar treatment was used for small scale plasmid isolation 
(minipreps). 1.5 ml of overnight E. coli culture was pelleted and treated with 
100 µl solution I, 200 µl solution II, and 150 µl solution III. The nucleic acid 
was purified by phenol extraction and precipitated with two volumes of cold 
ethanol. 
The resultant DNA solution from these methods was checked 
for concentration and purity by measuring absorbance at 260 nm and 280 
nm, a pure DNA solution having a ratio of 1.7 (260: 280). DNA concentration 
was calculated using the relationship that a solution of 40 pig/ml has an 
absorbance at 260 nm of 1.0. All solutions for DNA manipulations were 
routinely sterilized, either by autoclaving or filtration, to remove nuclease 
contamination. 
2.6 Molecular biology techniques 
2.6.1 Restriction enzyme digests 
Assay buffers for the restriction enzymes were made as 
indicated in Table 2.2 and stored with restriction enzymes at -20 °C The 
addition of nuclease free BSA at 100 µg/ml improved enzyme storage, and 
prevented the protein denaturing at low concentration. 
Analytical digests were typically done in a reaction volume of 
20 0 with 1 µg DNA and 5 units of enzyme (where 1 unit is sufficient to 
digest 1 gg of ). DNA in 1 hour). For restriction mapping a combination of 
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single and double digests were performed. Double digests were done, where 
ever possible, in a common buffer. Failing this a sequential digest was used; 
the lower salt requiring enzyme was incubated with the DNA then heat 
killed before salt and the second enzyme were added. Alternatively the first 
digest was ethanol precipitated and the pellet resuspended in the second 
buffer. Larger scale digests such as the digestion of chromosomal DNA used 
3-10 gg DNA in a final volume of 100-400 W. A tenfold excess of enzyme 
was used, keeping the volume of enzyme added less than a tenth of the 
Table 2.2 Restriction enzymegest conditions 
enzyme Tris-HC1 
(mm) 
pH NaCI 
(mM) 
MgC12 
(mM) 
b-ME Temp °C 
Accl 10 8.0 10 10 1 37 
BamHI 10 8.0 100 10 1 37 
BgIII 10 8.0 100* 10 10 37 
EcoRI 10 7.5 100 10 1 37 
EcoRV 10 8.0 100 10 10 37 
HindlII 10 8.0 60 10 1 37 
HindII 10 7.5 60 10 1 37 
KpnI 10 7.5 10 10 10 37 
Nael 10 8.0 20 10 10 37 
Nrul 10 8.0 150* 10 10 37 
Pst! 10 8.0 50 10 1 37 
PvuII 10 8.0 60* 10 10 37 
Sall 10 8.0 150 10 1 37 
Sac I 10 7.5 20 10 1 37 
Sma I 10 8.0 20* 10 10 30 
Xba I 10 8.0 100 10 1 37 
Xho 1 10 8.0 150 10 10 37 
*KC1 substituted for NaCl 
final volume to avoid inhibition by the glycerol buffer used in storage of the 
enzyme. These digests were performed for a minimum of 5 hours. At the 
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end of the incubation period restriction digests were terminated 
by the 
addition of one tenth volume loading buffer (0.25 % w/v 
bromophenol 
blue, 30 % w/v sucrose, 100 mM EDTA). 
2.6.2 Electrophoresis 
Buffers were made as 10 x stock solutions and stored at room 
temperature. 
TEA gLI TBE 9L: 
Tris 48.4 Tris 108.0 
NaOAc 27.2 
EDTA 6.7 
pH 7.8 
Boric acid 55.0 
EDTA 40.0 
pH 8.0 
For the resolution of fragments of restriction digests DNA was 
electrophoresed through a horizontal agarose gel. Normally 0.8 % w/v 
agarose in 1x TEA was used, however if greater resolution of smaller 
fragments was required more concentrated agarose gels were used, or if a 
fast result was required 1x TBE was used as the buffer, instead of TEA. The 
agarose was fully dissolved in the buffer by heating over a bunsun burner or 
in a microwave oven and allowed to cool to approximately 50 °C before 0.5 
gg/ml ethidium bromide (EtBr) was added and the gel was poured into a 
suitable sized tray; the ends of which had been taped and fitted with the 
appropriate sized comb. EtBr is a U. V. fluorescent dye that interacts between 
the stacked bp of the DNA giving an immediate indication of the quantity of 
DNA when viewed on a transilluminator. The gel was allowed to set before 
the comb and tape were removed and the gel was placed in the gel rig 
containing running buffer (the same buffer as was used to make the gel). 
Samples were loaded and the gel was run overnight at 75 V for H4 gels (250 
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ml capacity), 25 V for H5 gels (100 ml capacity). Minigels (H6,30 ml capacity) 
were run at 50V for approximately 2 hours. 
RNA was electrophoresed through a horizontal, formaldehyde 
denaturing 1.2 % agarose gel to allow good size separation and resolution of 
single stranded RNA. For a 100 ml gel volume, agarose was dissolved in 85 
ml of DEP treated distilled water and 10 ml of 10 x MOPS buffer (200 mM 
MOPS pH 7.0,50 mM NaOAc, 10 mM EDTA) with 0.25 gg ml-1 of EtBr. Once 
the gel had cooled to 50 °C, 5.4 ml of 40 % formaldehyde was added. RNA 
samples were taken up in 5 volumes of sample buffer (0.76 ml formamide, 
0.26 ml 40 % formaldehyde, 0.18 ml DEP distilled water, 0.16 ml 10 x MOPS 
buffer) and 1 volume of loading buffer. The secondary structure of the RNA 
was broken by boiling the samples for 2 minutes, followed by immediate 
quenching on ice. Samples were loaded onto the gel as before and generally 
run overnight at 15 V in 1x MOPS buffer. 
2.6.3 Recovery of DNA fragments 
Two methods of fragment recovery were used: 
Method A- Glassmilk 
DNA was digested and electrophoresed on a 0.8 % low melting 
point gel. The desired band was cut out of the gel and weighed. If the agarose 
weighed less than 0.4 g it was placed in a microfuge tube. Two to three 
volumes of NaI (chaotrophic agent) was added and the mixture was 
incubated at 50-55 °C for 5 minutes. After ensuring that the agarose had 
dissolved 5 gl glassmilk was added (for solutions containing greater than 5 
µg DNA, 10 more of glassmilk was added for each 0.5 µg DNA above 5 µg). 
The solution was incubated on ice for five minutes and spun at full speed in 
the microcentrifuge for five seconds. The resulting pellet was washed three 
times with 10-50 volumes of NEW and then dried. The pellet was 
resuspended in 5 gl TE (or a volume of TE equivalent to the volume of 
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glass milk used) and incubated at 55 °C for five minutes 
before being spun 
again. The supernatant was collected and the pellet was re-extracted with 
TE. 
Method B-NA45 membrane 
A membrane, purchased from Schleicher and Schuell, was 
prepared by cutting into strips and soaking in 2.5 M NaCl for 3 hours. It was 
then rinsed six times in distilled water and stored at 4 °C in 1 mM EDTA. 
The digested DNA was run on an agarose gel and then viewed under UV 
light. Any bands which were so close to the desired one, such that they 
might also migrate onto the paper were cut out and discarded. A slit was cut 
in front of the desired band and a piece of membrane inserted. The gel was 
run further so that the band migrated onto the paper, this could be 
determined by viewing under UV light; when the DNA was on the paper it 
could be seen as a red patch. The membrane was removed from the gel and 
washed for 1-2 minutes in 25 ml of distilled water. DNA was eluted by 
placing the membrane in 400 gl of elution buffer (20 mM Tris-HCl pH 7.5,1 
mM EDTA, 1.5 M NaCl) in a microfuge tube and vortexing for 1 minute. 
The microfuge tube was incubated at 37 °C for 2 hours and vortexed again, if 
any DNA remained on the membrane it was incubated further at an 
increased temperature. The resultant DNA solution was extracted three 
times with water saturated n-butanol, to remove the ethidium bromide, 
and twice with phenol: chloroform: iosoamyl alcohol and twice with 
chloroform: isoamyl alcohol. The DNA was then ethanol precipitated and 
resuspended in TE. 
2.6.4 Dephosphorylation of restricted DNA 
To ensure that vectors did not recirculize during ligation it was 
necessary to remove the 5' phosphate groups from the end of both DNA 
strands. Calf intestinal phosphatase (CIP) was used and a 10 x buffer made 
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consisting of 100 mM Tris-HCI pH 
8.3,10 mM M902,10 mM ZnC12. A 
reaction was set up as follows: 
DNA sample x µl 
10 x buffer 2.5 µl 
op Y1i 
H2O to 25 pI 
Under ideal conditions 0.01 units if CIP are needed to treat 1 tg DNA, cut 
with an enzyme yielding sticky ends, however it was more usual to use 3-5 
times this amount, although no more than this to prevent carry over of the 
CIP into the ligation-The reaction was incubated at 37 °C for 30 minutes 
before the same amount of buffer and enzyme was added along with water 
to 50 µl. The reaction was allowed to proceed at 37 °C for a further 30 
minutes before the enzyme was heat inactivated by incubation at 70 °C for 
15 minutes. The solution was then phenol: chloroform extracted twice and 
ether extracted and the DNA was ethanol precipitated. 
2.6.5 Bacteriophage T4 polymerase 
In order to blunt end DNA that had been cut with restriction 
enzymes that left protruding 3' sticky ends T4 polymerase was used. T4 
polymerase has a 5' to 3' polymerase and a 3' to 5' exonudease that is more 
active on single stranded DNA than on double stranded. The enzyme was 
purchased from NBL and the conditions were as recommended by the 
manufacturer. 
2.6.6 Ligations and subcloning 
A theoretical analysis of ligations was performed by Dugaiczyxk 
et at. (1975) based on studies of linear phase lambda DNA. Briefly, they 
obtained the following equation: 
Mw= (. 51.1/ (j/i[DNAI))2 
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where Mw is the molecular weight of the DNA sample, 
j is the effective 
concentration of one end of the molecule relative to the other end, 
i is the 
total concentration of ends and [DNA] is the concentration of DNA 
(g/1). 
This equation can be used to predict the type of products expected during the 
ligation of a specific DNA fragment at various concentrations. When j=i the 
probability of the two ends of the same molecule finding each other should 
be the same as that of finding the end of a different molecule. When j>i the 
formation of circular molecules is favoured and when j< i the formation of 
linear concatamers during a ligation will be favoured. When two fragments 
of different molecular weights are being ligated, a sufficiently accurate 
approximation can be made by averaging the molecular weights. Therefore 
when ligating a mixture of DNA fragments, it is possible to affect the 
ligation products by manipulating the ratio of the fragments in the ligation 
reaction. Preventing self-religation of the vector by treating with 
phosphatase also effects the balance of the equation. If the vector is treated 
with phosphatase then there is usually no need to drive the reaction with a 
high concentration of insert. In practice several concentration ratios of 
vector to insert were set up, keeping the total DNA concentration low to 
prevent the formation of concatamers. the reaction mix was as follows: 
ILI 
Vector DNA x 
Insert DNA y 
10 x ligation buffer 1 
CIP ligase 0.1 u/µl 1 
10 x Ligation buffer 
0.5 M Tris HC1 pH 7.5 
100 mM MgC12 
100 mM DTT 
6.6mMATP 
H2O 8-x-y 10 mM spermidine 
1 mg/ml BSA 
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For 'sticky end' ligation the mixture was incubated at room temperature 
for 2 hours and subsequently overnight at 4 °C. Blunt end ligations were 
carried out at room temperature for 2 hours and used a higher 
concentration of ligase (1 u/µg DNA). After incubation the reaction was 
arrested by heating at 65 °C and diluted with 40 µl TE, to reduce the 
inhibitory effect of the ligation buffer on the transformation. The ligated 
DNA was transformed into E. coli as previously described and plated onto 
LB plates containing antibiotic.. X-gal and IM. Colonies with inserts were 
white and those without were blue. Ligation controls included uncut 
plasmid, to test the transformation efficiency, cut plasmid with ligase, to test 
the ligation efficiency and cut, CIP treated plasmid with ligase to test the CIP 
efficiency. 
2.6.7 Hexaprime labelling of DNA with 32p (Feinburg and Vogelstein 1983,1984) 
Random sequence hexanucleotides are used to prime DNA 
synthesis catalysed by E. coli DNA polymerase (Klenow) in the presence of 
dNTPs and OL-32P dCTP. Template DNA was a single stranded, denatured 
restriction fragment with the sequence of interest. 
DNA was labelled using an Amersham Multiprime kit 
(RPN1601) as follows: 
DNA (50 ng) 10 
dH2O 30 µl 
Buffer I 10 µ1 
Primer II 5µl 
32P-dCTP (50 mCi) 50 
Enzyme III 2 µ1 
The DNA was mixed with the water and boiled for 2 minutes before being 
quenched on ice to allow single strand separation. Buffer I consists of dNTPs 
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in Tris"HC1 pH 7.8, MgC12 and ß-ME buffer; Primer II is random 
hexanudeotides which act as primers with nuclease free BSA and Enzyme 
III is Klenow (1 u/µl) in phosphate buffer pH 6.5,10 mM ß-ME and 50 % 
v/v glycerol. The reaction was mixed and incubated at room temperature 
for 3-18 hours or 37 °C for 30 minutes 
2.6.8 Removal of unincorporated nucleotides 
To separate the labelled DNA fragment from the 
unincorporated nucleotides the reaction mix was run through a Nick 
column (Pharmacia plc), comprising of Sephadex G-50 (DNA grade). The 
Nick column was equilibrated with 1 ml of TE buffer before the DNA is 
added. The labelled DNA, moving through the column at a faster rate than 
unincorporated nucleotides, was collected at the bottom in a sterile 
microfuge tube and extracted once with phenol : chloroform to remove 
impurities. The typical specific activity of each labelled probe was 1.5 x 107 
dpm µg-1 DNA. TE was continually added to the column until all the 
radioactivity was removed. 
2.6.9 End labelling oligonucleotides 
This reaction utilizes the 5' polymerase action of T4 
polynuclease kinase. In this reaction there was no need to boil the DNA as 
oligonucleotides are single stranded. The 10 x kinase buffer was made and 
the reaction was as follows: 
DNA 1 pl (10 ng) 10 x Kinase buffer 
10 x buffer 1 µi 0.5 M Tris HCL pH 7.6 
enzyme 10 0.1 M MgC12 
water 20 50 mM DTT 
'32p CTp 50 1 mM spermidine 
1 mM EDTA 
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The reaction mix was incubated at 37 °C for one hour and the 
unincorporated nucleotides separated out as described above. 
2.6.10 Southern transfer (Sambrook et al. 1989) 
Southern blotting is a technique used to transfer DNA from an 
agarose gel onto a nylon or nitrocellulose membrane placed directly above 
the gel. The DNA is denatured, neutralised and transfered in a high salt 
buffer by capillary action. DNA fragments larger than 15 kb require at least 
18 hours for transfer leading to dehydration of the gel and loss of transfer. 
To alleviate this, DNA is partially hydrolysed, by exposure to weak acid 
followed by strong base, prior to transfer. The resulting DNA fragments are 
approximately 1 kb. 
DNA was digested, electrophoresed and photographed as 
described previously. The gel was washed, with shaking, at room 
temperature, in depurinating solution (1 M HC1) for 20 minutes, in order to 
depurinate the DNA to allow hydrolysis of the phosphodiester backbone at 
these sites on the exposure to alkali. The gel was agitated for 40 minutes in 
denaturing solution (0.5 M NaOH, 1.5 M NaCl), required for separation of 
the two strands of DNA, permitting hybridization with a radiolabelled 
probe. Finally the gel was shaken in neutralizing solution (0.5 M Tris-HCl 
pH 7.5,3 M NaCl) for 40 minutes. In between each wash the gel was rinsed 
in distilled water. The gel was then placed upside down on a Whatman 
3MM paper wick soaked in 20 x SSC (3 M NaCl, 0.3 M sodium citrate pH 7.0). 
The edges of the gel and the tray containing 20 x SSC were sealed with 
clingfilm to prevent losses by evaporation or SSC leaking into the paper 
towels without going through the gel. An nylon or nitrocellulose filter the 
exact size off the gel was cut out, prewet in 3X SSC and placed on top of the 
gel. Three sheets of Whatman 3MM paper were prewet and placed on top of 
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the membrane, followed by 3 dry sheets of 3MM paper and a stack of paper 
towels (Figure 2.1) The assembly was weighted down with a glass plate and a 
one kilogramme weight. Transfer was allowed to proceed overnight and 
checked by restaining the gel in ethidium bromide and viewing under UV 
light. Nitrocellulose membrane was placed between two sheets of 3MM 
paper and baked under vacuum at 80 °C for two hours. The nylon 
membrane was allowed to air dry and then was wrapped in cling film and 
placed, DNA side down, on the transilluminator for 5 minutes to fix the 
DNA to the membrane. 
2.6.11 Prehybridization and hybridization of the filters 
Low stringency formamide hybridization techniques are 
described by Maniatis (1982). However, it was found that a hybridization 
method using Marvel (Cadburys) was easier and produced cleaner blots. 
Marvel replaces the Denhardts reagent as a blocking agent. It is generally 
easier to use and less expensive. PEG is added to increase the rate of 
hybridization by concentrating the probe (Nucleic acids are excluded from 
the volume of the solution occupied by the polymer). The 
prehybridization/hybridization solution is as follows: 5x SSPE (3 M NaCl, 5 
M NaH2PO4. H20,20 mM EDTA, pH 7.4), 6% PEG4000,0.5 %Marvel, 1% 
SDS, 1% sodium pyrophosphate, 250 µg/ml denatured herring sperm DNA. 
The smallest volume of solution required to cover the filter, which was 
prewetted with distilled water, was used and prehybridization and 
hybridization occurred in a plastic sandwich box. Prehybridization was for a 
m nimum of three hours and the solution was not changed unless it was 
left overnight. Hybridization was always carried out overnight at 56 °C for 
low stringency and 65 °C for high stringency unless oligonucleotides were 
used as probes. Then the hybridization temperature was dependent on the 
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melting temperature of the oligonucleotide which was worked out 
according to the following equation: 
Td; 5 = 4(G+C) +2 (A+T) 
Thyb=Tdis-5°C 
Theoretically the hybridization temperature should be 5 °C 
lower than the melting temperature of the oligonucleotide. However in 
practice it was found that better results were obtained at temperatures at 
least 10 °C lower than the melting point. 
Filters were washed for 30 minutes at the temperature at which 
they had been hybridized in SSC, 0.1 % SDS, 0.1 % sodium pyrophosphate. 
Lower stringency and oligonucleotide hybridizations were washed once or 
twice in 5x SSC. Higher stringency hybridizations were washed once in 5x 
SSC, followed by successive washes in 3x SSC, 2x SSC, 0.2 x SSC and 0.1 x 
SSC. Filters were then sealed in a polythene bag and placed in a Kodak film 
cassette between two intensifying screens. Autoradiograph (X-ray) film was 
placed over the filters under safe lights. The cassette was stored at -70 °C 
before developing. 
2.6.12 Northern transfer 
A formaldehyde denaturing gel containing the RNA to be 
blotted was photographed on a UV transilluminator as described 
previously. The RNA was denatured prior to, and during electrophoresis 
and therefore does not require treatment with alkali. Additionally, RNAs 
greater than 9 kb have been shown to transfer well and therefore do not 
require hydrolysis. 
The gel was washed in 10 x SSC for two periods of 30 minutes 
to remove formaldehyde from the gel (formaldehyde may inhibit the 
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transfer of the RNA to the nylon filter). The Northern blot was set up as for 
the Southern blot and left standing overnight. After dismantling the filter 
was treated in the same way as described for Southern blotting. 
2.6.13 Northern hybridization 
Northern blots were pre-hybridized in hybridization buffer for 
a period of 4-6 hours to reduce non-specific probe hybridization. The 
hybridization temperature was usually 20-25 °C below the melting 
temperature (Tm) of the probe. It has been shown that RNA: DNA hybrids 
have a Tm approximately 10 °C higher than the equivalent DNA: DNA 
hybrid. Therefore it is particularly important, with Northern hybridizations, 
to use 40 % deionised formamide decreasing the Tm and providing less 
harsh conditions at 42 °C. High ionic strength solutions (5 x SSPE or 5x SSC) 
maximise the rate of annealing of the probe. When formamide is included 
in the hybridization 5x SSPE is preferred due to its greater buffering 
capacity. Denhardt's reagent, 0.1 % SDS and 250 gg ml-1 herring sperm DNA 
are used as agents to block the non-specific attachment of the probe to the 
surface of the filter. 
The hybridization solution for Northern blots consisted of 40 
% formamide, 5x SSPE (3 M NaCl, 5M NaH2PO4. H20,20 mM EDTA, pH 
7.4), 1% SDS, 1x Denhardts solution (50 x Denhardts stock is 5g Ficoll, 5g 
poly vinyl pyrolidone (PVP), 5g BSA made up to 500 ml with distilled water 
and stored at -20 °C) and 250 µg ml-1 of denatured herring sperm DNA. 
(Prepared by dissolving the solid sodium salt of the DNA to 10 mg ml-1, 
sonicating and shearing through a 0.8 mm needle five times. It was stored at 
-20 °C and boiled for 10 minutes before adding to the hybridization buffer). 
For a filter of 12 x 11 cm, 20 ml of buffer was used, sealed in a plastic bag, 
excluding all air bubbles. Small volumes of hybridization solution allow 
faster nucleic acid reassociation. 
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The conditions for hybridization were the same as 
prehybridization. The labelled probe was added to the 
bag after boiling and 
incubation proceeded for sufficient time to allow the probe to achieve 3x 
Cot' /2 as specified by the equation: 
Cc1/2 =1/X X Y/5 x Z/10 x2 
where x is the weight of the probe (µg), Y is the length of the probe (kb) and 
Z is the volume of the reaction (Sambrook et al, 1989) Although this was 
routinely left over night. 
In general, the washing conditions should be as stringent as 
possible. A combination of temperature and salt concentration determine 
the stringency. The washing temperature of Northern blots was 55 °C with 
the salt concentration gradually decreased to 1x SSC. 0.1 % SDS was 
included in the washes. The stability of the RNA: DNA hybrid decreases as 
the salt concentration decreases. Only homologous hybrids should remain 
at the end of the washing procedure. 
2.6.14 Bal 31 
Ba131 has 3' exonuclease activity that removes 
monophosphates from both 3' termini of double stranded DNA and also 
endonuclease activity. Thus ssDNA generated by the 3' exonuclease is 
degraded by the endonuclease. The 3' exonuclease is 20 times more efficient 
than the endonuclease. If a high enzyme concentration is used the single 
strand is only about 5 nucleotides long at each terminus and 10-20 % of 
molecules can be blunt end ligated directly. At low enzyme concentrations 
the single stranded DNA is very long and repair with T4 polymerase is 
required before ligation. 
78 
In order to remove NaeI restriction enzyme sites from the a- 
amylase gene the gene was first cut with NaeI and then treated with a 
high 
concentration of Bal 31 according to the protocol described by Sambrook et 
al. (1989) 
2 .7 Bacterial phase 
lambda techniques and gene bank screening 
The method of bacteriophage DNA preparation exploits the 
biology of the virus. The bacteriophage adsorbs to maltose receptors on the 
outer membrane of E. coli, encoded by the 1amB gene, for this reason 
maltose is included in the media used to grow bacteriophage. In addition, 
the inclusion of magnesium ions aids absorbtion. After entering a host the 
bacteriophage replicates either via the lytic cycle or the lysogenic cycle. 
During lytic growth, important for DNA preparation, the viral DNA 
replicates many fold. Bacteriophage progeny are then assembled and the 
bacterial cell lyres, releasing the viral particles. An infected bacterial culture 
grown to lysis ensures a maxiuni concentration of bacteriophage DNA 
within the media. This removes the bacterial lysis step from the DNA 
preparatioon , allowing 
direct precipitation of viral DNA by the addition of 
PEG and salt. 
2.7.1 Preparation of plating bacteria 
An overnight culture of E. coii strain NM538 was grown in 
NYZDT broth (Difco), supplemented with 0.2 % maltose, at 37 °C with 
agitation. This was used to inoculate 20 ml NYZDT broth prewarmed to 37 
°C (1 in a 100 dilution). Cells were grown to OD600=0.5 and then pelleted at 3 
k rpm in the MSE bench top centrifuge, fixed angle rotor. The pellet was 
resuspended in 6 ml SM buffer. 
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M buffer I 
NaCI 5.8 g 
MgSO4 2.0 g 
1M Tris-HC1 pH 7.5 50 ml 
2% gelatin 5 ml 
2.7.2 Infection of plating bacteria with phage 
An aliquot of phage (10 µl) was placed in a5 ml centrifuge tube 
(sterilin) with 150 gl of plating bacteria prepared as above. The tube was 
incubated at 37 °C for 20 minutes with gentle shaking (200 rpm). If plaques 
were wanted then 3 mis of molten top agarose (0.7 % agarose in NYZDT) at 
50 °C was added to the tube, mixed quickly and poured onto a NYZDT plate. 
The plates were allowed to dry and incubated at 37 °C overnight. Phage 
lysates were titred, to determine the number of plaque forming units (pfu), 
by plating out serial dilutions, in SM buffer, in this way. 
2.7.3 Production of phage lysates 
Small scale lysates were produced by picking a single plaque off 
a lysed plate with a pasteur pipette. The plaque was added to 200 Al of SM 
buffer and left at 4 °C for a minimum of 3 hours. A 10 µl aliquot of this 
solution was then used to infect plating bacteria as before. The infected 
bacteria were then added to 10 ml of prewarmed NYZDT broth, 0.2 % 
maltose and incubated at 37 °C overnight with vigorous shaking (300 rpm). 
Small scale lysates were titred as previously described and used 
to infect large scale lysates. For large scale lysates NM538 were grown in 
NYZDT broth to OD600 = 1.0 (= 8x 108 cells/ml), spun down and 
resuspended in SM buffer to give 1x 1010 cells /ml. A3 ml sample of these 
cells were then taken and infected with 1x 109 phage particles as before. The 
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infected cells were added to 500 mis NYZDT broth and grown for 8-12 hours 
at 37 °C, 300 rpm. 
2.7.4 Amplification and purification of lambda DNA 
DNA was isolated using a number of different methods with 
varying degrees of success. It was found that the titre of the lysate was most 
important in determining the yield of DNA. If the ratio of bacteriophage to 
bacteria cells was too high, lysis occured prematurely, reducing the quantity 
of bacteriophage in the media. Likewise, if the ratio of bacteriophage to 
bacterial cells was too low, lysis did not occur, again reducing the yield of 
DNA obtained. The addition of 1 x109 pfu to 3 x1010 plating bacteria cells was 
considered to give the best lysates. 
Method 
-1 
This was the ) mini prep as described by Davis et al. (1986). To 
10 ml small scale lysates was added 10 ml TM buffer (50 mM Tris-HC1 pH 
7.4,10 mM MgSO4) and DNAase to 1 mg/ml final concentration, this was 
mixed by gentle inversion and incubated for 15 minutes at room 
temperature. Then 2 ml of 5M NaCl was added and solid PEG6000,10 % 
w/v, was dissolved in the lysate. The mixture was incubated for 15 minutes 
on ice and spun at 200 x g, 4 °C for 10 minutes. The pellet was resuspended 
in 30 ml TE and chloroform extracted twice. To the aqueous phase was 
added 15 ml 0.5 M EDTA pH 8.0 and 30 ml 5M NaCl and the solution was 
phenol extracted twice. The DNA was ethanol precipitated and resuspended 
in TE. 
Method 2 
This method of phage DNA preparation used LambdaSorb 
phage absorbent (Promega). Confluent plates were made as before and 
overlain with 5 ml phage buffer (20 mM Tris-HC1 pH 7.5,10 mM MgSO4,0.1 
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M NaCI). The top agarose and phage buffer were scraped into a centrifuge 
tube and incubated at room temperature for 30 minutes with intermittent 
shaking. The mixture was spun 10 k rpm, 4 °C, 10 minutes. The LambdaSorb 
absorbent was resuspended and added to the supernatant (100 µt to 10 ml 
lysate), mixed and incubated on ice for 30 minutes. After centrifugation at 
7500 rpm, 30 minutes, SS34 rotor the pellet was resuspended in 1 ml of 
phage buffer and transfered to a microfuge tube. This was spun for 1.5 
minutes and the pellet washed again in phage buffer. The pellet was 
resuspended in 0.5 ml 10 mM Tris-HC1 pH 7.5,10 mM EDTA and heated to 
70 °C for 5 minutes to release the phage DNA. The absorbent was removed 
by spinning for 2 minutes and the supernatant was extracted twice with 
phenol: chloroform and once with chloroform before ethanol precipitation 
and resuspension in 50 µl TE. 
Method 3 
Large scale lambda DNA prep as described by Maniatis et at. 
(1982). Large scale cultures were prepared as described and chloroform added 
to induce lysis in any infected bacteria. Bacterial cell debris was pelleted at 
7000 rpm in the GS3 rotor. The supernatant was carefully decanted and 
DNAase and RNase added to 1 mg/ml final concentration, this was then 
incubated at 37 °C for 1 hour with gentle shaking. The pellets were 
resuspended in 350 ml of SM buffer and pooled. Debris was again removed 
by centrifugation at 2500 rpm SS34 rotor for 5 minutes. 
CsC1 step gradients were prepared from: 
solution CsCI TM (ml) 
A 4.5 10 
B 8.2 10 
C 6.4 5 
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The gradient was achieved by layering 1.25 ml A, 0.72 ml B and 0.75 ml C 
into a centrifuge. The supernatant was layered on top of the gradient and 
the tubes filled with liquid paraffin and centrifuged in a Beckman 
ultracentrifuge, SW28 rotor, 35K rpm for 2 hours at 25 °C. The 
blueish/bownish phage band seen approximately three quarters of the way 
down the tube was removed with a pasteur pipette and dialysed overnight 
against TE with three changes of buffer. The dialysate was adjusted to 0.1 M 
NaCl and phenol extracted. The organic layer was back extracted with TE 
and the aqueous layer chloroform extracted before further dialysis against 10 
mM Tris pH 7.5. The DNA was ethanol precipitated and resuspended in TE. 
Method 4 (A. R Hawkins pers. comm. ) 
Lysates were prepared as before and bacteria were pelleted 
gently at 4k (GS3 rotor) for 5 minutes. The supernatant was poured off and 
the tubes were inverted and dried. The pellet was resuspended in 3.75 ml of 
SM buffer and layered onto a CsC1 gradient prepared as follows: 
Gradient CsCI stock (65 g CsCI 
in 35 ml water) 
SM buffer 
1.7 /cm3 4.67 ml 2.00 ml 
1.5 /cm3 3.33 ml 2.67 ml 
1.3 /cm3 2.40 ml 3.79 ml 
6 mis of each gradient solution were layered into a centrifuge tube 
commencing with the lightest. The tubes were topped up with liquid 
paraffin and spun 20 °C, 4 hours at 24K rpm in the Beckman SW28 rotor. 
The phage band was removed from the 1.5 g/cm3 band and dialysed against 
TE for 6 hours at 4 °C with 3 changes of buffer. RNAase (20 mg/ml) and 
DNAase (10 mg/ml) were added whilst dialysing further at room 
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temperature against TE. Protein was removed by treatment with 0.1 mg/ml 
predigested Proteinase K whilst dialysing against 20 mM Tris-HC1 pH 
8,1 
mM EDTA, 0.1 M NaCl, 0.01 % v/v Triton X 100 followed by phenol 
extraction. DNA was ethanol precipitated and resuspended in TE 
Method 
A Fast Phage DNA prep as described by Zabarovsky and Turino 
(1988). Lysates were prepared as before and bacterial debris pelleted by 
centrifugation; 5 k, GS3 rotor, 4 °C, 10 minutes. Solid PEG6000 and NaCl 
were added to 10 % w/v and 1M respectively and incubated on ice for 30 
minutes. The mixture was then spun 8k rpm, 4 °C, 10 minutes, GS3 rotor 
and the pellet resuspended in 5 ml TE, 10 mM MgC12 and chloroform 
extracted. The aqueous phase was transferred to centrifuge tubes and the 
phage DNA pelleted at 35 k rpm, 20 minutes, Beckman SW65. The pellet 
was resuspended in 600 0 TE, 10 mM MgC12 and spun for 2 minutes in the 
microfuge. The supernatant was collected and 3 gl 20 % SDS, 8 µl 0.5 M 
EDTA added. The mixture was incubated at 70 °C for 15 minutes then 
phenol extracted and chloroform extracted twice. The DNA was ethanol 
precipitated and resuspended in 50 0 TE. 
2.7.5 Library screening 
Glal, prol, niaD and amy3 clones were revealed in the 
A. oryzae gene bank by plaque hybridization (Benton and Davis, 1979). The 
screening took place in two parts; first the plaques were plated out at high 
density and positive areas were selected. These areas were then excised and 
plated out at a lower density, assuming each plaque contained 107 pfu, 
which enabled single plaques to be selected. 
E. coli MN539 were infected with phage, as previously 
described, and plated on 8 plates at an approximate density of 5,000 plaques 
84 
per plate. This yielded 40,000 plaques which, assuming the A. oryzae 
genome to be 2-3 x 107 kb (similar to A. niger) and bacteriophage lambda to 
contain 10-15 kb DNA, meaning that 10-20 times the genome was screened 
giving a greater than 95 % chance of selecting the desired gene. The plates 
were chilled at 4 °C for 2-3 hours and filter lifts made by placing a 
membrane, either a Schleicher and Scheull BA85 or a Hybond N, on the 
plate and allowing it to absorb for 2 minutes. Replica filters were made in 
the same way except that they were allowed to absorb for longer (5 minutes 
for the second replica and 10 minutes for the third). DNA was denatured 
and bound to the filters by placing the filters in 1M NaCl, 0.5 M NaOH for 
20 seconds, 0.5 M Tris-HC1 pH 7.4,1.5 M NaCl for 20 seconds and washing in 
3x SSC for 15 minutes. Filters were allowed to dry. Nitrocellulose filters 
were baked at 70-80 °C in vacuuo for 2 hours and nylon filters were exposed 
to UV light for 3-5 minutes. Filters were then prehybridized and hybridized 
as described before. 
2.8 Fungal Techniques 
2.8.1 Protoplast formation and transformation 
A. oryzae mycelial cells grown for 12 hours (at 30 °C for strains 
SAO1.1, SAO200 and SA0204, at 34 °C for strains A04-1, SAO201, SAO 202 
and SAO 203 and at 37 °C for strain 1560-6) were collected washed and 
resuspended in 20 ml lysis buffer (0.8 M MgSO4,10 mM PO4, pH 5.8). 
Novozyme 234 (batch number PPM2715) was added to a final concentration 
of 0.5 mg/ml, the mixture was incubated at 30 °C for 45 minutes with gentle 
shaking and centrifuged at 3000 rpm for 10 minutes. Four volumes of 
solution B (1.2 M sorbitol, 50 mM CaC12,10 mM Tris pH 7.5) was added to 
the supernatant and the solution was centrifuged at 2000 rpm for 5 minutes. 
Pelleted protoplasts were washed 3 times in solution B and finally 
resuspended at a concentration of 1-2 x 107 protoplasts in 100 ml. To this 
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suspension 1-5 µg plasmid DNA was added together with 12.5 µl of 
50 % 
w/v PEG4000,50 mM CaC12,10 mM Tris pH 7.5 and allowed to stand on ice 
for 20 minutes. This suspension was plunged into 1 ml of the PEG solution 
and mixed for a couple of seconds before diluting out the effects of the PEG 
with 2 ml of solution B. The suspension was added to the selection medium 
(minimal medium containing 1.2 M sorbitol) cooled to 45 °C. The plates 
were incubated at 30 °C for up to 5 days. Control protoplasts were treated as 
above without the addition of DNA. Protoplast viability was tested by 
suspending protoplasts in nonselective media. Viability was usually greater 
than 10 %. 
When mutant strain AO1.1 was transformed the selection 
medium contained 10 mM sodium nitrate, when strain 1560-6 was used the 
growth medium contained 10 mM arginine. When strain A04-1 was 
transformed the growth medium contained uridine and the selection media 
contained either ammonium tartrate or uridine and sodium nitrate 
depending on the selection system used. If the strains were transformed 
using the amdS system 1.0 M sucrose was used as the osmotic buffer and 10 
mM acetamide as the nitrogen source, additionally 5 mM CsCI was added to 
the selection media. 
2.8.2 Fungal DNA isolation 
Rapid DNA miniprep (Leach et al. 1988) 
Mycelial cells were grown in 10 ml minimal media for 24 
hours with agitation. Mycelium was harvested, washed with sterile distilled 
water and lyophilized. Mycelium was placed in a 10 ml tube with 0.7 ml 
LETS buffer (0.1 M LiCl, 10 mM EDTA, 10 mM Tris-HC1 pH 8.0,0.5 % SDS). 
Glass beads (0.5 mm) were added to the top of the buffer, the tube was 
vortexed for 2 minutes and then phenol: chloroform extracted three times. 
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The aqueous phase was transfered to a microfuge tube and the DNA was 
ethanol precipitated and resuspended in 400 0 of TE. 
Large scale DNA preparation 
Fresh mycelium (approximately 5 g) was frozen and 
powdered in liquid nitrogen. The powder was resuspended in 20 ml buffer 
(05 M sucrose, 25 mM Tris-HC1 pH 7.5,50 mM EDTA) and sarkosyl added to 
4% final concentration. The suspension was incubated at 60 °C for 1.5 hours 
and then centrifuged at 10 k rpm, 35 °C, SS34 rotor for ' 10 minutes. 
Proteinase K was added to the supernatant to give a final concentration of 
400 gg/ml and the mixture was incubated overnight at 35 °C. An equal 
volume of 30 % PEG6000 and 1.5 M NaCl was added and the solution 
incubated on ice for 1 hour with intermittent shaking and subsequently 
spun at 15 k, 4 °C, 20 minutes, SS34 rotor. The pellet was resuspended in one 
tenth volume 50 mM Tris"HC1 pH 8.0,10 mM EDTA and phenol extracted. 
RNAase A was added to 50 gg/m1 and the solution incubated at 37 °C for 1 
hour, then phenol extracted 4-5 times until the interface was clean. After 
chloroform extraction DNA was ethanol precipitated and resuspended in 
TE. 
Large scale DNA prep (Kolar et al. 1988) 
Mycelium from 100 ml cultures was washed in 0.9 % NaCl 
and frozen and powdered in liquid nitrogen. The powder was resuspended 
in 10 ml freshly prepared extraction buffer (0.2 mM Tris-HC1 pH 8.5,0.25 M 
NaCl- 0.05 M EDTA, 48 mg/ml PAS, 8 mg/ml NDP allowed to stand on ice 
for 15 minutes to form a precipitate which was not used) and then extracted 
with water saturated phenol: chloroform. If a greater yield of DNA was 
required the organic phase was back extracted with extraction buffer. All 
aqueous phases were extracted twice or more with phenol: chloroform and 
the DNA was ethanol precipitated and resuspended in TE. 
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2.8.3 Fungal RNA isolation 
Approximately 1g of mycelia, ground to a fine powder under 
liquid nitrogen in a mortar and pestle, was poured into 3 ml of stirring lysis 
buffer (5 M GuSCN (Fluka), 50 mM Tris Ha pH 7.5,10 mM EDTA and 10 % 
(v/v) of ß-mercaptoethanol is added immediately before use). The mycelial 
suspension was homogenised by passing four times through a 0.8 mm 
needle and once through a 0.6 mm needle. To the continuously stirring 
suspension was added 15 ml of 4M LiCI and the mixture poured into a 30 
ml corex tube (Du Pont). The reaction was stood for 20 minutes at room 
temperature followed by over night incubation at 4 °C. 
Cellular debris was pelleted at 2500 rpm for 5 minutes in a 
swing-out HB4 rotor (Du Pont) at 4 °C. Centrifugation of the supernatant 
proceeded at 8000 rpm for 90 minutes and the resulting pellet homogenised 
in 10 ml of 3M LiC1 through a 0.8 mm needle three times and a 0.6 mm 
needle twice. This suspension was spun out for 60 minutes at 8000 rpm and 
the pellet resolublized in 1 ml of TESDS (10 mM Tris HCl pH 7.5,1 mM 
EDTA and 0.1% sodium dodecyl sulphate (SDS)) by passing through a 0.8 
mm needle until homogeneous. 
RNA was purified by extracting with phenol: chloroform until 
no interface remained. To increase yields, the organic phase from the first 
extraction was re-extracted with 0.5 ml TESDS. Finally, RNA was ethanol 
precipitated. 
Vacuum dried pellets were resuspended in DEP water to allow 
the A260 and A280 OD measurements to be recorded. Given that 50 µg ml-1 
of RNA is equivalent to an OD A260 of 1.0 the prepared RNA was aliquoted 
into 100 µg samples, lyophilized and stored at -70 °C. The average yield was 
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approximately 600 µg. The /pip ratio provided a measurement of the 
RNA purity, 1.8 being ideal. 
All glassware was baked at 200 °C for 8 hours. Lysis buffer, 
prepared by dissolving the GuSCN at 50 °C and adding the Tris and EDTA 
was filtered through a 0.4 µm millipore filter. All other solutions were 
autoclaved with 0.1 % DEP and all equipment was autoclaved thoroughly. 
2.8.4 Generation of protease defective mutants 
Method 1 
Minimal media plates, supplemented with 0.8 mg/ml 
deoxycholate, 5 mM sodium nitrate and 1% Marvel, were inoculated with 
1.4 x 106 spores of wild type A. oryzae. These plates were then subjected to 
UV radiation for 1 minute 45 seconds, producing a kill rate of 99%. Most 
bacteria and possibly some fungi have a light mediated mechanism to repair 
any damage inflicted on the DNA by radiation (the SOS response). To 
overcome this possibility plates were incubated in the dark at 30 °C. 
Method 2 
As A. oryzae is a multinucleate organism (Williams and Kirk 
1988) a method was used that allowed separation of the nuclei based on Van 
Hartingsveldt et al. (1987). A spore suspension of 2x 107 spores was placed 
into small plastic petri dishes and subjected to UV radiation to produce a 99 
% kill rate. Spores were then collected and plated on to complete medium 
and incubated till sporulation occurred to allow separation of the nuclei. 
Spores were harvested off these plates and plated onto selection media. 
(minimal media containing 1% marvel, 5 mM glutamate) and incubated at 
30 °C in the dark. 
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2.8.5 Generation of pyrG mutants 
Spores were collected and treated in the same way as for the 
construction of protease mutants (section 2.8.4) except that the selection 
media was 10 mg/ml 5-Fluro orotic acid and 10 mM uridine. After 
incubation, 8 days at 30 °C, colonies were taken and tested for auxotrophy. 
2.8.6 Selection of chlorate resistant mutants 
Spores (-r 2x 107) were spread onto selection media, minimal 
media plates containing 470 mM chlorate and 10 mM glutamate as a sole 
nitrogen source. After incubation at 30 °C chlorate resistant mutants were 
further purified on selection media. 
2.9 Protein techniques 
2.9.1 Polyacrylamide gel electrophoresis 
Tube and slab gels were prepared according to Hames (1981) and 
are summerized below. 
Stock Solution Stacking 
Gel (ml) 
Final Acrylamide Concentration 
In Resolvin Gel (ml) 
12.5% 7.0% 5.0% 
A lamide: Bisa lamide 30: 0.8 2.5. 12.5 7.0 5.0 
Buffera 5.0 3.75 3.75 3.75 
10 % SDS 0.2 0.3 0.3 0.3 
1.5 % Ammonium Persulphate 1.0 3.0 3.0 3.0 
Water 11.3 11.95 16.95 19.45 
TEMED 0.015 0.015 0.015 0.015 
a resolving gel buffer stock 3M Tris-HC1 pH 8.8 
stacking gel buffer stock 0.5M Tris HCl pH 6.8 
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Reservoir buffer stock 
0.25M Tris 
1.92M glycine 
1% SDS 
Native gels used the same recipe except that the SDS was omitted. Gels were 
stained with Coomassie blue G250 (0.1%) in water: methanol: glacial acetic 
acid (5: 5: 2) and destained in 30 % methanol, 10 % glacial acetic acid. If greater 
sensitivity was required then gels were silver stained. 
2.9.2 Preparation of SDS-Polyacrylamide gels for amino acid sequence 
analysis 
The method used was that described by Hunkapiller and co- 
workers (1983). Reagents were purchased as electrophoresis grade and then 
further purified as follows; 
SDS purification The SDS was purified by crystalization from ethanol-water. 
SDS (100 g) was added to 450 ml ethanol and the suspension was heated to 
55 °C with stirring. Hot water was added to dissolve the SDS (50-75 mis) and 
10 g of activated charcoal was added. The solution was allowed to stand for 
10 minutes before being filtered through Whatman No. 5 paper. The 
solution was then successively chilled at 4 °C for 24 hours then -20 °C for 24 
hours before the crystaline SDS was collected on a sintered glass funnel and 
washed with 800 ml ethanol. The SDS was recrystallized using the same 
procedure but omitting the charcoal treatment and finally dried under 
vacuum overnight. 
Preparation of PAGE The gels were prepared with the addition of 0.1 mM 
sodium thioglycate, a free radical scavenger, to the cathode buffer and the 
gel was prerun for 2 hours before the protein samples were applied. 
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2.9.3 Electroblotting onto Polyvinylidene Diflouride (PVDF) membrane 
Using the method described by Matsudaria (1987) proteins can 
be transfered onto PVDF membrane, stained with Coomassie Blue and 
sequenced directly. Gels were prepared as above and after electrolysis soaked 
in transfer buffer [10 mM 3-(cyclohexylamino)-1-propanesulfonic acid, 10 % 
methanol, pH 11.0] for 5 minutes to reduce the amounts of Tris and glycine. 
The PVDF membrane was rinsed in 100 % methanol and stored in transfer 
buffer. The gel was sandwiched between a sheet of PVDF membrane and 
several sheets of blotting paper, assembled into the blotting apparatus 
(Mighty Small, Hoffer) and electroeluted for 10-30 minutes at 0.5 A in 
transfer buffer. The membrane was washed in deionized water for 5 
minutes and stained with 0.1 % Coomassie Blue R-250 in 50 % methanol for 
5 minutes and then destained in 50 % methanol, 10 % acetic acid for 10 
minutes. The membrane was finally washed in water and allowed to air dry. 
2.9.4 Silver staining (Wray et al. 1981) 
Gels were washed in 50 % reagent grade methanol for 2 hours 
with one change of solution. The methanol was discarded and the gel was 
stained for 15 minutes in 0.8 % AgNO3,0.00756 % NaOH, 0.0207 % NH4OH. 
The gel was then washed twice for 4 minutes and once for 2 minutes in 
water to remove any excess stain on the surface of the gel. The stain was 
developed with 2.5 ml 1% citric acid, 0.25 ml 37 % formaldehyde in 500 ml 
water. When the desired intensity if staining was reached the reaction was 
stopped with 50 % methanol, 8% glacial acetic acid. All water used in silver 
staining was milliQ. 
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2.9.5 Western blotting 
Protein samples were run down an SDS polyacrylamide gel 
and then western blotted onto nitrocellulose, using a wet blotting technique, 
in a home made rig, at 300 mA for 3 hours. The tank buffer was 20 mM Tris, 
193 mM glycine, 20 % methanol, pH 8.3. Alternatively a semi-dry technique 
was used with the Multiphor U Novo Blot apparatus according to the 
protocol and running conditions out lined in the manual for the 
discontinuous buffer system. 
The western blot was washed for 1 hour in TBST (10 mM Tris- 
HCl pH 8.0,150 mM NaCl, 0.05 % Tween 20) plus 4% Marvel with 3 changes 
of buffer and then incubated overnight in TBST plus 1% Marvel with 
polyclonal rabbit, or monoclonal mouse antiserum, to yeast recombinant 
hIL6 (1 in 10,000 dilution). The filter was again washed in TBST for one 
hour with 3 changes of buffer and then incubated in alkaline phosphate 
buffer ( 100 mM Tris-HC1 pH 9.5,100 mM NaCl, 5 mM MgC12) plus 1% 
Marvel with alkaline phosphatase linked goat antirabbit or antimouse IGG 
(1 in 1000 dilution) for 2 hours. The filter was then washed in TBST for 60 
minutes with 3 changes of buffer and incubated with the reaction mix (26.4 
mg NBT dissolved in 70 % DMF, 8.4 mg BCIP in 80 ml Alkaline 
phosphatase buffer) until colour developed. 
2.9.6 Protein break down assays 
Test strains grown in 100 ml minimal medium, 1% Marvel, 5 
mM glutamate were filtered over muslin to remove mycelium. Aliquots 
(500 µl) of the mycelium free media were incubated with 15 or 20 pg of the 
test protein (BSA, carbonic anhydrase, egg albumin, a lactalbumin, lysozyme) 
or 50 µl of yeast extract containing hIL6 for 6 hours at 37 °C. Break down of 
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protein was assessed by running the samples down SDS polyacrylamide gels 
and comparing with a control sample similarly processed. 
2.9.7 Protease assays 
A. oryzae is known to have five extracellular proteases, an 
alkaline protease, three neutral proteases and an acid protease. To compare 
the production of these proteases with time samples of supernatant taken 
from 100 ml cultures (minimal media, I% Marvel, 5 mM glutamate) were 
aliquoted in triplicate and incubated at 37 °C for 3 hours in the appropriate 
buffer system with either azocasin or haemoglobin. 
pH buffer 
10.5 1M Borate/Boric acid 
9 1M Borate/Boric acid 
7.0 1M Tris/HC1 or 1M MOPS 
3.0 4.034 g Potassium phalate dissolved in 100 ml 
water, 53 ml 0.2 N HC1,37 °C made up to 400 
ml 
Assay (pH 7.0 or 10.5) 
500 0 supernatant 
150 µ1 buffer 
100 µI10 % azocasein 
450 µl water 
Assay pH 3.0 
500 µl supernatant 
600 buffer 
100 µl 10 % haemoglobin 
After incubation at 37 °C the undigested protein was precipitated by the 
addition of 100µl 72 % TCA. and pelleted in the microfuge for 15 minutes 
The assays were developed by (pH 7.0 and 10.5) taking 1 ml of the 
supernatant and adding 1 m1 1M NaOH colour development was read at 550 
nM. For the pH 2.8 assay 1 ml of the supernatant was added to 2.5 ml 0.5 M 
NaCO3 and 0.5 ml Folins reagent (BDH stock solution 1 in 5 dilution) the 
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reaction mix was incubated at 37 °C for 30 minutes and colour 
development 
read at 660 nM. 
2.9.8 Protein determination (Bradford, 1976) 
Samples of culture fluid were aliquoted in triplicate and 
vortexed in a test tube with 5 ml of Bradford's reagent (see below). The 
absorbance was measured immediately at 595 nm and converted to 
micrograms of protein using a standard curve. 
Bradford's reagent was prepared by dissolving 0.1 g of 
Coomassie Blue G250 in 50 ml of %% ethanol. To this was added 96 ml of 
orthophosphoric acid and the solution made up to 1L with distilled water. 
The reagent was filtered twice through Whatman no. 1 filter paper and 
stored in the dark at 4 °C for up to 60 days. 
2.9.10 Deglycosylation of glycoproteins 
To remove N-glycosidically linked carbohydrate chains the 
protein sample was first denatured by boiling with 10 µg of the protein with 
10 µ1 of 1% SDS for 2 minutes, then repeated boiling for a further 2 minutes 
with the addition of 90 µl sodium phosphate buffer, 20 mM, pH 7.2, sodium 
azide 10 mM, EDTA, 50 mM, Nonidet P-40,0.5 % v/v. After cooling 0.4 
units N-glycosidase F was added and the reaction was incubated for 15-20 
hours at 37 °C. Removal of carbohydrate chains was visualised by PAGE. 
2.9.11 Clostripain digest 
Following the method described by Cole et al. (1971), clostripain 
was first activated by incubating in 1 mM calcium acetate, 2 mM DTT at a 
concentration of 2 mg/ml, at 4 °C overnight. Test protein was dissolved in 
75 mM sodium phosphate buffer pH 6. Reaction mixture, protein: enzyme, 
50: 1 was incubated at room temperature for 1 hour and then at 37 °C for 3 
hours. 
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2.10 Reducing sugar determination using 3,5, Dinitrosalycilic acid (DNSA) 
100 ml of 2M NaOH was heated to 70 °C and 5g DNSA was 
slowly added with stirring. Upon complete solution of the DNSA 100 ml of 
distilled water at approximately 70 °C was added, sodium potassium tartrate 
(150 g) was slowly dissolved and the volume made up to 500 ml with 
distilled water. A volume of 2 ml DNSA reagent was added to 1 ml sugar 
solution. The tubes were capped and incubated in a vigorously boiling water 
bath for 5 minutes and then cooled on ice The solutions were made up to 20 
ml and the absorbance was measured at 540 nm against a blank similarly 
processed. 
Test solutions were incubated with 0.5 % (final concentration) 
soluble starch at 37 °C for 30 minutes before being treated as above 
2.11 Glucose Trinder assay 
Glucose was assayed for using a Sigma Trinder 100 kit. Test 
solutions were first incubated with soluble starch (final concentration 0.5 %) 
at 37 °C for 30 minutes. 
2.12 Sl nuclease assay 
Samples were incubated for 30 minutes with 5 gg herring 
sperm DNA, rendered single stranded by boiling rapidly for 15 minutes and 
quenching on ice, in S1 buffer (33 mM sodium acetate, 50 mM NaCl, 0.03 
mM ZnSO4, pH 4.5). The reaction was then stopped by the addition of 
loading buffer and samples were run on a 0.8 % agarose gel. A crude 
estimate of activity was achieved by visually comparing the DNA 
remaining with that having been digested by known amounts* of 
commercial S1 nuclease (Sigma). 
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Figure 2.1 Assembly for Southern blotting 
97 
RIESUITS,; 4PART A 
Gene Transfer Systems For A. oruzae 
As discussed in the introduction, a transformation system that 
was both homologous and efficient would seem preferable for the 
introduction of heterologous genes into A. oryzae. This section describes the 
development of such a transformation system based on the nitrate reductase 
gene. Additionally other transformation systems are investigated. The 
selection of uridine prototrophic mutants, deficient in orotidine 5'- 
monophosphate is described along with the adaptation of the 
transformation system based on the A. nidulans amdS gene encoding 
acetamidase for use in A. oryzae. The application of other heterologous 
transformation systems are reported. 
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Chapter 3 
Development of a homologous transformation system for Asper lius 
oryzae based on the nitrate reductase gene 
3.1 Introduction 
The desired features of a transformation system are discussed 
in Section 1.8. To summarize; evidence would indicate that, from a point of 
view of expressing heterologous proteins, it would be advantageous if the 
transformation system used was homologous, efficient, did not cause 
disturbances in the general metabolism and if the recipient strain could be 
produced from an industrial strain without the use of general mutagenesis. 
The nitrate utilization pathway (Figure 3.1) is attractive for 
developing a transformation pathway for a number of reasons: - 
Fieure 3.1 The nitrate assimilation pathway 
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(1) The nitrate utilization pathway has been well defined genetically and 
biochemically, with most work having been done on A. nidulans and N. 
crassa (reviewed by Unkles 1989, Kinghorn 1989, Scazzocchio and Arst 1989, 
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Marzluf and Fu 1989). Briefly extracellular nitrate 
is taken into the cell by a 
permease (the gene product of crnA 
in A. nidulans). Inside the cell nitrate is 
converted to nitrite, by nitrate reductase (NR) 
(the gene product of niaD in 
A. nidulans), and then to ammonium by nitrite reductase (NiR) 
(niiA gene 
product). Both NR and NiR are under the control of two positively acting 
regulatory genes; nirA and areA. The nirA gene is a pathway specific control 
gene involved in nitrate induction of NR and NiB. All three gene activities 
are regulated by ammonium or nitrogen metabolite repression via the 
product of the positively acting regulatory gene, areA, which mediates the 
expression of a number of other ammonium repressible but otherwise 
unrelated pathways (Caddick et al. 1986). The products of both nirA and 
areA are required for enzyme expression. In A. nidulans the nitrate 
assimilatory genes are clustered with niiA and niaD divergently transcribed 
from an intergenic region (Johnstone et al. 1990). However these genes are 
unlinked in N. crassa (Tomsett and Garret 1980). 
(2) Mutants in nitrate assimilation can be selected for by positive selection, 
via the resistance to chlorate, reducing the time required in mutant 
selection. 
(3) This selection can be done by spontaneous means, reducing the 
possibility of secondary mutations arising in genes of commercial interest or 
in genes encoding for essential biochemical pathways. 
(4) Mutants defective in the structural gene niaD for NR apoprotein (EC 
1.6.6.8) but not NiR can be obtained on the basis of their resistance to 
chlorate. NR is a complex protein consisting of an apoprotein, which exists 
as a homodimer (Cooley and Tomsett, 1985), bound with a molybdenum 
cofactor. Additional mutations resulting in chlorate resistance can occur in a 
series of genes such as crnA, nirA, areA and genes cnxA-j encoding for the 
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biosynthesis of the co-factor which is necessary for NR and xanthine 
dehydrogenase activity. These can be distinguished by simple growth tests 
(Table 3.1). 
Table 3.1 Growth profiles of chlorate resistant mutants 
Mutation a Nitrogen source 
nitrate nitrite hypoxanthine g lutamate ammonium 
niaD - ++ + + 
crnA + ++ + + 
cnx - +- + + 
nirA - -+ + + 
areA - -- - + 
a denotes loss of function mutations 
b nitrogen sources at a concentration of 10 mM 
c+ denotes wild-type growth whilst - denotes no growth 
(5) The pathway is dispensable and therefore mutations in the nitrate 
assimilation pathway should not alter growth or metabolic fluxes through 
important pathways. 
(6) Most filamentous fungi will utilize nitrate as a sole nitrogen source (Lily 
and Barnet 1951). 
(7) Mutants show extremely poor growth on nitrate, providing an efficient 
transformation system. 
The nitrate reductase gene would therefore a priori appear to 
be a suitable basis for the development of a homologous transformation 
system in A. oryzae. 
3.2 Selection of nitrate reductase mutants 
Nitrate assimilation defective spontaneous mutants were 
obtained by positive selection for resistance to chlorate (Cove 1979). The 
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exact mechanism of chlorate toxicity is not 
fully understood. It was 
originally thought that chlorate was toxic only after conversion to chlorite 
by nitrate reductase (Aberg 1947). However, chlorate toxicity and mutations 
conferring resistance have been studied in a variety of fungi (Lewis and 
Fincham 1970, Cove 1976 a, b, 1979). These studies suggest that the toxic 
effects of chlorate probably result from chlorate acting as an analogue of 
nitrate, reducing catabolism without acting as a nitrogen source, resulting in 
nitrate starvation. It is suggested (Cove, 1979) that NR plays a role in both 
the mediation of chlorate toxicity and in the inhibition of nitrate catabolism, 
correlated by its ability to regulate nitrogen assimilation. 
Chlorate resistant mutants were selected as described in Section 
2.8.6. It was found that spontaneous mutants arose at a frequency of 1 in 106 
viable spores. In all 73 mutant chlorate resistant strains were isolated and 
further purified on chlorate-containing minimal medium with glutamate 
as the sole source of nitrogen. 
Mutations in at least 10 genes can produce a chlorate resistant 
phenotype; seven of these genes are involved in the production of an active 
NR (Cove, 1976b). One is the structural gene for NR (niaD), one (nirA) is 
encoded for a regulatory element and the remaining 5 (cnxA-J) are involved 
in the synthesis of a co-factor shared with xanthine dehydrogenase 
(Pateman et al. 1967, Cove 1970,1976b, Scazzocchio 1974). Fortuitously niaD 
mutants can be differentiated from crnA, cnxA-J, nirA and areA mutants on 
the basis of simple growth tests (Table 3.1). The ability of the A. oryzae 
mutants to grow on nitrate, nitrite, ammonium, hypoxanthine, proline or 
glutamate as A sole nitrogen source was assessed (Table 3.2). Eleven had a 
phenotype indicative of nitrate reductase structural mutants (niaD), i. e. they 
failed to grow with nitrate but grew on other nitrogen sources. 
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Three putative niaD mutants were tested for reversion to 
nitrate utilization and it was found that one allele, namely niaD 14, showed 
a reversion frequency of less than 1 in 107 viable spores and hence this 
strain, designated AO 1.1, was considered to be a suitable stable recipient for 
transformation experiments. Strain AO 1.1 was used to make a niaDl4pyrG1 
double mutant, (designated strain AO 4.2) for co-transformation 
experiments with pyrG, in a similar way to the method described in section 
2.8.5 (Mattern et al. 1987). 
Table 3.2 Characterization of A. oryzae chlorate resistant strains 
putative mutation a observed number 
niaD . 11 
crnA 6 
cnx 28 
nirA 28 
areA 0 
a denotes loss of function mutation 
3.3 Isolation and characterization of the A. oryzae niaD gene 
A 2.4 kb XbaI fragment of pILJ141 (Johnstone et al. 1989) 
containing the protein encoding sequences and introns of the 5' region of 
the A. nidulans niaD gene was radiolabelled and hybridized against 
genomic DNA from A. oryzae, A. niger, and P. chrysogenum digested with 
EcoRl. Unique bands of 2.8,2.5 and 6 kb were observed with A. niger, A. 
oryzae and P. chrysogenum respectively (Figure 3.2). Bacteriophage DNA 
from putative clones isolated by our EEC collaborator, Mrs. I. Mattern were 
digested with restriction enzymes and probed with the A. nidulans 
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fragment. However hybridization was very poor and did not correspond to 
sizes of genomic digests similarly probed 
(Data not shown). Thus, an A. 
oryzae DNA library of 40,000 plaques was hybridized with the 
A. nidulans 
2.3 kb Xbal fragment as described in section 2.7.4, and 17 positive clones were 
identified. Two of these clones ()STA51 and ? STA62) were purified further. 
Both clones contained SaII fragments (5.5 kb and 8.2 kb respectively) which 
hybridized strongly to the A. nidulans niaD probe and these overlapping 
fragments were subcloned into pUC18 to give plasmids pSTA13 and pSTA14 
respectively. 
These plasmids were introduced into the niaDl4 mutant, 
strain AO1.1, (described in Section 3.2) according to the transformation 
protocol detailed in Section 2.8.1. Only pSTA14 was capable of phenotypic 
rescue of the mutant to nitrate utilization. It was therefore assumed that 
pSTA14 but not pSTA13, contained the entire nitrate reductase structural 
gene. Radiolabelled Xbal digested pSTA14 was hybridized to a Southern blot 
of wild-type A. oryzae DNA (Figure 3.3). Fragments identical to the original 
genomic hybridization with the XbaI fragment of A. nidulans niaD were 
observed. This showed positive identification of the done. No evidence was 
detected for rearrangements of the clone sequences in pSTA14 (by 
comparison with wild type restriction endonudease profiles) was detected. 
The plasmid pSTA14 was mapped by restriction analysis (Figure 3.4). 
3.4 Homologous transformation with niaD. 
Transformation of A. oryzae niaD14 with circular pSTA14 gave 
an average of 64 transformants per µg plasmid DNA (Table 3.3). The back- 
ground growth, with nitrate as a sole nitrogen source, was extremely poor 
and no abortive transformants were observed (Figure 3.5). This observation 
is in contrast to other fungal transformation systems (Mattere et al. 1987, 
Hahm and Batt 1988, limura et a!. 1987, Ballance and Turner 1985, Hynes 
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1986, Johnstone 1985). Transformation levels were increased to an average 
of 455 transformants per µg DNA when pSTA14 was cleaved with Hind III 
(Figure 3.4), cutting the fungal DNA insert outside the gene. Other fungal 
research groups have likewise observed changes in transformation 
frequencies using linear molecules depending on the site of cleavage 
(Dhawale and Marzluf 1985, Skatrud et al. 1987, Wang et al. 1988). Increases 
in transformation frequencies with linear DNA is thought to be caused by 
increased cross-over between the ends of the linearized fungal DNA and its 
chromosomal counterpart. Increased transformation frequency was not 
observed if the plasmid was linearized within the bacterial sequence, similar 
results were observed in Cephalosporium acremonium by Whitehead and 
co-workers (1990). 
3.5 Molecular analysis of A. oryzae transformants 
To determine the types of integration events that had occurred 
using circular pSTA14, chromosomal DNA of 22 nitrate utilizing 
transformants was analysed by Southern blotting followed by hybridization 
with either A. oryzae niaD sequences or pUC18. Chromosomal DNA was 
digested with Pstl which does not cut the fungal insert of pSTA14 but does 
have a site in the polylinker (Figure 3.4). The expected genomic PstI 
fragment is 9.7 kb (Figure 3.3). Three types of hybridization profile were 
observed, representative examples of which are shown in Figure 3.6. Nine 
transformants similar to T027, lacked pUC sequences and had a niaD- 
hybridising Pstl band of approximately 9.7 kb which was indistinguishable 
from the recipient band. Such transformants were most likely a result of 
gene conversion and could be said to be of Type III integration as described 
in S. cerevisiae (Hinnen et al. 1978 and Section 1.8). A second group of five 
transformants, exemplified, by T024 showed a single band of 12 kb 
hybridizing to pUC while the resident n iaD band was replaced by two other 
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bands of 12 kb and 8.9 kb. In these cases it would appear that a single copy of 
pSTA14 had integrated at the resident niaD locus. This 
form of integration 
may be called homologous additive integration, as described 
by Hinnen and 
co-workers (1978). The third group of eight transformants represented 
by 
T026, were seen where the resident n iaD was replaced by three bands, 
border fragments of 12.0 kb and 8.9 kb as well as a band representing the unit 
length of pSTA14 (11.0 kb), indicating that more than one copy of pSTA14 
had integrated in tandem at the niaD locus. No examples were seen of 
integration into a non-homologous site, Type U transformants (Hinnen et 
al. 1978). Analysis of Southern blots of genomic DNA from eight 
transformants obtained using HindIII digested pSTA14 (Figure 3.3), showed 
the presence of a single 9.7 kb niaD hybridizing Pstl band in all 
transformants and no pUC-hybridising sequences (data not shown). This 
indicates that as expected, transformation with Hin dill- leaved pSTA14 
results in only gene replacement and eliminates bacterial sequences. 
3.6 Co-transformation 
The suitability of introducing non-selectable genes into A A. 
oryzae was assessed by using the pyrG gene for repair of uracil auxotrophy 
(de Ruiter-Jacobs et al. 1989), uidA for ß-glucuronidase (Roberts et al. 1989), 
N. crassa tub-2 for benomyl resistance (Orbach et al. 1986) and the S. 
hindustanus gene for phleomycin resistance linked to a A. nidulans 
promoter (van den Hondel pers. comm). Co-transformation was performed 
as described in section 2.8.2, results are shown in Table 3.3. 
Co-transformation of all the genes except that of phleomycin 
resistance was rather low when compared with, for example the pyrG 
system in A. oryzae, where using pyrG as a selectable marker, co- 
transformation frequencies were around 25 % (de Ruiter-Jacobs et al. 1989). 
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Table 3 .3 Co-transformation 
in A. oryzae with niaD 
System Co-transformation frequencya 
(%) 
PY cb4 
uidAc 9 
tub2c 6 
phleoc 24 
a Co-transformation of all genes was obtained as judged by 
phenotypic expression. Frequencies shown are an average 
of four experiments. 
b Strain A04.1 used 
c Strain AO1.1 used 
However, transformation with pAN8-1 was higher, 24 %. Additionally a 
higher than average transformation frequency to nitrate utilization was 
observed when both pSTA14 and pAN8-1 plasmids were introduced into 
strain AO1.1. Transformation of A. oryzae to phleomycin resistance using 
pAN8-1 plasmid gave unusually high frequencies of transformants for a 
heterologous system (see Section 5.2). Thus, in this case, it could be that the 
co-transforming DNA, the pANS-1 plasmid, influenced the transformation 
frequency and thus increased the co-transformation frequency of an 
otherwise low frequency co-transformation system. 
3.7 Discussion and conclusions 
An efficient homologous transformation system based on the 
niaD system has been developed for A. oryzae. The levels of transformation 
can approach 800 transformants per gg DNA. The average transformation 
frequency with circular plasmid DNA was 64 transformants per gg DNA, 
this is slightly higher than other homologous transformation systems 
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described for A. oryzae;. For example the pyrG system gives an average of 40 
transformants per gg DNA (de Ruiter-Jacobs et al. 1989) and the met system 
an average of 20 transformants per µg DNA (Iimura et al. 1987). 
The niaD system may be especially useful for transformation of 
industrial strains of A. oryzae since mutants can be easily isolated without 
the use of random mutagenesis, bacterial sequences can be eliminated by 
leaving pSTA14 with HindlI, and also no ectopic integration events occur, 
thus transformants are easy to analyse and interpret and there is little 
likelihood of the plasmid DNA integrating at, or disrupting, a site 
important for industrial enzyme production or essential for growth. The 
system also offers a tightly regulated promoter that could be linked with a 
gene of a heterologous protein, especially useful in cases where the 
heterologous protein may be toxic to the organism or a secondary product is 
required from the same fermentation. It is possible to introduce non- 
selectable genes into A. oryzae by co-transformation with niaD. Co- 
transformation frequencies were low in the experiments performed, but 
higher levels may be able to be achieved by using more favourable a ratio of 
non-selected plasmid to selected plasmid, instead of the 1: 1 molar ratio used. 
The nitrate reductase system may be of general usage for 
developing transformation in filamentous fungi. Nitrate reductase mutants 
have been isolated from a number of filamentous fungi (Unkles 1989, 
Malardier et al. 1989). Transformation systems have been developed based 
on the niaD gene for a number of fungi (Daboussi et al. 1989, Malardier et al. 
1989, Whitehead et al. 1989,1990). It is pertinent to state that I was also 
involved in developing this system in the related industrial fungus 
Gibberella fujikuroi (Sanchez-Fernandez et al. 1991) and improving the 
transformation frequency of A. niger (Campbell et al. 1989). 
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Figure 3.2 Heterologous hybridization of the Aspergillus nidulans niaD gene 
Panel (A) Genomic DNA from lane: - (1)A. niger, (2) A. oryzae, (3) 
Penicillium chrysogenum, was digested with EcoRI and fragments were 
seperated on a 0.8 % agarose gel. Panel (B) Following transfer to nylon the 
blot was probed with a 2.3 Kb 32p- labelled XbaI fragment containing the A. 
nidulans niaD gene. Hybridization was at low stringency (54°C, washed once 
with 5X SSC). The positions of ) Hindill molecular size markers are 
indicated. 
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Figure 3.3 Back hybridization of pSTA14 to Southern blots containing 
digested genomic DNA. Aspergillus oryzae genomic DNA was digested with 
lane: - (1) EcoRI, (2) Pst!, (3) BamHI, (4) Bgill. Following electrophoresis and 
Southern blotting, hybridization was carried out using Pst! -digested pSTA14 
as probe at 65 °C with washed to 0.2 X SSC. The positions of HindIIl 
molecular size markers are indicated. 
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Figure 3.5 Appearance of control and transformed niaD14 cells on nitrate 
and ammonium. (A) Untransformed cells on the non-selective nitrogen 
source ammonium; (B) Untransformed cells on nitrate; (C) and (D) cells 
transformed with circular pSTA14 on nitrate. 
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Figure 3.6 Southern Analysis of transformants. Genomic DNA from three 
representative transformants and the recipient strain AO1.1 was digested 
with PstI and fragments were separated on 0.8 % agarose. After transfer to 
nylon the blot was probed first with a 32p labelled, 5.5 kb HindiI fragment of 
pSTA14 Panel (A). Following boiling twice in distilled water containing 1% 
SDS, the blot was probed again with pUC18 Panel (B). Hybridization was 
carried out at 65 °C with washes down to 0.. 2 x SSC. The position of 
X/HindM molecular weight markers (kb) are indicated. 
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ýhapter4 
Homologous transformation of A. oruza_ e using pyrG 
4.1 Introduction 
Transformation systems based on the orotidine 
5'-monophosphate (OMP) decarboxylase gene (pyrG in A. oryzae, pyrA in A. 
niger, pyr4 in N. crassa) have been developed in a number of filamentous 
fungi (see Table 1.3), including A. oryzae We Ruiter-Jacobs et al. 1989). The 
OMP-decarboxylase gene is a convenient selectable marker for 
transformation since pyrimidine-auxotrophic mutants can be positively 
selected for using 5-fluroorotic acid (5-FOA) resistance (Boeke et al. 1984). It 
would seem that 5-FOA is converted to the toxic 5-fluro-IJMP by the action 
of enzymes involved in uridine metabolism. Mutations in OMP- 
decarboxylase and OMP-pyro-phosphorylase genes produce 5-FOA resistant 
mutants. 
This chapter describes the isolation of pyrimidine auxotrophs 
in A. oryzae, strain SAO200 (protease reduced, see Chapter 9) and the 
subsequent complementation of these mutants to uridine prototrophy by 
pAO4-2 plasmid DNA, containing the A. oryzae pyrG gene (de Ruiter-Jacobs 
et al. 1989). 
4.2 Generation of pyrimidine auxotrophs in A. orvzae strain SA200 
Spores from A. oryzae strain SAO200 were mutagenised, 
enriched to separate nuclei, and mutants in pyrimide metabolism selected 
for on media containing 5-FOA as described in Section 2.8.5. In order to 
ensure that the mutants obtained were independent, aliquots of conidia 
were kept separate in the mutagenesis and enrichment stages and only one 
5-FOA resistant mutant was selected per enrichment plate. Six independent 
5-FOA resistant strains were purified further and tested for auxotrophy 
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(Table 4.1). Three alleles, namely pyrG 54,81 and 120, were considered to be 
pyrimidine auxotrophs. These putative mutants were designated strains 
SAO201,202 and 203 respectively. Mutations in either pyrG or pyrF in A. 
oryzae can result in uridine auxotrophy, so the strains were transformed 
with pAO4-2, a plasmid containing A. oryzae pyrG gene (de Ruiter-Jacobs et 
al. 1989) and complementation of uridine auxotrophy with this plasmid was 
considered indicative of a pyrG- phenotype. 
Table 4.1 Growth tests of 5-fluroorotic acid (5-FOA) resistant mutants of 
Aspergillus oruzael 
mutant MMb MM + 
Uridine 
MM + Uridine 
+ 5-FOA 
CMC+ 
Uridine 
3 + +++ +++ +++ 
45 - + + + 
54 - ++ + ++ 
60 +/- + + ++ 
81 - +++ +++ +++ 
120 - ++ + +++ 
a +++ represents growth equivalent to wild type growth on non-selective 
media 
- represents no growth 
b Aspergillus minimal media 
c Aspergillus complete media 
4.3 Homologous transformation with pyrG 
Protoplasts of the putative pyrG mutant strains SAO201,202 
and 203 and strain A04-2, a niaD/pyrG double mutant (Mauern et al. 1987) 
were generated and transformed with circular pAO4-2 DNA according to the 
protocol outlined in Section 2.8.1. Transformation experiments yielded a 
maximum of 10 sporulating pyr+ colonies per gg of plasmid DNA. In 
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addition, many abortive colonies were found. Transformation frequencies 
(Table 4.2), were lower in all strains compared to a previous report in A. 
oryzae (de Ruiter-Jacobs et al. 1989), even when the exact transformation 
protocol described in this report was followed with strain A04-1, thus the 
low frequency could only be attributed to differences in equipment and 
operator. Since pAO4-2 transformed strains SAO201,202 and 203 to uridine 
auxotrophy, at an equivalent frequency to strain A04-2, all were considered 
to be pyrG - mutants as opposed to pyrF- 
Table 4.2 Transformation frequencies of Aspergillus oryzae strains with ti 
Strain Transformants µ plasmid DNAa Mean 
A04-1 lb, 1,1,1,2 1 
SAO201 lb, 10,9 7 
SA0202 lb, . 3,5 3 
SA0203 10b, 0,2,1,2 3 
a Transformation protocol as described in section 2.7.1 
b Transformation protocol as described by de Ruiter-Jacobs et al. (1989). 
4.4 Discussion 
The generation of three pyrimidine auxotrophs in A. oryzae 
strain SAO200 is described. The mutants were complemented with the A. 
oryzae pyrG gene (de Ruiter-Jacobs et al. 1989). The transformation 
frequency of the mutants (average of 7 per µg plasmid DNA) was lower than 
previously described in A. oryzae (de Ruiter-Jacobs et al. 1989). However, 
this was not considered to be a function of the mutants, but rather because 
of differences in the equipment and operator. Additionally many abortive 
transformants were obtained, a feature of this transformation system also 
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described by other workers (de Ruiter-Jacobs et al. 1989, Smith et al. 1991, 
Goosen et al. 1987, Ballance and Turner 1985). 
Although the transformation frequency of this system is not as 
great as others previously developed for A. oryzae (niaD Chapter 3, amdS 
Chapter 5) it may still be of use in introducing heterologous genes into A. 
oryzae. The strain SAO200 in which these mutants have been obtained has a 
protease reduced (prtA") phenotype (see Chapter 9). It is believed that this 
reduction in protease production is brought about by a mutation in one of 
the control genes involved in nitrogen metabolism which concomitantly 
confers chlorite resistance in strain SAO200, rendering it unsuitable for the 
selection of niaD mutants. Therefore, the generation of pyrG mutants will 
allow this strain to be genetically manipulated for the production of 
heterologous proteins. 
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Cha ter 5 
Heterologous Transformation in A. cry zae 
5.1 Transformation of A. oruzae with the amdS gene of A. niduians 
5.1.1 Introduction 
The A. nidulans amdS gene encodes acetamidase which has 
been studied in detail. Much is known about the genetics and regulation 
(Hynes 1978,1979) of this system and genetic clones have been isolated 
(Hynes et al. 1983). Many filamentous fungi grow poorly with acetamide as 
sole nitrogen and/or carbon source. Such fungi have been shown to lack 
DNA sequences detectably similar to A. nidulans amdS; for example, A. 
niger (Kelly and Hynes 1985). Thus the amdS transformation system has the 
advantage, in many cases, that metabolic mutants are not required. A 
feature that may be important in the genetic manipulation of industrial 
fungi. The A. nidulans amdS gene has been employed in a variety of fungi 
as a dominant marker for selecting transformants on the basis of acetamide 
utilization. It has been used in A. nidulans (Tilburn et al. 1983, Hynes et al. 
1983), A. niger (Kelly and Hynes 1985), A. terreus (Upshall 1986), 
Cochliobolus heterostrophus (Turgeon et al. 1985), T. reesei (Pentillae et al. 
1987), Glomerella cingulata (Rodriguez et al. 1987) and P. chrysogenum (Beni 
and Turner 1987). Additionally the amdS promoter has been used to obtain 
the controlled expression of the E. coli heat labile enterotoxin sub-unit B 
gene in A. nidulans (Turnbull et al. 1989). However, to date this attractive 
selection system has never been utilized in A. oryzae. It is the intention of 
this study to determine whether this system can be applied to A. oryzae and 
to assess its usefulness in the introduction of genes encoding heterologous 
proteins. 
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'. 12 Test of selection procedure 
Wild type strains of A. oryzae were found to grow relatively 
well on minimal medium containing 10 mM acetamide as the sole nitrogen 
source (Data not shown). This could possibly be due to degradation of 
acetamide by non-specific amidases and to impurities in the agar. However, 
it was found that this leaky growth was considerably reduced by introducing 
5 mM CsCI into the media. The rationale for this technique is not 
completely understood, but the addition of CsCl has been used to facilitate 
the selection revertents on a variety of nitrogen sources (Rand and Arst 
1977) and to suppress background growth of other fungal species on 
medium containing acetamide (Tilburn et al. 1983, Kelly and Hynes 1985). 
The addition of 5 mM CsCl reduced the background growth of A. oryzae on 
media containing acetamide sufficiently to detect transformants. 
5.1.3 Transformation of A. oryzae using the A. nidulans amdS gene. 
Mycelium from A. oryzae strains was grown and protoplasted 
according to the transformation protocol described in section 2.8.1. 
Protoplasts were transformed with 1.4 µg of p3SR2 plasmid DNA, a 8.8 kb 
pBR322 based derivative where the smaller EcoRI/SaII fragment has been 
replaced by a5 kb EcoRI/SaII fragment of A. nidulans DNA, containing the 
entire coding region and a cis-acting control region of the amdS gene (Hynes 
et al. 1983). Selection media contained 5 mM CsC1,10 mM acetamide as the 
sole nitrogen source and 1M sucrose as the osmotic stabilizer. 
Two types of transformants were observed; larger colonies that 
sporulated well and upon further incubation; numerous smaller, weaker 
growing colonies. It was later found that although the larger transformants 
were stable with no selective pressure through several rounds of 
sporulation, the smaller colonies were unstable and rapidly lost the ability 
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to utilize acetamide when successively replicated. This phenomenon of two 
forms of transformants, large stable and smaller unstable abortive 
transformants, is analogous to the findings in A. niger (Kelly and Hynes 
1985) and A. nidulans (Tilburn et al. 1983). Transformation frequency was 
on average 62 stable transformants per µg plasmid DNA, over six separate 
experiments. This compares favourably with frequencies noted in other 
heterologous transformation systems. 
5.1.4 Analysis of transformants 
Chromosomal DNA was prepared from untransformed A. 
oryzae and 12 amdS transformants and digested with BamHI before being 
transferred to nitrocellulose membrane and probed with radiolabelled 
p3SR2/EcoRI. The wild type strain showed no homology to p3SR2 (Figure 
5.1, lane 1). Transformant DNA hybridized strongly to the probe at a 8.8 kb 
BamHI fragment (Figure 5.1, lanes 2 to 13). The restriction enzyme BamHI 
cuts once in the 8.8 kb plasmid, p3SR2, suggesting multiple tandem 
integration had occurred. This was also observed in A. niger (Kelly and 
Hynes 1985). Further signals suggested internal rearrangements and/or 
multiple integration had occurred to different degrees in each transformant. 
(Figure 5.1). 
Lanes 14 to 17 of Figure 5.1 contain DNA from acetamide 
utilizing colonies which had been transformed with the plasmids pHIL61A 
and pHIL63*. These plasmids in addition to the amdS gene, which is used 
for selection, have the hIL6 gene under the control of the A. niger 
glyceraldehyde phosphate dehydrogenase (gpd) gene promoter (M. 
Broekhuijsen, TNO Laboratories, pers. comm. ). The transformation 
frequency using DNA from these plasmids was lower than when the 
plasmid p3SR2 was used, 5 transformants per µg plasmid DNA. However, 
these plasmids are larger than p3SR2; therefore there are less plasmid 
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molecules per gg plasmid DNA with pHIL61A and pHIL63* than with 
p3SR2. Additionally, direct comparisons of the transformation frequency 
cannot be made between the plasmids, as other variables such as plasmid 
purity must be taken into account (see Section 1.8). BamHI also cuts once in 
the 11.2 kb plasmids pHIL61A and pHIL63*. Figure 5.1 shows that 
hybridization of the pHIL61A and pHIL63* transformants to the amdS 
specific probe occurred at 11.2 kb BamHI fragments. Suggesting that multiple 
tandem integration had occurred with these plasmids. The plasmid copy 
number (as estimated by the intensity of the signal, judged crudely by eye) in 
transformants of pHIL61A and pHIL63* appears to be lower than in p3SR2 
transformants. This may be because the integration events and perhaps 
even the up-take of the plasmid DNA have been directed by the A. niger 
gpdA promoter, which would exhibit homology to the A. oryzae genome. 
5.1.5 Co-transformation 
The plasmid pFGA6HIL6T2Arg, carrying the hIL6 coding 
region fused with the control regions of the A. niger glucoamylase gene (R. 
Contreras, University of Gent, pers. comm. ), was introduced in equimolar 
concentration with p3SR2 to A. oryzae protoplasts, and transformants were 
selected for on media containing acetamide and ceasium chloride as before. 
Genomic DNA was prepared from 12 acetamide utilizing transformants, 
Southern blotted and probed with the radiolabelled hIL6 specific probe, an 
EcoRI/BamHI fragment of the plasmid pSP64GcHIL6 (R. Contreras, 
University of Gent, pers. comm. ). The hIL6 specific probe also bound to an 
8.8 kb BamHI fragment as the amdS specific probe had done. BamHI cuts the 
plasmid pFGA6HIL6T2Arg twice yielding pUC8 and the 8.8 kb insert. 
Sequences homologous to hIL6 were found in 10 out of the 12 
transformants tested (Figure 5.2). This correlates with other work, in A. 
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niger (Kelly and Hynes 1985) where the co-transformation 
frequency when 
using the amdS system was reported as high. 
5.1.6 Conclusion 
A transformation procedure has been adapted for A. oryzae 
based on the A. nidulans amdS gene, coding for acetamidase, first described 
by Hynes and co-workers (1983). The system is efficient, for a heterologous 
system, yielding an average of 62 transformants per µg of plasmid DNA. 
Additionally a high number of unstable transformants were obtained from 
the initial selection, however, these could be easily identified visually and 
distinguished from the larger more stable transformants which maintained 
the ability to utilize acetamide though several rounds of replication with no 
selective pressure. 
The am dS gene integrated apparently randomly into the 
chromosome and often in multi-copies, tandemly integrated. Plasmids with 
no selectable marker could be introduce into the A. oryzae genome using 
co-transformation with the amdS gene, probably also integrating in multi- 
copies like the amdS gene. However, if the amdS gene was used as a 
selectable marker on another plasmid, the transformation frequency was 
reduced. This reduction in transformation frequency may have been a result 
of differences in plasmid purity. Alternatively, integration of the plasmids 
and therefore transformation frequency, could have been affected by, the A. 
niger gpdA promoter, which showed some homology to the A. oryzae 
genome. 
This system may be particularly useful when working with 
industrial strains of A. oryzae as no mutant strain is required. The 
transformation and co-transformation frequencies were sufficient and 
integration was found to be multicopy, which may be an advantage if a high 
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yield of a gene is required. However, this may also 
be a disadvantage in that 
multicopy random integration into the genome of an 
industrial strain may 
cause a disruption in a gene of commercial value. 
It appears that the amdS 
gene has little or no homology with the A. oryzae genome. However, when 
the amdS gene is linked to DNA that does have some homology, 
integration could be directed by the homologous region and not the amdS 
gene, resulting in a reduction in transformation and integration 
frequencies. However, despite this the amdS system is still a useful system 
for the introduction of the gene encoding heterologous proteins into A. 
oryzae. 
5 .2 Heterologous transformation of 
A. oryzae using phleomycin resistance 
Use of an antibiotic resistance gene as a selectable marker has 
the advantages of not usually requiring mutant isolation and confers a 
positively selectable dominant phenotype. The coding region of most 
antibiotic resistance genes used in transformation systems are of bacterial 
origin. Transformation based on phleomycin resistance has been developed 
for a number of filamentous fungi including A. oryzae (Mattern and Punt 
1988). Phleomycin and the related antibiotic bleomycin appear to act 
through single DNA strand scission following sequence-selective binding 
(Fox et al., 1981). The product of the phleomycin/bleomycin resistance gene 
ble functions as a binding protein and has very high affinity for these 
antibiotics, thus preventing them from interacting with DNA. 
This transformation system is attractive as no mutant strain 
selection is required. This section briefly describes the results obtained when 
A. oryzae was transformed to phleomycin resistance using the plasmid 
pAN8-1, which carries the S. hindustatis ble gene under the control of the 
A. nidulans gpdA promoter and trpC terminator (C. M. J. J. van den Hondel, 
TNO Laboratories, pers. comm. ). 
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5.2.2 Results 
Transformation of A. oryzae with the pAN8-1 plasmid yielded 
an average of 16 transformants per µg plasmid DNA over an average of 
7 
experiments. Although this result appears to be very low when compared 
with the two transformation systems previously discussed (Chapter 3 and 
Section 5.1) it is important to realise that the transformation protocol used 
in these experiments differed slightly from that described in Chapter 3 and 
was not as efficient. Mycelial cells were grown for 18 hours and protoplasted 
for 2 hours in 50 ml protoplasting buffer containing 10 ml mercaptoethanol 
and 0.5 g Novozyme. No PEG solution was added during the 
DNA/protoplast incubation which was at room temperature. Four volumes 
of PEG solution (4 ml) was added afterwards. Protoplasts were allowed to 
regenerate on nonselective media for 24 hours at 30 °C and then overlain 
with 4 mls of CM containing 100 µg/ml of phleomycin. Regeneration of 
protoplasts was low (approximately 3% total cells) when this method was 
employed and transformation with the niaD gene was also lower than 
described in Chapter 3 (4 transformants per gg DNA, averaged over 10 
experiments). It therefore seems likely that the transformation efficiency 
with phleomycin would be quite high if the more efficient method detailed 
in Chapter 3 was followed. Transformants, however, were not stable with 
only 11 out of 53 transformants resistant to phleomycin after 3 rounds of 
replication on non-selective media. When pSTA14 was introduced as a co- 
transforming plasmid along with pAN8-1 co-transformation efficiency was 
25 %, similar to that previously reported (Mattern and Punt 1988). 
5.2.3 Discussion 
A. oryzae can be transformed with the S. hindustatis ble gene 
to phleomycin resistance indicating that A. oryzae is capable of recognising 
S. hindustatis genes. Transformation levels of an average of 16 
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Aransformants per gg plasmid DNA are reported however it is considered 
that this frequency would increase if a more efficient transformation 
protocol was employed. 
Whilst this transformation system has the advantage of not 
requiring mutant generation, it has the disadvantage that the method was 
more complicated and that the phleomycin required to maintain stable 
transformants is expensive. Also it may not be desirable in certain instances 
to introduce a bacterial gene, particularly one that encodes an antibiotic in 
clinical use 
5.3 Heterologous transformation of A. oryzae utilizing the A. nidulans argB 
5.3.1 Introduction 
While literature supports that the use of heterologous 
constructs generally yields lower transformation frequencies than 
homologous system (e. g. Ballance et al., 1983; Casselton and de la Fuente 
Herce, 1989; Randall et al., 1989; Wostemyer et al., 1987; Revuelta and 
Jayaram, 1986; Whitehead et al. 1990). Filamentous fungi have been shown 
to be able to recognise transcription signals from closely related species thus 
enabling the convenience of an available heterologous gene to be used. 
The argB transformation system has been extensively used in a 
variety of filamentous fungi (Table 1.3) including A. oryzae (Hahrn and Batt, 
1988, Imura et al. 1987). This section reports in the heterologous 
transformation of A. oryzae strain 1560-6, an arginine auxotroph of 
industrial interest, with the A. nidulans argB gene. 
5.3.2 Results , 
Two arginine requiring strains of A. oryzae, strains 1560-6 and 
YTH-13, were transformed to prototrophy with plasmids pILJ16 and pSTA4, 
both carrying the A. nidulans argB gene. Transformation frequencies of both 
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plasmids was low, 6 transformants per gg 
for pILJ16 and 3 transformants per 
µg for pSTA4. Some strain variation was seen, strain 
YTH-13 exhibited a 
slightly higher transformation frequency than strain 
1560-6 and had little or 
no spontaneously occurring revertents. Revertents occurred 
in strain 1560-6 
at a low frequency, however, these could be distinguished 
from 
transformants as the revertents were flatter, denser sporulating and more 
sprawling clonies. The co-transformation frequency was assessed by the 
introduction of pHIL61A and pHIL63*, co-transformants were detected by 
Southern blotting. The co-transformation frequency was found to be 50 %. 
5.3.3 Discussion 
Arginine auxotrophs of A. oryzae can be transformed to 
prototrophy with the A. nidulans argB gene. Transformation frequencies 
were low, an average of 6 per µg plasmid DNA. However, this was expected 
for a heterologous system. Co-transformation efficiency was 50 % allowing 
non-selectable genes to be introduced into the fungal genome. 
The arginine auxotroph, strain 1560-6, is an industrial strain 
and produces high levels of a-amylase and it is hoped that, since this strain 
is an efficient protein secretor, it can be genetically engineered to produce 
copious amounts of hIL6. The amdS system described earlier cannot be used 
as a method of transformation in this strain, because the arginine required 
for growth also acts as a nitrogen source, preventing selection on acetamide. 
Therefore, although the transformation frequency of this heterologous 
system is low, it may still prove a valuable tool in the high level expression 
of heterologous proteins in A. oryzae. 
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Figure 51 Analysis of A. oryzae amdS transformants 
Genomic DNA from acetamide utilizing transformants and the recipient 
strain, SA0204, was digested with HindIII and the fragments were seperated on 
a 0.8 % agarose gel. After transfer to nylon the blot was probed with 32p labelled 
p3SR2/ EcoRI. Lane 1 contains the recipient strain, acetamide utilizing 
transformants from p3SR2 Lanes 2-13; from pHIL61A Lanes 14 and 15; from 
pHIL63* Lanes 16 and 17. Hybridization was carried out at 65 °C and washed to 
0.2 x SSC. The position of X HindUI size markers are shown. 
127 
123456789 10 11 12 13 14 15 16 17 
qw 
Yý: Y 
op 
1 
I 
m 
Kb 
23. '1 
r 
9.9 
-mw 6.6 
4.4 
410 
2.3 
2.0 
Fiogure 5.2 Analysis of A. oryzae amdS co-transformants 
Genomic DNA from acetamide utilizing transformants and the recipient 
strain, SA0204, was digested with HindIII and the fragments were seperated on 
a 0.8 % agarose gel. After transfer to nylon the blot was probed with 32p labelled 
EcoRI/BamHI fragment of pSP64GcHIL6, containing a hIL6 specific probe. Lane 
1 contains the recipient strain, acetamide utilizing transformants from p3SR2 
Lanes 2-13; pHIL61A Lanes 14 and 15; pHIL63* Lanes 16 and 17. Hybridization 
was carried out at 65 °C and washed to 0.2 x SSC. The position of ). HindIlI size 
markers are shown. 
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The Isolation of Homologous Control 
Regions 
In order to facilitate the expression and secretion of a 
heterologous protein in A. oryzae it is necessary that the gene which 
encodes the protein is under the control of promoter and signal sequences 
that can be recognised and processed by the fungus. The nature of fungal 
promoters and signal sequences are discussed in Sections 1.4 and 1.6. 
Filamentous fungi have been shown to be able to recognise mammalian 
signal sequences (Leung et al. 1987ab, Cullen et al. 1987, Gwynne et al. 1987). 
However, if the control regions from a native protein were used, it was 
considered, that the protein would be translated, transcribed and secreted 
more efficiently. The benefits of having a strong and regulated promoter are 
also discussed in Section 1.4. The following three chapters report on the 
attempts made to isolate several genes from A. oryzae in order that their 
control regions may be harnessed to drive the expression and secretion of 
hIL6. 
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Chapter 6 
Isolation and characterization of the A. oryzae o vlase gene. 
6.1 Introduction 
Glucoamylase (EC. 3.2.1.3,1,4 a-D glucanglucohydrase) also 
referred to as amyloglucosidase, is an exoenzyme that catalyses the release of 
successive glucose units from the non-reducing ends of polysaccharides by 
hydrolysing a-1,4-D glycosidic linkages. Most forms of glucoamylase are also 
able to hydrolyze a-1,6-D glucan bonds when the next bond in the sequence 
is a-1,4. Glucoamylase is an important industrial enzyme; the chief users 
being the glucose syrup and the alcohol industries. 
The industrial importance of glucoamylase has generated a 
great amount of interest in this enzyme. A. niger and A. awamori secrete 
large amounts of this enzyme, up to 20 g per litre in some fermentations 
(Rambosek and Leach 1987). In A. niger two forms of glucoamylase enzyme 
are found, with MWs of 71 kDa and 61 kDa (Boel et al. 1984), both of these 
enzymes are transcribed from the same gene. The larger form of 
glucoamylase has a region which is able to bind to raw starch. This region is 
absent in the smaller enzyme. 
Glucoamylase is subject to carbon catabolite repression at a 
transcriptional and translational level (Bhella and Altosaar 1988). The genes 
encoding for glucoamylase have been cloned from A. awamori (Nunberg et 
al. 1984) and A. niger (Boel et al. 1984) and have been shown to have the 
same primary structure. 
Glucoamylase from A. niger is secreted in large quantities 
indicating that it has both an efficient promoter and signal sequence. The A. 
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niger glucoamylase gene control regions have been widely used in 
heterologous gene expression in filamentous fungi (Archer et al. 1990, 
Carrez et a!. 1990, Cullen et al. 1987, Gwynne et al. 1987) as not only is it a 
strong promoter but also it is regulated, being starch induced and subject to 
carbon catabolic repression (Bhella and Altosaar 1988). As many genes in 
filamentous fungi exhibit enough sequence homology to cross hybridize, 
the A. niger glaA gene was used to isolate the A. oryzae gene. 
6.2 Isolation of the A. o zae glucoamylase gene 
A glucoamylase specific probe was obtained from a BssHII 
restriction enzyme digest of the plasmid pFGA2, containing the A. niger 
glaA gene (Carrez et al. 1990). This was used to probe an A. oryzae gene bank 
of 40,000 plaques, heterologous hybridization techniques as described in 
Section 2.7.4 were employed. Five putative clones were isolated and one of 
these, 115A1, was purified further and DNA was isolated from it. A Southern 
blot of X5A1 DNA cut with restriction enzymes and hybridized with the A. 
niger glaA probe revealed a 6.6 kb EcoRI fragment which strongly hybridized 
to the probe. This fragment was subcloned into pUC13 and the resultant 
plasmid was designated pSTA1000 Restriction digests of pSTA1000 (Figure 
6.1) show it to have a different primary structure to A. niger (Boel et al. 1984) 
and A. awamori (Nunberg et al. 1984). 
6.3 Determination of glucoamylase production in A. ore. 
Glucoamylase is an inducible enzyme. To assay the production 
of glucoamylase in A. oryzae and to compare it with that of other 
organisms, fungi were grown in 100 ml of yeast nitrogen base (Difco) 
supplemented with 1% soluble starch (BDH) and 10 mM ammonium 
tartrate for 5 days at 30 °C. Mycelium was filtered off and the culture 
supernatants were assayed using the DNSA method described in Section 
2.10. The results (Table 6.1) indicate that A. oryzae produces a large amount 
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of starch reducing enzyme. Glucoamylase is produced commercially by A. 
niger so it seemed unlikely that A. oryzae produced more enzyme than the 
industrially favoured organism. DNSA actually assays the glucose 
equivalent in the test sample so large chain molecules with terminal 
reducing groups, produced by the action of an endoenzyme on starch would 
give similar readings to glucose. Glucoamylase is an ectoenzyme and 
hydrolyses both the al-4 and al-6 glucan bonds in polysaccharides splitting 
off glucose units from the non-reducing end of the chain. Thus the glucose 
Trinder assay (Section 2.11) was used to determine how much of the 
reducing sugar equivalent was actual glucose (Table 6.1). Results indicate 
that whilst A. oryzae produces a lot of starch reducing enzyme only a small 
percentage of this is glucoamylase, whereas most of the starch break down 
in A. niger supernatant can be attributed to glucoamylase. The anomalies 
arising in the actual amounts of reducing sugar in the table are most 
probably due to the sensitivities of the two assays. 
6.4 Conclusions 
The glucoamylase gene has been isolated from A. oryzae and 
shown to have a different primary structure from the A. niger (Boel et al. 
1984) and A. awamori (Nunberg et al. 1984) glucoamylase genes. 
The A. niger glaA control regions have been widely used in 
heterologous gene expression in filamentous fungi (Archer et al. 1990, 
Carrez et al. 1990, Cullen et al. 1987, Gwynne et al. 1978) as it offers a strong 
and regulated promoter and efficient signal sequence. However, assays 
indicated that A. oryzae does not produce large quantities of glucoamylase, 
therefore the A. oryzae gene may not have such a strong promoter. 
Glucoamylase is the subject of a patent by Novo Industries, thus may not be 
available for large scale industrial processes, also it is not the major secreted 
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protein in A. oryzae. It was decided therefore to investigate some of the 
enzymes produced commercially by A. oryzae. 
Filamentous Fungi. 
Organisms Glucose 
E uivalentb 
Actual 
Glucosec 
A. oryzae (Wild Type) 80.3 1.1 
A. oryzae strain SOA200 110.5 1.4 
A. niger (Wild Type) 2.3 7.9 
A. nidulans (Wild Type) 1.5 5.8 
P. chr so enum (Wild Type) 1.2 1.3 
a: Fungal cells were grown in YNB (Difco), 1% soluble starch, 10 mM 
ammonium for 5 days at 30 °C. Samples of mycelia free culture fluid were 
incubated at 37 °C 30 minutes with 0.5 % final concentration soluble starch. 
Enzyme activity was assessed by the amount of glucose liberated. 
b: Glucose equivalents were calculated using DNSA as described in Section 
2.10 expressed as g glucose per g dry weight of mycelium. 
c: Actual glucose was calculated with the glucose Trinder assay (Sigma) 
expressed as g glucose per g dry weight of mycelium 
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Chanter 7 
Isolation and dhaiacteri_zation of the a-amylase gene from A. oruzae 
7.1 Introduction 
a-Amylase (a 1,4-glucan-4 glucanohydrolase, EC3.2.1.1) 
catalyses the cleavage of a-1,4 glycosidic linkages. This enzyme has many 
technical applications particularly in the baking and brewing industries and 
in oriental fermentations, where it has been involved in the traditional 
production of soya sauce, miso and sake for 2000 years. Indeed this enzyme 
was included in a patented fermentation procedure by Jokichi Takamine as 
early as 1894. (Takamine 1894). A. oryzae is one of the most efficient 
a-amylase secreting fungi (Wirsel et al. 1989), this enzyme, also known as 
Taka amylase, was first described by Akarbori and co-workers (1954). The 
complete amino acid sequence and three dimensional structure of Taka 
amylase have been determined (Toda et al. 1982, Matsuura et al. 1984). From 
these studies it was determined that the mature secreted Taka amylase is a 
glycoprotein comprising of 478 amino acids folded into two globular 
domains; A (residues 1-380) and B (residues 381-478). The amino acids 
involved in substrate binding and calalytic function are located in domain 
A, but the function of domain B remains unclear (Matsuura et al. 1984, 
MacKay et al. 1985, Ito et al. 1987). Recent reports describe two a-amylases 
(Gines et al. 1989) that are produced from three genes in A. oryzae, one gene 
fails to produce mRNA (Wirsel et al. 1989) and the nucleotide sequences of 
these genes are detailed. However these reports were not available at the 
time this work was done. 
Much is known about the regulation of A. oryzae cc-amylase 
and the amino acid sequence of the protein has been described (Toda et al. 
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1982). Enzyme activity is induced by starch or maltose (Erratt et al. 1984, 
Yabuki et al. 1977) and is also regulated by catabolite repression (Bhella and 
Altosaar 1987). The a-amylase promoter is both strong and regulated in A. 
oryzae, and thus is attractive for utilizing in the expression of heterologous 
proteins. It was therefore decided to attempt to isolate the a-amylase gene 
from A. oryzae using oligonucleotide hybridization, the sequence of which 
would be extrapolated from the published amino acid sequence. 
7.2 Determination of cc-amylase production in A. orb 
After the disappointing yield of glucoamylase from the 
laboratory strain of A. oryzae (see Chapter 6), it seemed prudent to 
determine the a-amylase production, although previous work suggested 
that the major starch reducing enzyme in A. oryzae was a-amylase. 
Confirmation was with PAGE. Commercial a-amylase and samples of cell 
free culture fluid, taken after A. oryzae wild type had been grown in liquid 
minimal media, containing 1% soluble starch as a sole carbon source, were 
subjected to electrophoresis on both denaturing and native gels. The major 
extracellular protein from A. oryzae had identical mobility with the major 
protein in commercial a-amylase (Figure 7.1). Native gels were overlain 
with 1% agarose containing 1% soluble starch (BDH), and incubated at 37 
°C for 2 hours. After this time the agarose was stained with iodine and 
clearing was observed over the major protein band in the culture fluid 
extracts (Data not shown). 
7.3 Isolation of the A. oryzaec -am, ly ase gene 
Using the published amino acid sequence (Toda et al. 1982) an 
oligonudeotide was designed. Due to financial constraints it was decided to 
keep the nucleotide as short as possible. A 17-mer oligonucleotide was made 
from the information in this report, selecting amino acids 186-191 as this 
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sequence contained 2 tryptophan residues, an amino acid 
that has no 
degeneracy in its nucleotide sequence. 
Glu --- Trp -- Tyr --- Asp -- Trp -- Val 
GAAG UGG UAUC GAUC UGG GU JAM1 
The melting temperature for the above oligonucleotide was 
calculated to be 48 °C giving a hybridization temperature of 38 - 43 °C. The 
sequence of the oligonucleotide was compared with the sequences in the 
Genbank data base using Genetics Computer Group Sequence Analysis 
Software Package version 5.3 (1988). Allowing 2 mismatches a total of 22 
similarities were found, including S. cerevisiae 3-phosphoglycerate kinase 
and intracellular sporulation specific glucoamylase, none of the matches 
were with a-amylase sequences. Allowing three mismatches the 
oligonucleotide had similarities to greater than 200 genes, so hybridization 
conditions were made to be fairly stringent, to prevent adherence to 
unrelated genes. However, the melting temperature of the oligonucleotide 
and the fact that under stringent conditions (2 mismatches) no similarities 
to a-amylase sequences had been shown had to be taken into consideration. 
Thus, hybridization was at 6X SSC at 40 °C. However, no hybridization to 
Southern blotted A. oryzae and A. niger wild type DNA occurred, even 
when the hybridization temperature was lowered to 35 °C (Figure 7.2 Panel 
B). 
To confirm that this negative result was caused by lack of 
hybridization of the oligonucleotide and not inefficient transfer of genomic 
DNA onto the filter during Southern blotting. The blot was stripped by 
repeated boiling in 1% SDS and reprobed with an oligonucleotide that had 
been designed for identifying the A. niger gpdA gene, 
TAG GAG TGG ACG GTG GTC AT PPl 
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and also with a 3.7 Kb BamHI fragment of the pyrG gene 
from A. oryzae We 
Ruiter-Jacobs et al. 1989). Hybridization was at 50 °C for the oligonudeotide 
and 65 °C for the pyrG fragment. The results (Figure 7.3) confirmed that 
transfer of genomic DNA had occurred and this the negative result must 
have been due to lack of hybridization of JAM1. This could be because the 
oligonucleotide was produced from a non-conserved region of a-amylase 
and the strain of A. oryzae used by Toda and co-workers (1982) differed to 
the wild type strain used in this experiment. Later reports (Wirsel et al. 1989 
and Gines et al. 1989) comment on the differences in the amino acid 
sequence of their strains when compared to the strain of Toda and 
colleagues (1982). Two of these differences in the amino acid sequence have 
been corrected by Toda (cited in Ohnishi et al. 1986). However, there were no 
differences in between the published DNA sequences of the a-amylases, 
although they originated from different strains of A. oryzae (NRC401013, 
Gines et al. 1989 and DSM63303, Wirsel et al. 1989) and JAM1 was not 
synthesized from sequences corresponding to any of these alterations. 
Although this does not rule out changes in non-functional coding regions 
between strains of A. oryzae it seems unlikely as there is even extensive 
DNA sequence homology (greater than 98%) between the a-amylase genes 
of A. awamori and A. oryzae (Korman et al. 1990). These species of fungi, 
although members of the same genus are not considered to be closely 
related according to the taxonomic schemes outlined by Raper and Fennell 
(1977). It is worth comment at this point that Korman and co-workers (1990) 
used co-incidently, an almost identical oligonucleotide to JAM1 to attempt 
to isolate the A. awamori a-amylase gene. Their oligonucleotide, derived 
from amino acids 184-189 according to the sequence of Toda and colleagues 
(1982), failed to hybridize to A. awamori genomic DNA. 
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It has been reported (Rogers et al. 1985 and Nakajima et al. 1986) 
that 3 domains in a-amylase genes corresponding to the active sites are 
highly conserved through evolution. Meanwhile Novo Industries had 
published the nucleotide sequence of Taka amylase from A. oryzae (Boel et 
al. 1989). The nucleotide and the amino acid sequence of A. oryzae cc- 
amylase were compared with the corresponding sequences of B. subtilis 
a-amylase (Yamazaki et al. 1983), Streptomyces limosus a-amylase (Long et 
al. 1987) and human salivary gland a-amylase (Nakamura et al. 1984) using 
the Best Fit computer programme in the package described above the three 
regions were identified. Region one was found to be well conserved but the 
amino acid sequence was very degenerate in the use of nucleotides. Region 
2 had some degree of conservation but was very short and the amino acid 
sequence was also degenerate. Region 3 (amino acid residues 313 to 318 of A. 
oryzae) was considered the most suitable for the manufacture of an 
oligonucleotide as it was well conserved and the amino acids involved were 
not too degenerate in their use of oligonucleotides. Two further 
oligonucleotides were constructed one was an exact copy of the nucleotide 
sequence published by Boel et al. (1989) the other was a degenerate form of 
this. 
TTC GTC GAG AAC CAC GAC AA JAM2 (amino acids 313 to 318) 
T'I'C GTN GAAG AATC CATC GATC JAMS 
The degenerate oligonucleotide (JAM3) was compared with the sequences in 
the Genbank data base as previously described. Allowing 2 mismatches 120 
similarities were found, the majority of these similarities were either 
a-amylases or the related cyclodextrin transferases (Schmid 1989). 
The oligonucleotides were hybridized to Southern blots of A A. 
oryzae and A. niger DNA, digested with BamHI, EcoRI and SaII at 50 °C for 
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the conserved oligonudeotide and 35 °C for the 
degenerate oligonucleotide. 
Both the oligonudeotides hybridized to 2 bands in the EcoRI and Sail digests 
and to 3 bands in the BamHI digest of the A. oryzae DNA and the 
degenerate oligonudeotide hybridized to 2 bands in the A. niger DNA 
(Figure 7.2). This result was checked by hybridizing radiolabelled pHW300 
(containing the cDNA sequence of (x-amylase) to the same digests of 
A. oryzae at 65 °C, high stringency conditions. The same banding pattern as 
the conserved oligonucleotide was observed (Figure 7.4). As a stronger 
signal was obtained using the cDNA done of a-amylase this was used to 
screen the A. oryzae and A. niger gene banks. Banks of 40,000 plaques were 
screened as previously described and 20 positive clones were identified from 
each bank. One of these A. oryzae putative clones was purified further and a 
BamHI fragment of the DNA which hybridized strongly to JAM2 was 
subcloned into pUC18, the resultant plasmid was designated pSTA900 
(Figure 7.5). The result was confirmed by back hybridization of radiolabelled 
plasmid to the original X done and to genomic DNA (Figure 7.6). 
Genomic hybridization of the cDNA and oligonucleotides (Figure 
7.2 and 7.4) showed that A. oryzae has several a-amylase genes. Wirsel and 
co-workers (1989) describe three a-amylase genes from A. oryzae (amyl, 
amy2, amy3), one of which amy2 does not produce mRNA. In order to 
establish which gene was contained in pSTA900, restriction digests were 
compared with published maps (Wirsel et al. 1989). Plasmid pSTA900 was 
found to contain an insert of fungal DNA that corresponds to amy3 (Wirsel 
et al. 1989) and a northern blot of A. oryzae total RNA, purified from 
mycelium grown on media containing 1% starch as a sole nitrogen source, 
when probed with radiolabelled pHW300 gave a hybridizing message of 
approximately 1800 base pairs (Figure 7.7), which correlates with the size of 
message produced by amy3 (Wirsel et al. 1989). 
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7 .3 Isolation of the a amylase control sequences 
In order to utilize the control regions of a-amylase for 
heterologous expression it was necessary to link them with the hIL6 gene. 
To facilitate this our collaborators in Gent had constructed an 
oligonucleotide (RCI) 
5' GTC CAC AGG CGT GCC CAA AGG AGG 3' RCl 
that was homologous to, the start of transcription of the A. oryzae a-amylase 
gene and also contained a NaeI restriction enzyme recognition site, into 
which the hIL6 gene could be inserted. Unfortunately, things were 
complicated slightly by the fact that, the amy3 gene possessed two NaeI 
restriction sites, which first had to be disrupted. As NaeI is a blunt end cutter 
Ba131 was utilized for the mutagenesis. Plasmid DNA from pSTA900 was 
cut with NaeI and then treated with a high concentration of Ba131 according 
to the protocol described by Maniatis et al (1988). Ba131 has 3' exonuclease 
activity that removes monophosphates from both 3' termini of double 
stranded DNA and also endonuclease activity. Thus ssDNA generated by 
the 3' exonudease is degraded by the endonuclease. The 3' exonuclease is 20 
times more efficient than the endonudease. If a high enzyme concentration 
is used the single strand is only about 5 nucleotides long at each terminus 
and 10-20 % of molecules can be blunt end ligated directly. At low enzyme 
concentrations the single stranded DNA is very long and repair with T4 
polymerase is required before ligation. However, despite repeated attempts 
this method was unsuccessful. It was therefore decided to circumvent this 
problem by subcloning the control sequences, thus removing the unwanted 
NaeI recognition sites. An EcoRI/Sail fragment of pSTA900 containing the 
a-amylase control regions was subcloned into pUC13 and the resultant 
plasmid was designated pSTA36 (Figure 7.5). 
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In order to introduce the NaeI site, required for the linking of 
the hIL6 gene, a method of oligonucleotide-directed site-specific 
mutagenesis described by Morinaga and co-workers (1984) was employed. 
This method used a plasmid vector instead, of the more usual single- 
stranded M13 phage vector. Since a cloned gene in an M13 vector consists of 
single stranded DNA, double stranded constructs can be directly constructed 
using synthetic oligonucleotides as primers achieving a high yield of 
mutants. In contrast, when a gene is cloned into a plasmid vector, the 
position to be mutagenised must be made single stranded, resulting in a 
lower yield of mutants. However, this method has the advantage that the 
plasmid vector requires no further manipulation after mutagenesis, 
whereas the mutated gene in a M13 vector must be transferred into a 
plasmid vector. 
The method is out-lined in Figure 7.8. The plasmid pSTA36 
was cleaved within the ampicillin gene with the restriction enzyme Scal. 
This enzyme leaves blunt ends after cutting so self-circularization was 
selected against during the subsequent ligation, and to be certain that it did 
not occur, the plasmid was treated with CIP. Plasmid DNA from pUC13 was 
cut with EcoRI and Sall. Both cut plasmids were purified and all traces of 
enzyme removed by phenol: chloroform extraction. The cut plasmids 
(fragments I and II respectively) were mixed together with 12.5 pmol of the 
synthetic oligonudeotide RC1 and 0.1 x TE to give a final volume of 10 µl 
and 2 µl of ligase buffer. The DNA fragments were denatured by boiling for 
3 minutes and then allowed to reanneal by gradual cooling; 30 °C for 30 
minutes, 4 °C for 10 minutes and ice for 10 minutes. Upon reannealing of 
the DNA fragments two new DNAs were formed, DNA-A and DNA-B 
(Figure 7.8), in addition to the original fragments I and II. The 
oligonucleotide is complementary to only one of the strands so it therefore 
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hybridizes only to DNA-A (Figure 7.8). The mixture of renatured DNA was 
treated with Klenow and ligase, to convert to dosed circular DNA, before 
transforming into E. coli. Since fragments I and II cannot religate the 
ampicillin resistant transformants should be a mixture of two different 
plasmids; one carrying the mutant a-amylase control regions and the other 
the wild type. Transformants carrying the mutant gene were selected by 
colony hybridization to the synthetic oligonucleotide. Out of the 55 
transformants analysed in this way one was found to hybridize to RCI. 
However, restriction analyses of the DNA from this transformant showed it 
to be incorrect. Morinaga and co-workers (1984) reported a 13 % yield in 
mutants using this method so clearly the yield of a-amylase mutants was 
lower in this experiment, possibly caused by inefficient CIP treatment of 
pSTA36. Insufficient time prevented the repeating of this experiment but it 
is hoped that a mutant can be achieved in future attempts at this method. 
7.4 Conclusions 
An cc-amylase gene was cloned from A. oryzae and identified 
as Amy3 (according to Wirsel et al. 1989). The control regions from this gene 
have been isolated and attempts were made to introduce a synthetic 
oligonucleotide into them in order that the hIL6 gene could be put under 
the control of the a-amylase promoter and signal sequence. Unfortunately 
the first attempt was unsuccessful and time constraints prevented 
subsequent attempts. However, hopefully constructs can be made when this 
project is continued. 
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Figure 7.1 a-amylase production in A. oryzae. Aliquots (200 µl) of 
mycellia free media were taken from wild type A. oryzae cultures grown 
for 63 hours in minimal media containing (Lane 1) 1% glucose, (Lane 2) 1 
% soluble starch, (Lane 3) 1% glucose, 1% soluble starch as the sole 
carbon source, and applied to a 7.5 % SDS-PAGE. For comparison 
commercial a-amylase from A. oryzae was applied to the same gel. Lanes 
5-9 contain 20,10,5,3 and 1 µg a-amylase respectively. Lane 4 contains 
protein size markers as indicated 
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Figure 7.2 Genomic hybridization to three a"amylase derived 
oligonucleotides. Genomic DNA from A. oryzae was digested with (Lane 
1) BamHI (Lane 2) EcoRl, (Lane 3) Sall and genomic DNA from A. niger 
was digested with (Lane 4) Ba m HI, (Lane 5) EcoRl, (Lane 6) Sail. 
Fragments were seperated on a 0.8 % agarose gel and transfered to 
nitrocellulose. Hybridization with 32P labelled oligonucleotides (Panel A) 
JAM2 at 50 °C, (Panel B) JAMI at 35 °C, (Panel C) JAM3 at 35 T. All were 
washed to 6x SSC at the hybridization temperature. The position of 
). /HindfI molecular size markers (kb) are indicated 
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Figure 7.3 Hybridization of a A. niger glyceraldehyde 3-phosphate 
dehygrogenase (gpdA) specific nucleotide and the A. oryzae pyrG gene. 
Genomic DNA from A. oryzae was digested with (Lane 1) BamHI (Lane 2) 
EcoRI, (Lane 3) Sall and genomic DNA from A. niger was digested with 
(Lane 4) BamHI, (Lane 5) EcoRI, (Lane 6) Sall. Fragments were seperated 
on a 0.8 % agarose gel and transfered to nitrocellulose. Hybridization was 
with 32P labelled (Panel A) PPI, a A. niger gpdA derived oligonucleotide 
at 50 °C and washed to 6x SSC. (Panel B) A 3.7Kb BamHI fragment of the 
A. oryzae pyre gene at 65°C and washed to 0.1 x SSC. The postion of 
). /HindIIl molecular size markers (kb) are shown 
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Figure 7.4 Genomic hybridization of an u-amylase cDNA clone. Genomic 
DNA from A. oryzae was digested with (Lane 1) BamHl, (Lane 2) EcoRl, 
(Lane 3) Sall and A. niger with (Lane 4) BamHI, (Lane 5) EcoRI, (Lane 6) SaII. 
After electrophoresis and Southern blotting hybridization, with 32P labelled 
HW300 (A. oryzae (x"amylase cDNA) was at 65 °C with washing to 0.1 x SSC. 
The position of ). /HindIII molecular size markers (kb) are indicated 
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Figure 7.6 Back Hybridization of pSTA900 to Southern blots containing 
digested genomic DNA. Genomic DNA fron A. oryzae was digested with 
(Lane 1) EcoRl (Lane 2) Bam HI and (Lane 3) Hind!!!. Following 
electrophoresis and Southern blotting, hybridization was carried out using 
radiolabelled pSTA900 as a probe at 65 °C , washed to 0.2 x SSC. The position 
of A. /HindIII molecular size markers (kb) are indicated. 
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Figure 7.7 Hybridization of a-amylase clones to northern blots containing 
total RNA. Total RNA was prepared from A. oryzae; (Lane 1) Strain AO1.1 
grown on minimal media (MM) containing 1% glucose, (Lane 2) Strain 
AOI. 1 grown on MM containing 1% soluble starch, (Lane 3) Strain 1560-6 
grown on MM, 1% glucose, (Lane 4) Strain 1560-6 grown on MM containing 
1% soluble starch as a sole carbon source. Hybridization with 32p labelled 
pSTA900 was at 42 °C. 
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Figure 7.8 Schematic diagram depicting the steps involved in site specific 
mutagenesis of the A. oryzae cc-amylase gene. Experimental details are 
described in the text 
151 
Add oligonucleotide 
Denatwce 
chapter 8 
Purification and sequencing off; zae Si nuclease 
8.1 Introduction 
Sl nuclease (EC 3.1.30.1) is an endonuclease (Sutton 1971) 
yielding 5'-monophosphates (Ando 1966). Under optimal conditions, the 
rates of hydrolysis of single- and double-stranded nucleic acids have been 
estimated to differ by a factor of 75,000 (Wiegand et al. 1975). Thus, S1 
nuclease is widely used in molecular biology, mainly for trimming single 
stranded protruding ends of DNA or RNA without significant nibbling of 
duplex ends (Hallewell and Eintage 1980, Berk and Sharp 1977). S1 nuclease 
can therefore be used for mapping transcripts (Weaver and Weissman 1979) 
and introns (Gannon et al. 1980) and for removing hair pin structures 
during cDNA synthesis. 
Purification of Sl nuclease from A. oryzae was first described by 
Ando (1966). The enzyme is a monomeric protein (Vogt 1973) with a 
molecular weight of 38,000 daltons (Oleson and Sasakuma 1980). It is a 
glycoprotein containing 18% carbohydrate residues (Oleson and Sasakuma 
1980) and has an optimum activity pH value of pH 4.2 (Vogt 1973). 
As Sl nuclease is a fairly important commercial enzyme in 
polynucleotide research and for the industrial production of 5' nucleotides 
it would be of interest to isolate the gene in order to study its expression and 
regulation, with a view to over expressing it in order to increase yields. In 
addition, the control regions from the gene could be used to regulate the 
expression of a heterologous protein in A. oryzae. As no data was available 
for the Si nuclease gene it was proposed that the protein should be purified 
and its amino acid sequence determined. An oligonucleotide probe could 
152 
then be extrapolated from the amino acid sequence and used to isolate the 
Sl nuclease gene. 
8 .2 Purification of 
Sl nuclease using PAGE 
A method of purification of A. oryzae Sl nuclease from crude 
a-amylase powder has been described (Vogt 1983), however, commercial 
preparations of S1 nuclease, designed for use in molecular biology, are 
readily available. It was thought that these would be an ideal source of 
purified enzyme for protein sequencing. However, when commercial Sl 
nuclease (Boehringer Mannheim) was analysed using SDS-PAGE at least 
two protein bands could be visualised with Coomassie Blue staining (Data 
not shown). Sl nuclease is prepared commercially from crude a-amylase it 
was therefore suspected that the contaminating protein was a-amylase. This 
was confirmed by SDS-PAGE the higher and stronger band in the 
commercial Sl nuclease enzyme ran to the same position as commercial a- 
amylase from A. oryzae (data not shown). Enzyme activity was analysed by 
electrophoresing Sl nuclease down native, tube-gels, which were then 
overlain with 1% agarose containing either 1% soluble starch or 10 gg/ml 
denatured Herring sperm DNA in 0.3 M NaOAc, 0.5 M NaCl before being 
incubated for 4 hours at 37 °C. The gels overlain with starch were stained 
with iodine and a-amylase activity was visualized by areas of clearing. The 
gels overlain with DNA were stained with EtBr, nuclease activity was 
judged as areas of clearing when visualized under U. V. light. The higher 
band was judged to be cc-amylase and the lower band Si nuclease (Figure 
8.1). The lower band was excised from the SDS tube gel and the protein was 
eluted. After extensive dialysis against Trifluroacetic acid the protein was 
lyophilized and attempts were made to sequence the protein using the 
Applied Biosystems protein sequencer, Model 470A/477A, at the SERC 
protein sequencing facility the University of Aberdeen. 
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Proteins eluted from PAGE gels often have blocked N-terminal 
ends, resulting from the reaction of the free radicals in the the gel with the 
N-terminal amino acid of the protein. This reaction effectively prevents the 
initiation of the protein sequencing reaction. Unfortunately, this was found 
to have occurred in this instance. In an attempt to overcome this problem 
the commercial Sl nuclease was electrophoresed using a SDS-gel that had 
been specially prepared to mop up the free radicals (Section 2.9.2). The 
protein was transferred onto Immobilon Transfer Membrane (Millipore) 
according to the protocol described by Matsudaira (1987 and Section 2.9.3). 
The membrane was stained using Coomassie Blue (Figure 8.2). As 
Coomassie Blue stain does not interfere with the sequencing reaction 
(Vandereckhove et a1.1985) the band that corresponded to the correct size of 
Sl nuclease was excised and then sequenced directly (Matsudaira 1987). 
Unfortunately, two sequences were detected in equal 
concentrations so it seemed that the mini SDS-PAGE system used in the 
above method had failed to separate the proteins in the commercial Sl 
nuclease efficiently. The equipment for this high purity form of SDS PAGE 
electroblotting is highly specialized and the cost of purchasing a larger rig 
was prohibitive, thus a alternative form of protein purification had to be 
investigated. 
8.3 Development of an enzyme assay for Sl nuclease 
As purification of Sl nuclease with PAGE had proved 
ineffective it was decided to attempt to isolate the protein using HPLC. In 
order to identify which fractions contained Sl activity it was necessary to 
develop an assay. Assays for Sl nuclease have been described (Wiegand et al. 
1975, Vogt 1973). However, these are very complex and involve the use of 
radionucleotides. Thus a simple, fast and economical assay was developed. 
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Herring sperm DNA was denatured and incubated with Si nuclease in the 
appropriate buffer (See Section 2.12). Degradation of nucleic acids was 
visualized on an agarose gel. The amount of Si nuclease activity 
in the 
fractions could be estimated by comparison with the amount of ssDNA 
degraded by known activities of commercial Sl nuclease (Figure 8.3). 
8.4 Purification of Sl nuclease using LC 
Commercial Sl nuclease was added to a reverse phase, wide 
bore (300A) column (RP-300, Brownlee) and subjected to a gradient. The 
initial solvent was 0.1% Trifluroacetic acid (pH 2) and final solvent 
Acetronitrile, Isopropanol, Methanol (1: 1: 1). The profile (Figure 8.4) showed 
two major peaks. Since the commercial enzyme had previously been shown 
to contain a-amylase and Sl, nuclease (ratio 5: 1) it was assumed that these 
were the two peaks, especially as the ratio looked correct. It was impossible 
to assay for St nuclease activity, as Sl nuclease is irreversibly denatured 
below pH 3.0 (Vogt 1973). Samples of fractions B and A were investigated 
using SDS-PAGE. Fraction number B was shown to be a homologous 
peptide of approximately - 32 kDa. Fraction A contained a peptide of 
approximately 52 kDa and a small amount of a contaminating protein. The 
major peptide in this fraction was assumed to be a-amylase. The peptide in 
fraction B was assumed to be Sl nuclease and the first 24 amino acids were 
sequenced (Table 8.1). 
Table 8.1 Amino acid sequence of the N-terminus of A. orvzae S1 nuclease 
Thr Glu Val Thr Asp Cys 6 
Lys Gly Asp Ala Glu Ser 12 
Ser Leu Thr Thr Ala Leu 18 
Ser Asn Ala Ala Lys Leu 24 
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Although this sequence bears no resemblance to that of a- 
amylase (Toda et al. 1982) and the peptide has a MW of 32 kDa as does S1 
nuclease it was not possible to assay the fraction, thus it could not be 
conclusively proven that the protein sequenced was Sl nuclease. 
Furthermore, the amino acid sequence in Table 8.1 is very degenerate in its 
use of nucleotides, so designing an oligonucleotide from this sequence 
would be difficult. It was therefore decided to attempt to purify Sl nuclease 
in away that would permit activity assays and, if this proved to be the same 
protein as initially sequenced, to produce a further, more extensive 
sequence in an effort to find a region of amino acids more amenable to 
oligonucleotide generation. The HPLC conditions were therefore changed; 
S1 nuclease was applied to an anion exchange column and treated with a 
gradient of 20 mM Tris-HCl pH 7.5 and 0.5 M NaCl, 20 mM Tris-HC1 pH 7.5. 
However, separation of peptides was extremely poor (Figure 8.5) and when 
fractions were analysed using SDS-PAGE they were found to be 
heterogeneous. An FPLC system was then utilized and separation of 
peptides appeared to have occurred (Figure 8.6). However, S1 nuclease 
activity was found to be present in two fractions, removed from separate 
peaks on the trace (Figure 8.7). Further attempts to purify Sl nuclease were 
then made using the reverse phase column, this time the initial buffer was 
1% Ammonium bicarbonate (pH 8.0) (Figure 8.8). Fractions corresponding 
to several of the peaks were analysed using SDS-PAGE and Sl nuclease 
activity assays. Fraction B was found to contain a protein MW 32 kDa, which 
degraded ssDNA (Figure 8.9). No a-amylase activity could be detected in any 
of the fractions, possibly due to the HPLC separating a Ca2+ ion or co-factor 
from the enzyme, but this meant that it was not possible to assay for any 
contaminating a-amylase in fraction B. Fraction B was therefore run down 
the RP-300 column at pH 2 and was found to consist of more than one 
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peptide (Figure 8.10). The first peptide 
had the same retention time as the 
original peptide that was sequenced (Table 8.1). The other peaks on the trace 
were considered to be either a small amount of contaminating a-amylase or, 
more probably, an artefact of the system, since these peaks occurred in 
varying amounts in several blank runs. Therefore the original peptide that 
was sequenced was probably Si nuclease. 
8.5 Cleavage of S1 nuclease with clostripain 
The 24 amino acid residues that were sequenced from the 
N-terminal end of A. oryzae Sl nuclease were unsuitable for designing an 
oligonudeotide as their codon usage was very degenerate. It was therefore 
decided to digest the Si nuclease protein into smaller peptides and sequence 
these in order to obtain a more suitable sequence for producing a 
oligonucleotide. Clostripain cleaves on the C-terminal side of arginyl 
residues. To a lesser extent cleavage can also occur on the C-terminal side of 
lysyl residues although this can be minimised by decreasing the reaction 
time or eliminated by succinylation of lysyl residues. 
Si nuclease was digested with activated clostripain according to 
the method of Cole and co-workers (1971 and Section 2.9.11). The resultant 
peptides were separated using the RP-300 using the pH 2 conditions 
described earlier and the two traces were compares (Figures 8.9 and 8.11). 
Peak C was thought to contain a new peptide so this was sequenced. 
Unfortunately the first two amino acid residues sequenced were glycine, 
which has a very high carry over on the sequencer and masks the 
appearance of other amino acids. 
8.6 Conclusions and further work 
A system to purify Sl nuclease has been described and the first 
24 amino acid residues of the protein have been sequenced (Table 8.1). The 
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nucleotide usage of these amino acids is very degenerate. In an attempt to 
sequence more of the protein, Sl nuclease was digested with clostripain, 
however the first two amino acids of the peptide fragment sequenced were 
glycine which prevented the detection of any more amino acids. 
It would be possible to digest Si nuclease further with 
dostripain, possibly by reducing the S1 nuclease and then pyridyethylating it 
to open the structure of the protein, making it more amenable to digestion 
with the clostripain. The resultant peptides could then be sequenced and the 
amino acid sequence of S1 nuclease determined. 
However the original aim of these experiments was to isolate 
the control regions of native proteins of A. oryzae in order that they could 
be utilized in the expression of heterologous proteins. While this work was 
proceeding I was able to isolate the a-amylase gene from A. oryzae (Chapter 
7). Also available are the genes of glucoamylase (Chapter 6), alkaline 
protease (Chapter 9) and glyceraldehyde dehydrogenase (Punt et al. 1987). As 
these genes are highly expressed in A. oryzae and time and finances limiting 
it was decided not to proceed further with this work in the short term. 
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Figure 8.1 PAGE analysis of A. oryzae commercial Si nuclease. S1 nuclease 
was applied to 7% native tube gels (pH 8.5,0.08 M Tris HCl) after 
electrophoresis the gels were soaked for 30 minutes in (Panel A) S1 
nuclease buffer (33 mM NaOAc, 50 mM NaCl, 0.03 mM ZnSO4, pH 4.5) 
(Panel B) a-amylase buffer (Tris-HC1 pH 4.8,10 mM CaCI). The gels were 
then over lain with 1% agarose containing (Panel A) 10 µg/ml Herring 
sperm DNA in S1 buffer, (Panel B) 1% soluble starch in a-amylase buffer 
and incubated at 37 °C for 4 hours. The gels were stained with (Panel A) 
ethidium bromide and (Panel B) iodine and clearing was visualized under 
UV light. 
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Figure 8.2 S1 nuclease protein blot onto Immobilon membrane. Sl nuclease 
was applied onto a specially prepared SDS-acylamide gel, lanes 2,3 and 4 
(see section 2.9.2). Following electrophoresis the protein was transfered 
onto immobilon membrane and stained with Coomassie Blue. Lane 1 
contains protein size markers (kDa) as indicated. 
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Figure 8.3 S1 nuclease assay. S1 nuclease enzyme (Lanes 1-5 contain 0,0.4,4, 
40 units respectively) was incubated with 5 µg herring sperm DNA 
(rendered single stranded by boiling for 10 minutes followed by quenching 
on ice) for 30 minutes at 37 °C. Following electrophoresis on 0.8 % agarose 
the gel was stained with EtBr and visualized under UV light. 
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Figure 8.4 HPLC profile of A. oryzae S1 nuclease. Commercial S1 nuclease 
was applied to a reverse phase wide bore (300A) column (RP-300 
Brownlee). The gradient was applied at 100 ml/minute, initial solvent 
concentration was 0.1 % Trifluroacetic acid (pH 2) and final solvent was 
acetronitrile: isopropanol: methanol (1: 1: 1). 
162 
9 
8 
7 
6 
S 
4 
C 
m 
i 
0 
23 
22 
21 
20 
19, 
18ý 
6 
17 
t 
i T7 i 
ý . i ' 
ý 
- 
I 
1 .I 
I"ýý !! 
1 ili 
!1 ý 
II 
1 1 1 
H 
liý 
; 
Iý: 1 !; II 
lI11 I12' Ii 
i 
i . 
s 
li: 
,! 
I'i ' i 
i 
li 
i !1 14 !' 111 
( 
j 
I g I 
1 
( 10 
º .' ,ý ii i ý 
Z 
I !! lil ' ' li t ' 1 !I 
ýj 
i 
I 
I 
il ;I I: Iý 
" 
iil 
l I 
I - 
ýi. 
ýi 
rtiý 
,i 
f1 
1}, 
ý ryý ' 
1, 
ý_ý 
1 
I 
ji l l ') 
j 
ill i ýI I I I I I ?H il 
,l 
H . l ll ý ,ý , !I ' i I, I e I t 1; r vr+iz nä, zi 'U 9920 iöd I! I ! I { I I III j ýj Ij ! I ý ý Ij ! I la 
l i 
Itl .: 
ýi l 
. C 
= I1 Lý 
- - - - -- - - -- -- 
T H 
. 10. 
ý 
i 
I 
. 
I I 1 i - r .. . . º , " I ii; ' i!. ' 1 Iý ( - R o l t0 9' I'i I 1 
1' ' 
'll' 
! 
'ýI! 
'1 (iil (I 
ý 
' 
I I T 
Figure 8.5 HPLC profile of A. oryzae S1 nuclease. Commercial S1 nuclease 
was applied to a anion exchange column (AX300,2.1 x 30 mm). The 
gradient was applied at 100 ml/minute, initial solvent concentration was 
20 mM Tris-HC1 (pH 7.5) and final solvent was 0.5 M NaCl, 20 mM Tris- 
HCl (pH7.5). 
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Figure 8.6 FPLC profile of A. oryzae Si nuclease. Commercial Si nuclease 
was applied to an Applied Biosystems FPLC 
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Figure 8.7 Sl nuclease assay of FPLC separated peptides. The lane numbers 
represent fractions from the FPLC separation of S1 nuclease (Figure 8.6). 
Samples were incubated with 5 gg Herring sperm DNA (rendered single 
stranded by boiling for 10 minutes followed by quenching on ice) for 30 
minutes at 37 °C. Lane 7 is a negative control and lane 8a positive control with 
40 units of S1 nuclease Following electrophoresis on 0.8 % agarose the gel was 
stained with EtBr and visualized under UV light. 
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Figure 8.8 HPLC profile of A. oryzae Si nuclease. Commercial Si nuclease 
was applied to a reverse phase wide bore (300A) column (RP-300 
Brownlee). The gradient was applied at 100 ml/minute, initial solvent 
concentration was 1% Ammonium bicarbonate (pH 8) and final solvent 
was acetronitrile: isopropanol: methanol (1: 1: 1). 
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Figure 8.9 S1 nuclease assay of S1 nuclease fractions seperated by HPLC pH 8. Fractions A and B collected from the HPLC separation shown in Figure 
8.8 were incubated with 5 µg Herring sperm DNA (rendered single stranded by boiling for 10 minutes followed by quen ching on ice) for 30 minutes at 37 °C. Lane 1 is a negative control and lanes 2 and 3 are positive controls 
with 4 and 40 units of S1 nuclease Following electrophoresis on 0.8 % 
agarose the gel was stained with ethiudium bromide and visualized under UV light. 
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Figure 8.10 HPLC profile of A. oryzas S1 nuclease. Fraction B obtained 
from HPLC separtion of commercial S1 nuclease at pH 8 was applied to a 
reverse phase wide bore (300A) column (RP-300 Brownlee). The gradient 
was applied at 100 ml/minute, initial solvent concentration was 0.1 % 
Trifluroacetic acid (pH2) and final solvent was 
acetronitrile: isopropanol: methanol (1: 1: 1). 
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Figure 8.11 HPLC profile of costropain digested A. oryzae SI nuclease. 
Commercial S1 nuclease was digested with activated clostripain according 
to the method of Cole et a!. (1971) and then applied to a reverse phase 
wide bore (300A) column (RP-300 Brownlee). The gradient was applied at 
100 ml/minute, initial solvent concentration was 0.1 % Trifluroacetic acid 
(pH 2) and final solvent was acetronitrile: isopropanol: methanol (1: 1: 1). 
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Extracellular Protease Production in A. oruzae 
Members of the genus Aspergilli are widely used commercially 
for the production of proteases, particularly in the manufacture of oriental 
fermented foods, as discussed in Section 1.10. For example, A. oryzae 
produces a number of extracellular proteases, a feature which is unlikely to 
be desirable in a host organism for the production of heterologous proteins. 
Many workers consider that proteolysis of the heterologous product is the 
cause of low yields of these proteins in a number of organisms. (Carrez et al. 
1990, Turnbull et al. 1989, Ward et al. 1990, Barr et al. 1988). Additionally a 
recent report describes an increase in heterologous product when a protease 
mutant of A. awamori is employed (Ward et al. 1989). This section reports 
research investigations carried out on protease production by A. oryzae and 
describes the generation and characterization of protease reduced strains 
and assesses their usefulness in the production of heterologous proteins. 
The isolation of the A. oryzae alkaline protease gene is described and its 
subsequent mutagenesis in order that a specific protease mutant of A. 
oryzae can be made by reverse genetics. 
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Chapter 9 
Studies on the protease activity of A. or; zae and isolation of protease 
reduced strains 
9.1 Introduction 
The genus Aspergillus is widely used commercially for the 
production of proteases, particularly in the manufacture of oriental 
fermented foods (Section 1.10). The production of proteases from members 
of the Aspergilli, as discussed in Section 1.10, appears to be species and strain 
specific. Cohen (1973b, 1977,1981) reports that extracellular fungal proteases 
are produced in response to starvation of any one of carbon, nitrogen or 
sulphur. Additionally his strain of A. nidulans did not require an external 
protein source for the induction of protease production (Cohen 1973b). 
However, Gill and Modi (1981) describe a strain of A. nidulans that does 
require an external source of protein to induce protease production, a 
requirement also shared by A. niger (Pourrat et al. 1988), N. crassa (Hanson 
and Marzluf 1975) and Microsporum canis (O'Sullivan and Mathieson 
1971). This chapter reports investigations on extracellular protease 
production by strains of A. oryzae; describes the selection and 
characterization of protease mutants, and assesses their usefulness in the 
production of heterologous proteins. 
9.2 Characterization of extracellular proteases in A. oryzae. 
To study the extracellular protease production in the wild type, 
A. oryzae was inoculated onto media containing 1% Marvel (Cadburys) 
with or without an additional nitrogen source (either 5 mM glutamate, 10 
mM NH4 or 10 mM N03) and carbon source (1 % glucose), the plates were 
incubated at 30 °C for 48 hours. Extracellular protease production was as 
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judged by the clearing of the milk plates. It was found that further 
incubation at 4 °C for 2 days intensified the clearing. Under these conditions 
protease production was found to be inhibited in the presence of 
ammonium or nitrate. However, protease production remained unaffected 
by the addition of glucose to the media. (Figure 9.1). Additionally protease 
degradation assays were performed. Cell free extracts of culture fluid, in 
which A. oryzae had been grown, were incubated with known quantities of 
protein. Protein degradation was monitored using PAGE. A. oryzae 
extracellular proteases were found to require an external source of protein. 
Figure 9.2 Panel D, lane 1 is the result of incubating cell free culture fluid, 
after A. oryzae had been grown without protein in the medium, with 
carbonic anhydrase. The carbonic anhydrase is not degraded. In contrast 
Figure 9.2 Panel B, lane 6 is cell free culture fluid from A. oryzae, grown in 
media containing 1% skimmed milk (Marvel, Cadburys) and incubated 
with a similar amount of carbonic anhydrase. In this case the protein has 
been completely degraded, indicating that a external source of protein is 
required for protease induction in A. oryzae. 
The need for an external source of protein to induce protease 
production is not required in A. nidulans (Cohen 1973b) although a report, 
also on A. nidulans, by Gill and Modi (1981) suggests the the converse. 
Indicating therefore, that this need for induction probably varies between 
strains. Additional confirmation of the need for an external protein for 
induction of protease production in the laboratory strain of A. oryzae was 
obtained when a northern blot of total RNA from A. oryzae grown on 
media with and without 1% skimmed milk, was probed with a 
radiolabelled ), clone containing the alkaline protease gene from A. oryzae 
(Section 9.4) (Figure 9.3). Message RNA of the correct size, 1.7 Kb (Tatsumi of 
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al. 1988) was found only when the total RNA had been prepared from 
mycelia grown on media containing milk. 
9.3 Development of protease assays 
Protease assays were modified from an azocasein assay used to 
measure proteolytic activity in Bacteroides fragilis (Gibson and Macfarlane 
1988) the protocol is described in Section 2.9.7. To determine the optimum 
incubation period for these assays, mycelia free culture fluid from A. oryzae, 
grown in minimal media containing 1% skimmed milk, was incubated 
with azocasein for 1-6 hours and reactions were stopped at hourly intervals. 
The results indicate that protein degradation is complete after 6 hours, this 
must be due to exhaustion of the protease enzymes, as the substrate is in 
excess (Figure 9.4). To obtain maximum enzyme activity a3 hour 
incubation period was considered to be the most appropriate. 
It has previously been shown that A. oryzae produces several 
different extracellular protease enzymes, summarized below: 
rotease optimum pH reference 
Alkaline protease 10.5 Nakadai et al. 1973a 
Neutral protease I, 7.0 Nakadai et al. 1973b 
Neutral protease II 5.5-6 Nakadai et al. 1973c 
Aminopeptidase III 8.0 Nakadai et al. 1973d 
Acid protease 3-4 Davidson et al. 1975 
Using the above information it was decided to assay the 
protease activity of the strains under test at three pH values; 10.5,7.0 and 3.0, 
as it was expected that the results obtained from assays at these pH would 
reflect the activity of alkaline protease, the neutral proteases (I, U and III 
173 
combined) and acid protease respectively, without too much interference 
from proteases with other pH optima. The azocasein assay was found to be 
unsuitable at pH 3.0, as the protein precipitated out at this low pH, thus the 
degradation of haemoglobin was followed using Folins reagent. Samples of 
mycelia free culture fluid from A. oryzae strains induced with 1% skimmed 
milk were taken at different times and stored at -20 °C before being assayed 
according to the protocol in Section 2.9.7. It was later found that freezing, at 
any temperature ; -20 °C, -40 °C or -70 °C, had a deleterious effect on protease 
activity thus samples had to be taken immediately before being assayed. 
9.4 Isolation and characterization of A. oryzae mutants reduced in protease 
activi . 
Wild type conidia were mutagenised with UV light, to produce 
a 95 % kill rate and mutants defective in protease activity were selected for 
on minimal media, 0.8 mg/ml Sodium deoxycholate, 1% skimmed milk, 5 
mM sodium nitrate (Section 2.8.4). A protease defective mutant (mutation 
designated prtAl, strain designated SAO200) was generated in this way. This 
mutant did not produce a clear "halo" around the colony on milk plates 
(Figure 9.1). When samples of media fluid, taken from cultures of this 
mutant, grown under induced conditions, were incubated with BSA, 
carbonic anhydrase and lysozyme (see Section 2.9.6, for further conditions), 
degradation of these proteins was considerably reduced when compared to 
the wild type (Figure 9.2 Panels A, B, Q. However, when media extracts 
were incubated with hIL. 6 protein in a similar experiment, for as short a 
time as three hours, no hIL6 protein could be visualised with silver staining 
(Figure 9.2 Panel E). It has been shown that A. oryzae has several different 
proteases (Nakadai 1973 a, b, c, d, Davidson 1975) and also that certain 
proteases can be fairly specific in the peptide residues that they recognise 
(North 1982, Ido et al. 1987). Thus it was considered that strain SAO200 may 
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have one specific protease gene mutagenised, such that the protease 
responsible for recognising the predominant peptide residues in BSA, 
carbonic anhydrase and lysozyme had been mutagenised where as the 
protease, or proteases, which were responsible for degradation of hIL6 had 
not been mutagenised. To determine if the production of a single protease 
had been reduced, assays of protease activity at different pH, over a time 
course were performed. The results (Figure 9.5 Panels A, B, C) show that up 
to 60 hours of growth, wild type cultures produced more protease, active at 
all three pH, than the putative protease defective mutant (strain SAO200), 
however, after 60 hours the reverse is true. If the biomass curve (Figure 9.5 
Panel D) is compared with the protease activity curves it can be seen that the 
large increase in protease activity at 60 hours co-incides with the levelling 
off of growth. Thus the increase of protease production, after 60 hours of 
growth, by strain SAO200, may in part be due to the release of internal 
proteases caused by fragmentation of the older mycelium. The gradual rise 
of protease activity with time, shown in both strains, was thought, to be 
partially due to the length of time the media extracts were stored at -20 °C. It 
was later found that these conditions were detrimental to protease activity, 
and that storage at -20 °C for 14 days led to a complete inactivation of 
extracellular protease activity. Therefore these results were artificially low 
and cannot be taken quantitatively, however since both strains were treated 
in a similar way direct comparisons can be made. 
As strain SAO200 showed no hIL6 protection against 
extracellular protease activity; further mutants were screened for. Strains 
SAO1.1 (niaD-) and 1560-6 (argB-) were mutagenised using Method 2 
described in 6ection 2.8.4. This method allowed for separation of the nuclei 
before screening for reduced protease activity. Several niaD mutants that 
produced a reduced halo on milk plates were obtained. Media fluid extracts 
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from seven of these, that had been grown in minimal media containing 
glutamate and milk, were incubated with hIL6 protein. Figure 9.6 shows the 
extent to which hIL6 protein was degraded by the extracellular enzymes of 
putative protease mutants. One strain which did not visibly degrade the 
hIL6 or milk proteins (Figure 9.6, Lane 5) was designated prtA2 (strain 
designated SA0204). Several unsuccessful attempts were made to produce a 
similar mutant in strain 1560-6. However, azginine required by the strain 
for growth, concomitantly acted as a nitrogen source, that was sufficient to 
suppress protease production making detection of the mutants difficult. 
Notwithstanding this several putative mutants that failed to produce a halo 
on milk plates were isolated. However no hIL6 degradation assay could be 
performed on these putative mutants as the wild type strain did not degrade 
hIL6 under test conditions; presumably because of suppression of the 
proteases by the arginine required for growth. 
As the storage of the samples had effected proteases activity in 
the earlier assays, the experiments were repeated. Mycelium from Strains 
SA0200 and SA0204 and the wild type A. oryzae was filtered off and media 
extracts were assayed immediately at pH 7 and 10.5 as described in Section 
2.9.7. The assay was not performed at pH 3.0 because protease activity at this 
pH was not considered to be significant. Under the test conditions the 
original pH of the media was pH 6.5, which rose during growth of the 
fungus to pH 8.5. It seemed unlikely that a protease with an optimum pH of 
3.4 would be important to the organism during growth under these 
conditions. A study of 278 strains of fungi indicates that it is only acid 
producing fungi that produce a significant amount of acid protease and 
non-acid producing fungi that produce alkaline protease (Matsushimi et al. 
1981). A. oryzae is capable of growth at a wide pH range (pH 3- 10), so under 
certain growth conditions, acid protease may be essential. The protease 
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activity detected at pH 3 (Figure 9.5 A) may be a result of acid protease 
produced by the organism, but more likely was due to residual activity of 
the alkaline protease which is thought to be active at both pH 10.5 and pH 3 
(Poulsen and Hau 1986). Additionally, the low pH of the assay required that 
a different substrate and means of detection of degradation was used, 
resulting in different sensitivities in the assays, preventing direct 
quantitative comparisons with the assays at pH 7.0 and pH 10.5. 
The assays were repeated three times at both pH 7.0 and 10.5, 
the results of the assays of the three strains of A. oryzae are shown in 
Figures 9.7 to 9.10. These show similar profiles, but are not directly 
comparable as differences in biomass occurred on each occasion. The 
fluctuations in biomass were probably due to slight changes in growth 
conditions; media, temperature or age and amount of inocula, although 
efforts were made to standardize these parameters. The results are difficult 
to interpret; initially the two protease reduced mutants showed less protease 
activity than the wild type strain. However, this difference decreased with 
time and was highly dependent on biomass. It is impossible to say whether 
protease activity was reduced due to lower biomass or whether biomass was 
less because of reduced protease activity. The protease mutants could not 
utilize the milk protein for growth, so were not as rapidly growing as the 
wild type strain, and therefore were not able to secrete as much protease. At 
later growth times the protease mutant strains seemed to increase their 
protease output. However, as the mycelium became older, cell lysis would 
have occurred, releasing membrane bound proteases and internal proteases. 
These proteases in addition to participating in the azocasein reaction, would 
have broken down milk proteins during growth, allowing the mutants to 
grow more rapidly, and so secrete more proteases. 
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Strain SAO200 produced generally less protease than Strain 
SA0204, which in turn produced generally less protease than the wild type 
strain. Increasing the growth temperature (Figure 9.10) increased the rate of 
biomass production and therefore protease production, effectively shifting 
the profiles to the left. It was not possible to identify individual activities of 
the protease enzymes as, in addition to contaminating internal and 
membrane bound proteases, inhibitor studies showed that the external 
proteases did not operate exclusively at the different pH assayed (Figure 
9.11). Reports also indicate that the specificities of A. oryzae proteases to 
their substrates may alter with pH (Davidson et al. 1975, Poulsen and Hau 
1986). 
In both the mutants it would seem that all extracellular 
protease activity is reduced during the first 24 hours of growth. It is 
extremely unlikely that U. V. mutagenesis has mutated all the protease 
genes in both of the mutant strains, it is therefore assumed that some 
general control mechanism has been damaged. 
Strain SAO200 secreted cc-amylase and glucoamylase at levels 
equivalent to wild type A. oryzae (Table 6.1), so is not a general secretion 
mutant. This mutant grew normally on a variety of' nitrogen sources 
including nitrate but was resistant to chlorate. It is known that nitrogen 
metabolism and protease production are linked, so possibly a mutation has 
occurred in some control gene common to both systems. Figure 9.3 is a 
northern blot of total RNA from A. oryzae grown for 24 hours on media 
containing milk, probed with a radiolabelled X clone containing the alkaline 
protease gene isolated from A. oryzae (Section 9.5). The protease message is 
present in the wild type strain and SA0204 but absent from SAO200 
indicating that some control mutation has indeed occurred in this strain. 
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Strain SA0204 however, is not sensitive to chlorate and will not grow with 
nitrate as a sole nitrogen source (ie. still has its original niaD- phenotype). 
Additionally, if protease production is expressed per gram of biomass, 
protease activity increases to wild type levels after 36 hours of growth, 
therefore the mutation in this strain may have occurred in a temporally 
expressed protease enzyme (gene, secretion pathway or recognition system). 
Strain SA0204 did not digest hIL6 protein under conditions of 
the assay thus it was used in further experiments (Chapter 10) to assess the 
value of a protease mutant in the expression of a heterologous protein. 
Although strain SAO200 does not protect against hIL6 degradation by 
external proteases, other proteins were unaffected. Thus this strain may 
prove useful in the expression of heterologous proteins other that hIL6. As 
the strain is resistant to chlorate, it was not possible to easily generate a niaD 
mutation (see Chapter 4) therefore pyrG mutants were obtained in this 
strain for use in transformation experiments (Chapter 5). 
9.5 Isolation and characterization of the alkaline protease gene of A. or ze 
Alkaline protease from A. oryzae is a very important 
industrial enzyme, it is widely used in the baking and brewing industries 
and in oriental fermentations where it is recognised as one of the most 
important enzymes involved in the production of soy sauce. This enzyme 
has therefore attracted considerable interest. The enzyme has been purified 
and characterized (Nakadai et al. 1973a) and the DNA sequence has been 
published (Tatsumi et al. 1988). Alkaline protease from A. oryzae is a serine 
protease, consisting of 282 amino acids, MW 29,010 Da. Tatsumi and co- 
workers (1988) report that it is homologous with other serine proteases. For 
example protease B from S. cerevisiae (Moehle et al. 1987) shows 43.9 % 
similarity, the extracellular protease from Yarrowia lipolytica (Davidow et 
at. 1987) 41.2 %, and subtilisin from B. amyloiquefaciens 29 % similarity 
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(Wells et al. 1983). The three amino acid residues (Asp 32, His 64 and Ser 221 
of the subtilisin) which compose the active centre and the amino acid 
sequences surrounding these residues are conserved among the serine 
proteases. As a clone of the published sequence was not available it was 
decided to attempt to isolate the alkaline protease gene from the laboratory 
wild type A. oryzae strain using a oligonucleotide probe. In a previous 
attempt to design an oligonucleotide probe problems were encountered, 
where slight differences between strains of A. oryzae appeared to have been 
sufficient to prevent oligonucleotide hybridization (Chapter 7). It was 
therefore decided, to design the oligonucleotide from one of the active sites 
of the protease gene as these amino acid residues are the most likely to have 
been conserved between strains. Using the GenDataBase best fit program the 
published cDNA sequence and projected amino acid sequence of alkaline 
protease was compared to the nucleotide and amino acid sequence of the 
proteases mentioned previously and the three regions of conservation 
around the active site were identified. It was decided that the third region 
corresponding to the serine active site, nucleotides 637-690 would provide 
the best oligonucleotide so both an exact copy and a degenerate version was 
made. 
TCTGGTACCTCCATGGCTACTCCCCAC JAM 4 
ACYTCYATGGCYACYCCYCA JAM 5 
The oligonudeotides were compared against GenBank data 
bank but no similarities were found. When, the oligonucleotides were 
compared with the nucleotide sequences from the three protease genes 
described above allowing 2 mismatches the conserved oligonucleotide 
matched only the A, oryzae gene but the degenerate oligonucleotide 
matched with all three. Thus low stringency conditions were used. 
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The melting temperature of the homologous oligonucleotide 
was calculated to be 86 °C and that of the degenerate oligonudeotide 58 °C, 
both oligonucleotides were radioactively end labelled and hybridized at 50 
°C to Southern blots of genomic A. oryzae and A. niger DNA. JAM4 
hybridized to single fragments in the BamHI, EcoRI and SaII digests of the 
A. oryzae and A. niger genomic DNA. (Figure 9.12). This oligonucleotide 
was used to screen the A. oryzae and A. niger gene banks as previously 
described and 10 putative clones were identified from each bank. Three of 
these A. oryzae clones were purified further. Southern blotted DNA from 
all clones gave a3 kb BamHI fragment that hybridized strongly to the 
oligonucleotide. This was sub-cloned into pUC13 and the resultant plasmid, 
pSTA1001, was partially restriction mapped (Figure 9.13). The restriction 
map is very similar to that derived from the sequence published by Toda et 
al (1987) except for the EcoRI site within the gene. Confirmation of this 
result was obtained by back hybridization of the radiolabelled plasmid to 
genomic DNA (Figure 9.14). Bands obtained from this were of the same size 
as those obtained with the oligonudeotide. 
9.6 In-vitro mutagenesis of the protease gene 
The plasmid pSTA1001 (Figure 9.13) has a unique Kpnl site 
just upstream from the active serine site. It was thought that if this site was 
mutagenised then the resultant frame shift would disrupt the active site. It 
is known that if bacteria is transformed with linearized plasmid DNA then 
the E. soli inherent repair mechanisms will ligate the DNA and produce 
transformants at a frequency reduced by between 2-3 orders of magnitude. 
However short homologous sequences in the plasmid can align and the E. 
coli nucleases can cause deletions in the plasmid DNA (Conley 1985). A 
simple method of mutagenesis was therefore attempted. Plasmid linearized 
with KpnI was transformed directly into E. coli, and DNA from several of 
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the resultant transformants were mini-prepped. DNA from 2 of the 
plasmids did not cut with KpnI. One plasmid pSTA1002 was purified 
further. Restriction digests revealed that a 0.5 kb fragment between the 2 
HinCII sites had been deleted (Figure 9.13). 
It was expected to use this mutated gene to replace the working 
protease gene in A. oryzae. However, this process relies on gene conversion 
and it was thought that the long DNA sequence following the gene on the 
plasmid may inhibit hybridization and crossing over of the protease region, 
since it was larger than the gene itself. Therefore this region was deleted. 
DNA from pSTA1002 was digested with HindfI, Pstl and Xbal and then re- 
ligated the resulting plasmid was called pSTA1003. 
Plasmids pSTA1003 and pSTA1002 were used in co- 
transformation with the A. oryzae pyrG gene carrying plasmid, pAO4-2 We 
Ruiter-Jacobs et al. 1989) in strain A04-2 (niaD-, pyrG- double mutant, 
Mattern et a!. 1987). Also a pFGA6HIL6T2Arg transformant of strain 1560-6 
(designated TGA611) was co-transformed with pSTA1003 and pSTA1002 
employing the amdS system (Chapter 5). The transformation frequency for 
the pyrG system was low, as described in Chapter 4. Ten Uridine auxotrophs 
and 40 acetamide utilizing transformants resulting from these 
transformation were screened for reduced protease activity on milk plates. 
However, it was not possible to detect any reduction in protease activity. 
The two mutant plasmids have quite large deletions in the protease gene, 
these may have prevented hybridization to the homologous protease gene 
thus a further, more specific, mutation in pSTA1001 was attempted. 
Bacteriophage T4 polymerase was utilized to remove the 3' 
protruding sticky ends from KpnI digested pSTAI000, the DNA was then 
blunt end ligated. Plasmid DNA was prepared from the E. coli 
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transformants and digested with KpnI. A plasmid which did not cut with 
KpnI was amplified further and designated pSTA1004. From restriction 
digests it was ascertained that no large regions had been deleted from this 
plasmid as sites on either side of the KpnI site were still intact, although the 
EcoRI restriction site, mapped immediately adjacent to the KpnI site, was 
also mutagenised. This plasmid was co-transformed into protease positive 
strains of A. oryzae. Strain A04-1 and the transformant TGA611 were co- 
transformed with pAO4-2 and p3SR2, respectively, as before.. Additionally 
strain 1560-6 was co-transformed using the argB system (Chapter 5). In total, 
5 uridine auxotrophs, 100 acetamide utilizing transformants and 20 arginine 
auxotrophs resulting from these transformation experiments were screened 
on milk plates. However, it was not possible to detect any reduction in 
protease activity of the transformants on milk plates, the possible reasons 
for this are discussed below. 
There are several proteases in' A. oryzae and it is not known 
which are responsible for the digestion of the milk protein, used for the 
detection of reduced protease activity in the transformants. Experiments 
were performed to try to discover if one specific protease was mainly 
involved in the digestion of the milk protein, by using protease inhibitors 
incorporated into the milk plates. Serine proteases are selectively inhibited 
by PMSF, metalloproteases are inhibited by chelating agents such as EDTA 
and cysteine type proteases are inhibited by iodoacetate (Barrett and 
Salvesen 1986). Unfortunately the addition of these inhibitors to the milk 
plates caused; either the milk to clear, probably because of a pH change, or 
were toxic to the fungus preventing growth. It was not possible therefore to 
detect which protease was responsible for breaking down the milk protein. 
Thus, it is possible that the mutant alkaline protease gene had successfully 
replaced the homologous protease gene in the transformants, however, 
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detection was not possible by growth on milk plates as a protease other than 
the alkaline protease could be responsible for degradation of the milk 
protein. 
In the above transformants the mutant protease gene had been 
introduced into the fungus as a co-transforming plasmid, therefore not all 
the fungal transformants tested would contain the mutant protease gene 
and an even smaller percentage would have undergone gene replacement. 
Possibly not enough transformants were screened to detect a gene 
conversion. The transformation systems used may have also effected the 
gene conversion frequency, by targeting the co-transforming mutant 
protease gene to a locus homologous to the transforming plasmid. It has 
been reported, (this work, Chapter 3) that the nitrate reductase system 
selectively incorporates the transforming plasmid at the resident niaD 
locus. However, it is not known how this would influence the co- 
transforming plasmid and the transformation systems used in these 
experiments were selected to avoid this possible phenomenon. 
It was not possible to determine by Southern blotting whether 
the transformants contained the mutant protease gene as the homologous 
gene would also hybridize to any probe and the desired gene conversion 
events could not be detected. It was therefore decided to introduce a 
selectable marker into the mutant protease plasmid. This would at least 
enable conformation of transformation. However, it was considered to be 
important, that the selectable marker did not strongly direct the plasmid to 
integrate at a site other than the resident alkaline protease gene. For this 
reason it was decided to introduce the A. nidulans amdS gene into 
pSTA1004; as previous experiments (Chapter 5) had indicated that 
integration is not directed by the amdS gene, but possibly by homologous 
regions of DNA on the plasmid. 
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The plasmid p3SR2 was digested with EcoRI and SaII and the 5 
Kb fragment, containing the entire coding region and a cis-acting control 
region of the amdS gene (Hynes et at. 1983), was isolated. The ends of the 
fragment were blunt ended with T4 polymerase and it was subsequently 
ligated into pSTA1004 cleaved in the polylinker with SmaI. Unfortunately, 
this approach was unsuccessful even when the whole process was repeated. 
A different proceedure was then attempted. The 5 kb EcoRI/Sa11 fragment 
was isolated again and attempts were made to ligate it into similarly 
digested pSU20, a cloning vector carrying the chloramphenicol resistance 
gene. The intention was then, to digest the resultant pSU20 derived plasmid 
with Hin dIII and to introduce to this, the fungal DNA insert of Hin dIII 
cleaved pSTA1004. However, the initial ligations were unsuccessful and the 
purity of the amdS fragment was suspected as the cause. Unfortunately time 
constraints prevented the conclusion of this work. 
9.8 Conclusions 
The interaction of the several different proteases produced by 
A. oryzae makes characterization of the production of individual proteases 
difficult. In general, protease production in A. oryzae is repressed by 
ammonium, and to a lesser extent by nitrate, and requires a external source 
of protein for induction. 
A simple method for selecting A. oryzae protease defective 
mutants, on media containing skimmed milk, is described. Employing this 
method several mutants with reduced protease activity were obtained. Two 
of these mutants have been subsequently characterized. One mutant, 
SAO200 was considered to be control mutant, possibly in a general nitrogen 
metabolism control gene. The second mutant, SAO204 was thought to have 
a mutation that affected the temporal expression of one specific protease 
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gene, although it was not possible to determine exactly what this gene 
affected was. Strain SAO200 (mutation designated prtAl) protected against 
proteolytic degradation of a number of standard proteins so may prove 
useful as a host for the expression of heterologous proteins. However, the 
mutation prtAl did not protect against proteolysis of hIL6 so therefore 
would be of little use in this particular study. Strain SA0204 carrying the 
mutation prtA2 did not degrade hIL6 protein under the conditions of this 
study and so it was used in further experiments to assess the value of this 
protease mutant in the heterologous expression of this protein (Chapter 10) . 
The A. oryzae alkaline protease gene has been isolated. This 
gene may be important for a number of reasons. Proteases from A. oryzae 
have a number of commercial applications (Section 1.11 ) and also A. oryzae 
is used in the fermentation of oriental foods because of its high protease 
production. It may be possible to increase the yield of proteases in 
commercial strains of A. oryzae by introducing additional copies of the 
alkaline protease gene. Additionally the balance of the different proteases 
could be altered perhaps improving the flavour of oriental fermentations. 
Alkaline protease is secreted in large quantities from A. oryzae, The signal 
sequence for this gene is therefore very efficient additionally the promoter is 
strong and tightly regulated making the control regions of the alkaline 
protease gene attractive for use in heterologous expression. 
The alkaline protease gene has been mutated and work is 
proceeding to obtain mutants in this gene by reverse genetics. Mutants 
obtained in this way would be specific offering the opportunity to study the 
effects of the alkaline protease gene both generally and on heterologously 
expressed proteins. 
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Figure 9.1 Protease production in A. oryzae Proteases are repressed by 
ammonium and nitrate but not by glucose. All plates contain minimal 
media with. (plate A) 1% skimmed milk; (plate B) 1% skimmed milk, 1% 
glucose; (plate C) 1% skimmed milk, 5 mM glutamate; (plate D) 1% 
skimmed milk, 5 mM glutamate, 1% glucose; (plate E) 1% skimmed milk, 1 
% glucose, 10 mM ammonium; (plate F) 1% skimmed milk, 1% glucose, 10 
mM nitrate. WT denotes wild-type, SAO200 is strain SAO200, (prtAl). Plates 
were incubated at 30 °C for 48 hours to permit growth and then at 4 °C for 48 
hours to allow development of protease activity. 
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Figure 9.2 Degradation of proteins by A. oryzae extracellular proteases. 
A. oryzae strains were grown under induced conditions (minimal 
media, 1% Marvel, 5 mM glutamate)(unless otherwise stated), 100 µl 
of mycellial free culture media was incubated with the test protein 
overnight (unless otherwise stated) at 37 °C. After electrophoresis on a 
10 % SDS polyacrylamide gel, protein degradation was visualized by 
either coomassie blue or silver staining. As a control, media in which 
no fungus had been grown was incubated with the test protein. 
(Panel A) 
Lane 1 Control growth media 
2 Control- growth media, 25 pg BSA 
3 A. oryzae wild type culture fluid 
4 A. oryzae wild type culture fluid, 25 pg BSA 
5 A. oryzae strain SAO200 culture fluid 
6 A. oryzae strain SAO200 culture fluid, 25 pg BSA 
725pgBSA 
8 Protein size markers as indicated 
(Panel B) 
Lane 1 Control growth media 
2 Control- growth media , 10 jig carbonic anhydrase 3 A. oryzae strain SAO200 culture fluid 
4 A. oryzae strain SAO200 culture fluid, 10 µg carbonic anhydrase 5 A. oryzae wild type culture fluid, 10 µg carbonic anhydrase 6 A. oryzae wild type culture fluid 
7 10 µg carbonic anhydrase 
8 Protein size markers as indicated 
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Figure 9.2 (continued) 
(Panel C) 
Lane 1 Control, growth media 
2 Control, growth media, 25 µg lysozyme 
3 A. oryzae wild type culture fluid 
4 A. oryzae wild type culture fluid, 25 µg lysozyme 
5 A. oryzae strain SAO200 culture fluid 
6 A. oryzae strain SAO200 culture fluid, 25 µg lysozyme 
7 25 µg lysozyme 
8 Protein size markers as indicated 
(Panel D) 
Mycellia free culture extracts were taken from A. oryzae cultures grown 
under uninduced conditions (minimal media, 5 mM glutamate) 
Lane 1 A. oryzae wild type culture fluid, 10 µg carbonic anhydrase 
2 A. oryzae wild type culture fluid 
3 A. oryzae strain SAO200 culture fluid, 10 µg carbonic anhydrase 
4 A. oryzae strain SAO200 culture fluid 
5 Control, growth media , 10 µg carbonic anhydrase 6 Control, growth media 
7 10 µg carbonic anhydrase 
8 Protein size markers as indicated 
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Figure 9.2 (continued) 
(Panel E) 
Lane 1 A. oryzae wild type culture fluid 
2 A. oryzae wild type culture fluid, 25 µg h1L6 
3 Protein size markers as indicated 
4 25 µg hII. 6 
5 A. oryzae strain SAO200 culture fluid 
6 A. oryzae strain SAO200 culture fluid, 25 tg hIL6 
(E) 
Figure 9.3 Northern hybridization of the A. oryzae alkaline protease 
gene. (Panel A) Total RNA was prepared from A. oryzae strains grown 
for 24 hours as follows; (1) Wild type A. oryzae grown in minimal 
media (MM), 1% Marvel 5 mM glutamate, (2) Strain SAO200 and (3) 
Strain SA00204 grown under the same conditions. (4) Wild type A. 
oryzae grown in minimal media, 10 mM Ammonium. (Panel B) After 
electrophoresis under denaturing conditions and northern transfer to 
nylon, hybridization was at 42 °C with a radiolabelled X -clone 
containing the A. oryzae alkaline protease gene, with washing to 5x 
SSC at 53 °C. The position of RNA size markers are indicated. 
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Figure 9.4 Determination of Assay Incubation times 
Assays were adapted from the azocasein assay used by Gibson and 
Macfarlane (1988). Samples of mycelium free culture fluid taken from wild 
type A. oryzae grown in minimal media, 1% Marvel, 5 mM glutamate at 30 
°C were incubated 37 °C, with azocasein in 0.1 M phosphate buffer pH 7.0, 
0.5 M CaC12 for the periods of time indicated. The reactions were stopped 
and undegraded protein was precipitated by the addition of TCA. Colour 
was developed with 0.1 M NaOH and protease activity was measured 
spectophotometrically at 450 nm. 
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Figure 9.5 Protease assays. Assays were adapted from the azocasein assay 
used by Gibson and Macfarlane (1988). Samples of mycelium free culture 
fluid taken from A. oryzae grown in minimal media, 1% Marvel, 5 mM 
glutamate at 30 °C were incubated 37 °C, with azocasein in the appropriate 
buffer . (Panel A) 10 mM Tris HC1 (pH 7.0) (Panel B) 10 mM Borate Buffer (pH 9.0) (Panel C) 10 mM Phalate buffer pH 3.0 for 3 hours. The reactions 
were stopped and undegraded protein was precipitated by the addition of 
TCA. Colour was developed with 0.1 M NaOH and protease activity was 
measured spectophotometrically at 450 nm. (Panel D) Mycellial biomass was 
measured as dry weight from 100 ml cultures 
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Figure 9.6 Analysis of protease mutants. Putative prtA2 protease mutants 
(Lanes 2 to 8) obtained from UV mutagenesis of A. oryzae strain AO1.1 
(niaD14) and the wild type strain (Lane 1), were grown in 100 ml of minimal 
media, 1% Marvel, 5 mM glutamate. Mycelium free culture fluid (100 µl) 
was incubated with 25 gg hIL6 for 3 hours at 37 °C. After electrophoresis on 
a 12.5 % SDS polyacrylamide gel and Coomassie Blue staining, degradation 
of hIL6 was assessed by comparison with Lane 9 which contains 25 gg hIL6. 
Lane 10 contains protein size markers as indicated. Lane 5 contains the 
mutant strain designated SA0204 
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Figure 9.7 Protease assay 1 Assays were adapted from the azocasein assay 
used by Gibson and Macfarlane (1988). Samples of mycelium free culture 
fluid taken from A. oryzae grown in minimal media, 1% Marvel, 5 mM 
glutamate at 30 °C were incubated 37 °C, 3 hours, with azocasein in the 
appropriate buffer; (Panel A) 10 mM MOPS pH 7, (Panel B) 10 mM Borate 
pH 10.5. the reaction was stopped and undegraded protein was precipitated 
by the addition of TCA. Colour was developed with 0.1 M NaOH and 
protease activity was measured spectophotometrically at 450 nm. (Panel C) 
Biomass was measured as dry weight from 100 ml cultures. 
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Figure 9.8 Protease assay number 2 Assays were adapted from the azocasein 
assay used by Gibson and Macfarlane (1988). Samples of mycelium free 
culture fluid taken from A. oryzae grown in minimal medium, 1% Marvel, 
5 mM glutamate at 30 °C were incubated 37 °C, 3 hours, with azocasein in 
the appropriate buffer; (Panel A) 10 mM MOPS pH 7, (Panel B) 10 mM 
Borate pH 10.5. the reaction was stopped and undegraded protein was 
precipitated by the addition of TCA. Colour was developed with 0.1 M 
NaOH and protease activity was measured spectophotometrically at 450 nm. 
(Panel C) Biomass was measured as dry weight from 100 ml cultures. 
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Figure 9.9 Protease assay number 3 Assays were adapted from theazocasein 
assay used by Gibson and Macfarlane (1988). Samples of mycelium free 
culture fluid taken from A. oryzae grown in minimal medium, 1% Marvel, 
5 mM glutamate at 30 °C were incubated 37 °C, 3 hours, with azocasein in 
the appropriate buffer; (Panel A) 10 mM MOPS pH 7, (Panel B) 10 mM 
Borate pH 10.5. the reaction was stopped and undegraded protein was 
precipitated by the addition of TCA. Colour was developed with 0.1 M 
NaOH and protease activity was measured spectophotometrically at 450 nm. 
(Panel C) Biomass was measured as dry weight from 100 ml cultures. 
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Figure 9.10 Protease assays at 37 °C Assays were adapted from the azocasein 
assay used by Gibson and Macfarlane (1988). Samples of mycelium free 
culture fluid taken from A. oryzae grown in minimal medium, 1% Marvel, 
5 mM glutamate at 37 °C were incubated 37 °C, 3 hours, with azocasein in 
the appropriate buffer; (Panel A) 10 mM MOPS pH 7, (Panel B) 10 mM 
Borate pH 10.5. the reaction was stopped and undegraded protein was 
precipitated by the addition of TCA. Colour was developed with 0.1 M 
NaOH and protease activity was measured spectophotometrically at 450 
nm. (Panel C) Biomass was measured as dry weight from 100 ml cultures. 
203 
(A) 
0.8 
0.6 
E 
0.4 
le 
im 
0 
0.2 
0. ( 
(B) 
Inhibitor study pH 7.0 
0.5-1 
Inhibitor study pH 10.5 
0.4 
0.3' 
0.2 
0.1 
0.0 
0 20 40 60 
Time (Hours) 
Wild Type 
d type + PMSF 
aline protease 
Wild Type 
Wild type + PMSF 
Alkaline protease 
80 
Figure 9.11 Protease inhibitor assays Assays were adapted from the azocasein 
assay used by Gibson and Macfarlane (1988). Samples of mycelium free 
culture fluid taken from A. oryzae grown in minimal medium, 1% Marvel, 
5 mM glutamate at 37 °C were incubated 37 °C, 3 hours, with azocasein and 
PMSF protease inhibitor if approprite, in the appropriate buffer; (Panel A) 10 
mM MOPS pH 7, (Panel B) 10 mM Borate pH 10.5. the reaction was stopped 
and undegraded protein was precipitated by the addition of TCA. Colour 
was developed with 0.1 M NaOH and protease activity was measured 
spectophotometrically at 450 nm. Biomass was as Figure 9.10 (Panel C) 
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Figure 9.12 Hybridization of an alkaline protease specific 
oligonucleotide to Southern blots of genomic DNA. Genomic DNA 
from A. oryzae was digested with Lane 1 BamHI, Lane 2 EcoRl, Lane 3 
Sall and genomic DNA from A. niger was digested with Lane 4 BamH, 
Lane 5 EcoRl and Lane 6 Sall. Following electrophoresis and transfer to 
nitrocellulose, hybridization was at 50 °C with radiolabelled (A) JAM3 
and (B) JAM4 with washing to 6x SSC. The position of ?, /HindIII 
molecular weight markers (kb) is indicated. 
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Figure 9.13 Restriction enzyme profiles of pSTA1001, pSTA1002 and 
pSTA1004. The plasmid pSTA1001 is a 2.9 kb genomic fragment of 
DNA containing the A. oryzae alkaline protease gene (amy3), inserted 
into pUC13. Plasmids pSTA1002 and pSTA1003 are deletion sub-clones 
derived from pSTAl001. The position of the restriction enzyme sites 
was determined by single, double and triple digests with the enzymes 
indicated. The approximate position of the alkaline protease gene and 
its direction of transcription, shown by the arrow, was determined by 
hybridization to a oligonucleotide probe (JAM4) derived from the 
extreme 5' terminus of the amy3 gene. Hybridization was at 50 °C with 
washing to 6x SSC. Vector sequences are not shown. 
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Figure 9.14 Back hybridization of A. oryzae alkaline protease gene to 
Southern blotted genomic DNA. Genomic DNA from A. oryzae was 
digested with Lane 1 HindIII, Lane 2 BamHI and Lane 3 EcoRI after 
electrophoresis and transfer to nylon hydridization with 32P labelled, KpnI 
digested pSTA1001, at 65 °C with washing to 0.2 x SSC. The positions of 
) /HindIII size markers (kb) are indicated 
207 
lReamatecalpairt ý 
Heterologous Expression of Human 
Interleukin 6 in A. oryzae 
Human interleukin 6 is a multifunctional cytokine which 
influences many different cells and tissues, the structure and function of 
this protein are briefly discussed in Section 1.10 (for review see Hirano et al. 
1990). Further detailed investigations of the multiple functions of hIL6 
depends on the availability of a pure and biologically active product, hIL6 
also has future implication in medical usage for vaccines, treatment of 
cancers (Seigal et al. 1990) and wounds (Pierce et al. 1989), 
immunostimulents and immunosuppresents. (Smith 1989). This section 
details the attempts that were made to express human interleukin 6 in A. 
oryzae. 
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Chapter 10 
Heterologous expression of hIL6 in A. oruz_e 
10.1 Introduction 
Due to the interest in the function of hIL, 6 and the possible 
clinical applications of the protein, hIL6 has been expressed in a number of 
heterologous systems; including E. coli, mammalian tissue culture and 
yeast. This work has produced hIL6 in several different forms. For example, 
some workers synthesized hIL6 in mammalian cell lines and expressed a 
protein that had a high antiviral activity but a weak effect on B cells 
(Zilberstein et al. 1986). However, other workers produced a 21 kDa protein 
in E. coli that had no antiviral action but a strong effect on B cell activity 
(Hirano et al 1986). jambou and co-workers (1988) report that some activities 
of hIL6 are altered if cysteine residues are removed to maximise protein 
expression in bacteria. Oka and co-workers (1985) made an unsuccessful 
attempt to secrete hIL6 in E. coli using the phoA signal sequence. 
A recent report (Guisez et al. 1990) details the production of 
hIL6 in the yeast S. cerevisiae. The protein is secreted, but not glycosylated, 
which may be of importance to its function. It is the intention of this study 
to attempt to produce this valuable protein, in an active state in A. oryzae 
and to assess whether this organism can process the protein correctly. It is 
also hoped that the levels of hIL6 excreted by A. oryzae. will be significantly 
higher than those achieved when hIL6 is expressed in yeast. 
10.2 Introduction of the hIL6 gene into A. oryzae 
The original intention of this thesis was to place the hIL6 
cDNA under the control regions from homologous A. oryzae genes, 
preferably ones that had strong and regulated promoters and an efficient 
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signal sequence. However, although the genes encoding a-amylase, 
glucoamylase and alkaline protease had been isolated (Chapters 6,7 and 9), 
constructs linking the control regions of these genes with the hIL6 gene 
were not yet available. Therefore expression cassettes made by our 
collaborators in Belgium and The Netherlands were utilised, in order to see 
if hIL6 could be produced from A. oryzae. The constructs, outlined in Figure 
10.1, employ the control regions of the A. niger g&aA gene, the A. nidulans 
gpdA gene and the hIL6 gene in different combinations fused in phase to 
cDNA encoding the mature hIL6 protein and either the A. nidulans argB or 
trpC terminator. Plasmids pFGA3HIL6T2Arg, pFGA5HIL6T2Arg and 
pFGA6HIL6T2Arg had the A. niger argB gene and plasmids pHIL61A and 
pHIL63* had the A. nidulans amdS gene as a selection markers. The 
plasmids were transformed into A. oryzae strains 1560-6, and SA0204, either 
directly or by co-transformation with equimolar concentrations of either 
p3SR2 (A. nidulans amdS) or pSTA4 (carrying the A. niger argB gene). 
Transformants and co-transformants were checked for integration of the 
hIL6 gene using Southern analysis with a hIL6-specific probe. 
Transformation frequencies and co-transformation efficiencies are 
summarized in Table 10.1. 
10.3 Analyses of A. oryzae transformants 
Plasmids pFGA3HIL6T2Arg, pFGA5HIL6T2Arg and 
pFGA6HIL6T2Arg were introduced into strain SA0204 by co-transformation 
with p3SR2. Co-transformation was detected by Southern hybridization of 
hIL6 specific probe to BamHI digested transformant DNA (Figure 5.2). 
BamHI cuts twice in these plasmids yielding the 8.8 kb insert and pUC8. The 
hIL6 specific probe hybridized to an 8.8 kb BamHI fragment in the 
transformant DNA. Additional bands suggested that internal 
rearrangement and/or multiple integration had occurred to different 
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Plasmids pFGA3HIL6T2Arg, pFGA5HIL6T2Arg and pFGA6HIL6T2Arg were 
kindly provided by Dr. R. Contreras, University of Gent and pHIL61A and 
pHIL63* were gifts from Dr. C. A. M. J. J. van den Hondel, TNO laboratories, 
Rijswijk. In pHIL63* the gpdA promoter had been altered (amino acid 15 
was Leu instead of Thr) to more closely follow a promoter consensus 
sequence. 
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Table 10-1 Introduction of a hIL6 cDNA clone into A. oryzae 
Strain SA0204 (niaD14, rtA2)d 
Co-transforming Transformation Co-transformation Integration 
Plasmid plasmida fr uen b efficiency (%) 
pFGA6HIL6T2Arg p3SR2 64 54 multi-copy 
pFGA5HIL. 6T2Arg p3SR2 64 54 multi-copy 
pFGA3HIL6T2Arg p3SR2 64 54 mutli-copy 
pJL63* NA 5 NA multi-copy 
pHIL61A NA 5 NA multi-co 
Strain 1560-6 (argB)d 
Plasmid 
Co-transforming 
plasmida 
Transformation 
frequency b 
Co-transformation 
efficiency (%) 
Integrations 
pFGA6HTL6T2Arg NA 1 NA single and 
multi-copy 
pFGA5HIL 6T2Arg NA 1 NA as above 
pFGA3HIL6T2Arg NA 6.4 NA as above 
pHIL63* pSTA4 3.2 50 multi-copy 
HH, 61A PSTA4 2.4 17 multi-co 
a Co-transforming plasmids were introduced in equimolar quantities with 
hIL6 expression plasmids. Selection with p3SR2 was for acetamide 
utilization and with pSTA4 for arginine prototrophy. 
b Transformation frequency expressed as number of transformants per µg 
plasmid DNA 
c Integration as judged by Southern blotting 
d Strain SA0204 is a protease reduced nitrate reductase mutant of A. oryzae 
wild type strain IMI144242 (=ATCC91002, a-amylase over producing). A. 
oryzae strain 1560-6 (NOVO Industries, Denmark) is an a-amylase over 
producing, arg B- mutant 
NA not applicable 
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degrees in each transformant. Plasmids pHIL61A and pHIL63* carried, 
in 
addition to hIL6 cDNA, the A. nidulans amdS therefore direct selection was 
possible. Hybridization of the hIL6 specific probe revealed an 11.2 kb BamHI 
fragment, suggesting that multiple tandem integration of the 11.2 kb 
plasmids had occurred (Figure 5.2 and discussed in Chapter 5). 
Transformation frequency with these plasmids was lower than with p3SR2, 
the possible reasons for this are discussed in Chapter 5. 
Plasmids pFGA3HIL6T2Arg, pFGA5HIL6T2Arg and 
pFGA6HIL6T2Arg carried the A. niger argB gene and were introduced 
directly into strain 1560-6. HindIII cleaves these plasmids three times 
yielding fragments of 3.5,3 and 1 kb. Southern hybridization of the hIL6 
specific probe to HindfII digested transformant DNA revealed a 3.5 kb band 
(Figure 10.2). Ten pFGA6HIL6T2Arg transformants were analysed in this 
way; the majority of them only showed hybridization to the 3.5 kb fragment, 
one however, had additional bands indicating that multiple integration 
and/or internal rearrangement had occurred. Plasmids pHIL61A and 
pHIL63* were introduced into strain 1560-6 as co-transformations with 
pSTA4. Co-transformants were selected by acetamide utilization. DNA of 
two co-transformants from each plasmid was digested with BamHI and 
Hin dIII enzymes which both cleave once in pHIL61 A and pHIL63*. 
Hybridization of Southern blots to the hIL6 specific probe revealed multiple 
bands in all the transformants. A 11.2 kb band was common to all the 
transformants indicating that tandem integration had occurred (data not 
shown). 
10.4 Regulation of transcription of hIL6 - 
Regulation of transcription of hIL6 in A. oryzae strains 
transformed with plasmids, pHIL61A and pHIL63*, carrying the hIL6 gene 
under the control of the constitutive A. niger gpdA gene promoter, was 
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studied in transformants grown on minimal media containing 1% glucose 
as a carbon source. Fungal strains transformed with expression cassettes, 
pFGA3HIL6T2Arg, pFGA5HIL6T2Arg and pFGA6HIL6T2Arg, having hIL6 
under the control of the glucoamylase promoter, were grown an minimal 
media with one of 2% soluble starch, 2% maltose, 2% xylose or 1% glucose 
as a carbon source. Maltose and starch are co-inducers of the glucoamylase 
promoter, glucose is a co-repressor and xylose produces non-inducing 
conditions. Ammonium was used as a nitrogen source to repress protease 
production. 
The transcription and regulation of the heterologous hIL6 gene 
was followed by northern analysis. RNA of 1.2 kbp hybridized to the 
radiolabelled hIL6-specific probe. (Figure 10.3) The hIL6 specific probe also 
hybridized to the 18s ribosomal band in the wild type, this could however, 
be 'washed off if the conditions were made more stringent (Figure 10.4). 
The hIL6 gene appeared to have been transcribed at different efficiencies in 
different transformants tested (Figure 10.4). RNA transfer onto the 
membrane was standardized by stripping the blot and subsequent 
rehybridization with an actin specific probe. RNA was approximately the 
same quantity in each lane (data not shown). Transformants with the 
glucoamylase promoter produced message homologous to hIL6 when 
induced with maltose or starch but not when grown on glucose or xylose 
(Figure 10.5). Hence, it can be concluded that the A. niger promoter is 
regulated in A. oryzae . Total RNA was prepared from one transformant at 
different culture times, hIL6 message levels were strong at 12 and 48 hours 
but not at 24 hours (Figure 10.3). 
It did not necessarily follow that the transformants with 
multiple copies of the hIL6 gene produced the most hIL6 specific mRNA. 
For "example, Southern analysis of pFGA6HIL6T2Arg transformants of 
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strain 1560-6 indicated that transformant designated TGA67 had multiple 
inserts of the hIL6 gene and transformant TGA611 appeared to hybridize 
strongly to the probe indicating that this transformant had multiple copies 
of the hIL6 gene (the amount of DNA is approximately the same for each 
transformant) (Figure 10.2). Northern analysis analysis of these 
transform ants indicated that the transformants with the multiple 
integration of the hIL6 gene produced more hIL6 specific RNA than a 
transformant with lower gene copy number; for example TGA64 (as judged 
visually from southern analysis) (Figure 10.4). However, a 
pFGA6HIL6T2Arg transformant of strain SA0204, designated T15 appeared 
to have a lower amount of hIL6 DNA than transformants T8, T9 and T10 
(Figure 10.6). Northern blots of total RNA of these transformants suggested 
that T15, produced more hIL6 specific RNA than T10 (Figure 10.4). 
Transformant T10 appeared to have very similar plasmid integration 
patterns to T8 and T9, however, the hIL6 specific RNA levels were very 
different (Figure 10.4). These results possibly indicate that not only is the 
copy number of plasmid DNA important for expression but also the site of 
integration. 
10.5 Heterologous protein production in A. oryzae. 
Samples of mycelium free culture fluid, in which A. oryzae 
transformants had been grown under induced conditions, were examined 
for hIL6 protein using western blotting techniques. Media samples were 
electrophoresed using PAGE, the protein was transferred to nitrocellulose. 
The membrane was hybridized to either polyclonal or mondonal antibodies 
raised against yeast recombinant hIL6 and detection was with alkaline 
phosphatase. No protein could be detected in unconcentrated fluid using 
either the polyclonal antibody or the monoclonal antibody which had 
sensitivities of 8 and 800 ng yeast recombinant hIL6 protein respectively, 
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under the conditions used (data not shown). Protein in the media was 
concentrated by either TCA precipitation or CentriconlO protein 
concentraters, Amicon. Very low levels of hIL6, ie. less than 1 ng per ml, 
could be detected in some of the concentrated media samples (data not 
shown). 
To ascertain that the low levels of protein were not due to 
inefficient secretion, total internal protein was prepared from transformant 
mycelium and was analysed by western blotting. No proteins homologous 
to the polyclonal antibody were detected in either transformants in which 
hIL6 could be detected in the media or those which apparently did not 
secrete hIL6 (data not shown). The size of the secreted hIL6 protein was 23 
kDa, as detected by western blot analysis. The hIL6 protein secreted from A. 
oryzae transformants had the same mobility on the gel as S. cerevisiae 
recombinant hIL6. The S. cerevisiae recombinant hIL6 is not glycosylated 
(Guisez et at. 1991) it can therefore be assumed that neither is the protein in 
A. oryzae transformants. 
Media from the transformant (T15) that appeared to produce 
the highest levels of hIL6 on western blotting was quantified by biological 
assay of hIL6 (van Snick et al. 1986). The results (Figure 10.7) showed that A. 
oryzae is capable of producing biologically active hIL6, although the 
concentration is very low (approximately 1µg per litre culture fluid). 
Further biological assays showed that most hIL6 was produced in 24 and 48 
hours cultures. This was perhaps surprising as hIL6 specific RNA levels 
were lowest at this time (Figure 10.3). 
10.6 Condusions 
A system has been described by which A. oryzae can be 
engineered to produce low levels of biologically active hIL6. The levels of 
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hIL6 produced by A. oryzae are in the same order of magnititude as levels of 
mammalian proteins produced by other filamentous fungi (Table 1.5). 
It is difficult to determine why the levels of hIL6 in the 
transformants is so low as there is no available method for tracking the 
translation of the protein and its subsequent processing and secretion. Many 
possible reasons have been offered for low heterologous protein production 
in other organisms including inefficient transcription and translation and 
instability of the mRNA. The stability of the mRNA is- thought to be 
influenced by the terminator (Furuichi et al. 1977) the terminators used in 
the hIL6 expression cassettes although from highly expressed genes, were 
not homologous to A. oryzae and so may not have been correctly 
recognised. Additionally, there have been many reports of cDNA based 
transgenes not being expressed reliably in animals (Archibald et al. 1990, 
Brinster et al. 1988). All the constructs used in this work employed hIL6 
cDNA therefore, this may be affecting the expression of the gene in A. 
oryzae. It is considered that the cDNAs are not transcribed as efficiently as 
genomic genes and produce transcripts that are unstable (J. Clark, AFRC, 
Edinburgh pers. comm. ). However, the A. oryzae transformants appeared to 
produce adequate levels of mRNA and since this could be detected on 
northern blotting over a period of 48 hours it was not considered to be 
unstable. Thus the reason that A. oryzae produces such low levels of hIL6 
must occur later in the protein production pathway. There have been at 
least three reported instances of heterologous genes, successfully transcribed 
in yeast but whose mRNAs are not translated, for what ever reason, into 
protein; human synthetic proinsulin (Stepien et al. 1983), rat growth 
hormone (Ammerer 1983) and the Drosophila hsp70 gene (Nicholson and 
Moran 1984). There is little evidence that codon choice plays an important 
role in determining the steady state levels of a heterologous protein in yeast 
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although it may influence the fidelity with which a heterologous mRNA is 
translated (Tuite 1991). However, the 5' untranslated mRNA leader 
sequence has been shown to affect translation in yeast (Bairn et a!. 1985, Laz 
et al. 1988). Thus possibly the constructs used in these experiments, 
although possessing control regions from filamentous fungal genes, had 
inefficient mRNA leader sequences which affected the efficiency of 
translation. 
Our collaborating laboratory in Belgium found that when the 
plasmids carrying the glucoamylase promoters were transformed into A. 
niger, no hIL6 could be detected (Carrez et al. 1990). They suggested that 
proteolysis of the heterologous product may be the reason for this as when 
hIL6 was added to the culture media of A. niger it was degraded. This has 
also been offered as a causal agent by a number of other workers (Ward et al. 
1990, Turnbull et al. 1989, Barr et al. 1988). The transformant which secreted 
the highest amounts of hIL6 was a protease reduced strain SA0204. This 
strain carries the mutation designated prtA2 and has been shown not to 
digest hIL6 in the media (Chapter 9) However, the levels of protein secreted 
by this transformant were still considerably lower than native proteins, 
possibly because some proteolysis is still occurring. Since strain SA0204 does 
not digest hIL6 protein in the media (Chapter 9), it can be assumed that any 
proteolysis must therefore be internal. The secretion process is complex and 
not fully understood but it is known that in order to pass into the rough ER 
the protein has to undergo a conformational change. This unfolded 
structure is mediated by chaperon proteins (Kumomoto 1991) and is 
resistant to proteolysis. It is possible that the heterologous hIL6 is not 
recognised by the A. oryzae chaperon proteins and therefore is broken down 
by internal proteases. 
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Another possibility for the lack of secretion of hIL6 is that the 
hIL6 gene construct contains insufficient information for the secretion 
process. The control regions of the expression cassettes were all 
heterologous to A. oryzae and so may not posses enough information for 
the correct processing and sorting that is known to occur during secretion. 
Another reason could be that A. oryzae is simply not capable of processing 
the hIL6 protein. In a previous report on A. nidulans workers described 
how a heterologous protein became 'stuck' in the secretory system 
effectively blocking it and preventing any further secretion and causing 
proteolytic degradation of the remaining unsecreted product (Upshall et al. 
1987). This may well have occurred in the experiments reported in this 
chapter. Guisez and co-workers (1990) report that the hIL6 protein is fairly 
hydrophobic; based on studies with gel filtration and cation exchange and 
reverse phase columns. Davis and Model (1985) observe that in E. coli a 
hydrophobic region in the coliphage fl gene II protein (piI) acts as an 
artificial anchor domain and suffices to stop transfer across the cytoplasmic 
membrane into the periplasmic space. Although the hydrophobicity of the 
hIL6 protein was not sufficent to prevent transfer in yeast the protein may 
have taken on a different conformation in A. oryzae, exposing more 
hydrophobic residues and this may have prevented secretion in A. oryzae. 
There seems to be a general difficulty in the production of 
mammalian proteins in filamentous fungi, whilst fairly high levels of 
heterologous proteins originating from other microorgansisms can be 
achieved the heterologous mammalian proteins are never produced in 
great quantity. The problem(s) in A. oryzae seems to be increase protein turn 
over and/or decreased translation. Therefore an alternative approach was 
investigated. 
219 
Figure 10.2 Southern analysis of A. oryzae pFGA6HIL6T2Arg 
transformants. Transformant DNA was digested with HindIII and 
fragments were separated on 0.8 % agarose gel. Following transfer to 
nylon, hybridization with a radiolabelled hIL6 specific probe was at 65 °C 
with washing to 0.2 x SSC. Lane numbers represent untransformed strain 
1560-6, transformants and pFGA6HIL6T2Arg DNA as a positive control. 
The position of ). /HindM molecular size markers are indicated. 
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Figure 10.3 Northern analyses of a A. oryzae pFGAHIL6T2Arg 
transformant. (Panel A) A. oryzae was grown on minimal media 
containing 1% soluble starch and Total RNA was prepared from (Lane 1) 
untransformed strain 1560-6 and a pFGA6HIL6T2Arg transformant of this 
strain designated TGA63 with samples taken after (Lane 2) 12 hours; 
(Lane 3) 24 hour; (Lane 4) 36 hours and (Lane 5) 48 hours of growth. 
Electrophoresis was on a 1% agarose gel under denaturing conditions. 
(Panel B) Following transfer to nitrocellulose the blot was hybridized to a 
radiolabelled hIL6 specific probe at 42°C, washed to 5x SSC at 45 °C 
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Figure 10.4 Northern hybridization of A. oryzae transformants. Total 
RNA was prepared from A. oryzae transformants grown under induced 
conditions. After electrophoresis on a1% denaturing agarose gel and 
transfer to nylon, hybridzation to a radiolabelled hIL6 specific probe was 
at 42 °C. The blot was washed to 0.2 x SSC at 56 °C. The lane numbers 
represent pFGA6HIL6T2Arg transformants of strains SA0204 and 1560-6 
as indicated 
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Figure 10.5 Regulation of transcription of A. oryzae transformants. Total 
RNA was prepared from A. oryzae strain 1560-6 transformants. After 
electrophoresis on a1% denaturing agarose gel, hybridization with a hIL6 
specific probe was at 42 °C with washing to 0.2 x SSC at 56 °C. (Lanes 1-3) 
pFGA3HIL6T2Arg transformant designated TGA34 grown on minimal 
media containing 1% starch, 1% xylose and 1% glucose respectively 
(Lanes 4-6) pFGA5HIL6T2Arg transformant designated TGA53 grown on 
minimal media containing 1% starch, 1% xylose and 1% glucose 
respectively (Lane 7 and 8) pFGA61-HL6T2Arg transformant designated 
TGA63 grown on minimal media containing 1% xylose and 1% glucose 
respectively (Lane 9-11) untransformed strain 1560-6 grown on minimal 
media containing 1% starch, 1% xylose and 1% glucose respectively 
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Figure 10.6 Southern Analyses of A. oryzae pFGA6HIL6T2Arg 
transformants. Transformant DNA was digested with HindIII and 
fragments were separated on 0.8 % agarose gel. Following transfer to 
nylon, hybridization with a radiolabelled hIL6 was at 65 °C with washing 
to 0.2 x SSC. Lane 1 contains the untransformed strain SA0204, and 
transformants designated TI to T20 are as indicated. Lane 21 contains 
pFGA6HIL6T2Arg DNA as a positive control. 
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Figure 10.7 Biological assay of hIL6 production by an A. oryzae 
transformant. Assay was preformed according to van Snick et al. (1986) on 
a pFGA6HIL6T2Arg transformant of strain SAO200 designated T15. 
Transformant was grown for 24 hours on minimal media containing 1% 
soluble starch. Mycelium was removed and the culture fluid was filter 
sterilized and stored frozen on dry ice until assayed. 
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Chapter 11 
Increased production of hIL6 in A. oruzae utilizing a ftision protein 
11.1 Introduction 
Fusion proteins; where the gene for the protein of interest is 
fused in phase with the gene for another protein, usually a highly expressed, 
homologous protein, have been widely used to increase the expression of 
heterologous proteins. In some cases only the first few amino acids have 
been employed (Smith et al. 1985, Rothstein et al. 1984, Ward et al. 1989, 
Makoff et al. 1989), whilst other workers have utilized the whole gene for 
highly expressed proteins (Ecker et al. 1988, Cousens et al. 1987). The fusion 
gene product is a protein concatamer. The two proteins can be separated 
later either by chemical cleavage, cyanogen bromide cleaves proteins at the 
methionine start residue, or by specific enzymes, for example, ubiquitin 
fusions can be cleaved by the highly specific ubiquitin hydrolyase (reviewed 
in Sherwood 1991). In one system the product has been self-cleaving; calf 
chymosin autolytically removes the pre-pro sequence to produce active 
chymosin (Ward et al. 1989), however, this is a specific case. 
The protein concatamer could increase the production of the 
heterologous protein at a variety of levels, for example initiation of 
translation could be improved, mRNA may be more stable or the fusion 
protein may be more resistant to proteolysis. Increased stability at the 
mRNA level is unlikely as in vivo experiments have shown that 
transcripts are degraded in a 3' to 5' direction (von Gabrain et al. 1983, Mott 
et al. 1985). Therefore the presence of mRNA from the well expressed 
protein is not likely to protect the mRNA from the heterologous protein 
from nuclease attack. Most workers consider that the increase in product is 
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because the fusion protein is more resistant to proteolysis. This could be due 
to the correct conformation of protein being formed during secretion, 
protecting the product from internal proteolysis. 
11.2 Transformation of A. oryzae with fusion vectors. 
A vector had been constructed by the collaborating laboratory 
in Belgium which contained the entire information for the efficiently 
secreted A. nidulans glucoamylase protein (Finklestein 1987, Gywnne et al. 
1989) under the transcriptional control of its own, or of the efficient gpdA 
promoter, followed by a short spacer peptide containing a putative 
KEX2-type processing site and the cDNA for the mature hIL6 protein. The 
plasmids, designated pFGPDGLAT and pFGPDGLAHIL6T respectively, were 
co-transformed into A. oryzae strains 1560-6, SAO200, SA0204, SAO1.1, 
using equimolar concentrations of either pSTA4 or p3SR2, as previously 
described. Transformation frequency for the amdS system was considerably 
lower than previously experienced, averaging only 5 transformant per gg 
plasmid DNA, over 8 transformation experiments. Co-transformants 
producing hIL6 were detected by western blotting. The protein present in 1 
ml of media was concentrated by lyophilization and was analysed on 
denaturing PAGE. (Figure 11.1). Although 60 acetamide utilizing 
transformants and 51 arginine prototrophs were analysed, only 5 were 
detected to have hIL6 in the culture media (Table 11.1). 
It is not known why so few of the transformants contain the 
hIL6 gene. The co-transformation efficiency with the argB transformation 
system has been previously reported as 50 % and that with the amdS system 
as greater than 90 % (Chapter 5). Therefore a greater number of hIL6 
producing transformants was expected in the above experiments. A number 
of possibilities could explain this; 
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Straina Phenotype Transformant 
number 
plasmidsb yield 
µg ml 
Mswý 
1560-6 argB T1 pGPDGLAHIL6T, pSTA4 1 
SAO200 prtA T2 pGL , 
HIL6T, p3SR2 1 
SA0200 prtA T3 pGLAHIL6T, p3SR2 0.1 
SA0204 prtB niaD T4 pGLAHIL6T, p3SR2 0.1 
SA0204 prtB niaD T5 pGLAHIL6T, p3SR2 0.1 
a Strain SAO200 is a protease reduced mutant and Strain SA0204 is a 
protease reduced, nitrate reductase mutant derived from A. oryzae wild type 
strain 1M1144242 . A. oryzae strain 1560-6 (NOVO Industries, Denmark) is an 
a-amylase over producing, argB- mutant 
b Plasmids were introduced in equimolar concentrations. When pSTA4 was 
used the selection was for arginine prototrophy, when p3SR2 was used 
selection was for acetamide utilization. 
c Yield as deduced from PAGE and Coomassie Blue staining 
1) The hIL6 gene may have integrated in a greater number of transformants. 
However, the transformants may be expressing the hIL6 protein in such 
low levels that it is impossible to detect. Alternatively, the heterologous 
hIL6 protein may be being degraded by protease action before it can be 
detected. It is obvious that proteolysis of hIL6 is occurring to some extent, as 
more glucoamylase is being produced, when transformants with the 
expression cassette containing the gpdA promoter are grown under 
conditions that would repress the native glucoamylase, than hIL6, although 
the genes are present in equimolar concentration (Figure 11.3) 
2) The hIL6 construct may be incorporated into the A. oryzae genome in 
such away that it is not expressed; the position of integration may be of 
consequence. It is thought that the co-transforming plasmid integrates in 
multiple tandem copies when the amdS system is used as method of 
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transformation (Chapter 5). Long gene concatamers are foreign to the 
organism and it is not known to what extent these can be transcribed. 
3) The hIL6 protein may be toxic in quantity to A. oryzae. This would create 
a negative selection pressure both on the regenerating protoplasts 
transformed with the constitutive expression cassette pGPDHIL6T and also 
on transformants grown under induced conditions. 
4) It has been reported that high copy number of the amdS gene reduces the 
catabolism of ca-amino acids (Hynes and Andrianopoulos 1989) acting via 
the amdR and amdT regulation genes. There is a slight possibility that this 
could in turn effect the general amino acid pool and thus the translation of 
the hIL6 gene. 
11.3 Characterization of Heterologous hIL6 
The heterologous hIL6, hybridizing to the polyclonal antibody 
appeared to be of heterogeneous mass and to have a different mobility to the 
S. cerevisiae hIL6 used as a control (Figure 11.1). The media extracts were 
treated with N-gycosidase F and analysed by PAGE. Treatment with N- 
gycosidase F did not alter the mobility of the heterologous hIL6 on the gel 
(Figure 11.2). This could indicate that the protein was not N-glycosylated. 
However, as detection of changes in mobility on the polyacrylamide gel was 
with western blotting with a hIL. 6 specific antibody, it was not possible to 
determine whether other proteins produced by A. oryzae had had their 
carbohydrate moieties removed, therefore the experiment had no internal 
control. It could be possible that the N-gycosidase F treatment was 
inefficient, which would result in no changes in mobility of the hIL6 
protein even if it was N-glycosylated. The experiments could be repeated 
and the results visualized using PAGE and Coomassie Blue staining. 
However, this would require larger amounts of protein to be concentrated 
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as all the different mass proteins cannot be seen if the protein present in 1 
ml of media is applied to the gel (Figure 11.3). Constraints on time 
prevented any further analysis of the hIL6 protein. Experiments to 
determine whether A. oryzae had 0-glycosylated the hIL6 protein were 
prohibited by the expense of the enzymes required to perform this 
technique. 
There are two putative N-glycosylation signals present in the 
protein sequence, which are only recognised to a limited extent in human 
cells (Gross et al. 1989) the main type of glycosylation being O-linked. From 
preliminary results it appears that the A. oryzae glycosylation pattern has a 
similar specificity as the mammalian. However, the slight increase in 
molecular weight could have been caused by incorrect processing of the 
KEX-2 protease recognition site. These constructs have also been introduced 
into A. nidulans by the Belgium laboratory and their findings suggest that 
the hIL6 protein is un-glycosylated in this organism (Contreras et al. 1991). 
A report on the secretion of human epidermal growth factor 
(hEGF) in S. cerevisiae considers that the KEX-2 protease site may act as a 
chaperon, guiding the hEGF through the secretory pathway to the golgi 
(Clements et al. 1991). These workers found that the S. cerevisiae invertase 
signal sequence alone did not facilitate secretion of the hEGF. However, if a 
pre-pro sequence containing a KEX-2 protease cleavage site was introduced, 
secretion occurred in S. cerevisiae. It may therefore be the KEX-2 site that is 
increasing the secretion of the hIL6 in these experiments and it would be 
interesting to produce further constructs linking a pre-pro region containing 
a KEX-2 site with the hIL6 gene in order to see if secretion is also increased 
in A. oryzae. 
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The amount of hIL6 protein secreted by the transformants 
(Table 11.1) was calculated from comparisons with the yeast recombinant 
hIL6 protein on Coomassie Blue stained gels (Figure 11.3). This amount is 
more than 250-fold higher than the best values obtained with equivalent 
constructions containing only the glucoamylase signal sequence or prepro- 
sequence fused to the hIL6 cDNA as described before, suggesting a clear 
positive influence of the presence of the entire glucoamylase on the 
translocation of the hIL6 protein through the secretory pathways. This 
amount is similar to the amount produced by A. nidulans when the same 
constructs are used (Contreras et al. 1991). However, unlike this report the 
amount of hIL6 produced is not in equimolar concentrations with the 
glucoamylase (Figure 11.3) indicating that some proteolysis of hIL6 has 
occurred or that there is some problem with the translation of the mRNA. 
The latter is unlikely since A. oryzae has been shown not to be selective in 
its codon usage of amino acids, unlike many other organisms (Marauyama 
et al. 1986). No high molecular weight protein was detected by western blot 
analysis indicating that the KEX-2 site was recognised by the A. oryzae 
proteases. 
Glucoamylase and hIL6 protein were produced in the presence 
of glucose when the gpdA promoter was used indicating that the promoter 
is correctly regulated (Figure 11.3). The slight differences in the amounts of 
hIL6 produced when the A. oryzae transformants were grown on the 
different carbon sources, seen in Figure 11.3, can most likely be attributed to 
different growth patterns as the total amount of protein loaded onto the gel 
was not standardized and differences can be seen in the concentration of 
other A. oryzae proteins. 
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11.4 Conclusions 
A system has been described utilizing a gene fusion where A. 
oryzae can be engineered to produce relatively high levels of interleukin 6, 
in the range of 1 mg per Litre. This system yielded transformants producing 
250-fold higher amounts of hIL6 than previously reported. The hIL6 
produced may be glycosylated although results are not yet conclusive. 
The gene fusion constructs used in these experiments 
employed the A. niger glucoamylase gene. Not only is this gene 
heterologous to A. oryzae but also it has been shown that A. oryzae only 
produces low levels of glucoamylase. It is expected that the yield of hIL6 will 
increase if a construct is made that is both homologous and efficient. The A. 
oryzae a-amylase gene has been isolated and work is currently proceeding to 
produce a construct linking the a-amylase gene to the hIL6 cDNA. 
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Figure 11.1 Heterologous hIL6 production by A. oryzae transformants. 
Transformants were grown for 24 hours under induced conditions. 
Mycelium was removed and 1 ml of culture fluid was concentrated by 
lyophilization. Proteins were seperated on a 10 % denaturing 
polyacrylamide gel and transferred to nitrocellulose. Heterologous hIL6 
protein was detected by antibody hybridization. 
(Panel A) Lane 1 Untransformed strain SA0204 (protease reduced, nitrate 
reductase mutant derived from A. oryzae wild type 
strain IMII44242) 
Lane 2 T4 
Lane 3 T5 
Lane 4 Untransformed strain 1560-6. (NOVO Industries, 
Denmark an a-amylase over producing, argB-) 
Lane 5T1 
Lane 6 73 
Lane 7 Untransformed strain SA0200 (protease reduced 
mutant derived from A. oryzae wild type strain I 
M1144242) 
Lane 8 800 ng yeast recombinant hIL6 
(Panel B) Lane 1 800 ng yeast recombinant hIL6 
Lanes 2-6 Acetamide utilizing transformants of SAO200 not 
producing hIL6 
Lane 7 T2 
Lane 8 Untransformed strain SAO200 
12345678 
6 
*4* 
(A) 
, 4-- hIL ok wit 
4bhm Alsommook 
(B) 
-4-- hIL6 
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Figure 11.2 Glycosylation of A. oryzae heterologous protein. A. oryzae 
transformants were grown under induced conditions for 48 hours, 
mycelium was filtered of a1 ml of culture fluid was concentrated by 
lyophilization. Proteins were resuspended in N-glycosidase F buffer, 
denatured and treated with the N-glycosidase F as indicated. Following 
electrophoresis on 10 % polyacrylamide, hIL6 protein was detected by 
western blotting. (Lane 1) Untransformed strain 1560-6 not treated with 
N-glycosidase F (Lane 2) Untransformed strain 1560-6 treated with N- 
glycosidase F (Lane3) Untransformed strain SA0204 treated with N- 
glycosidase F. (Lane 4) T4 not treated with N-glycosidase F, (Lane 5) T4 
treated with N-glycosidase F, (Lane 6) T5 treated with N-glycosidase F 
(Lane 7) T1 not treated with N-glycosidase F (Lane 8) T1 treated with N- 
glycosidase F. 
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Figure 11.3 Heterologous hIL6 production by A. oryzae. A. oryzae strain 
1560-6 was grown for 24 hours in minimal media containing (Lane 1) 1% 
starch and (Lane 2) 1% maltose. Transformant T1 was grown for 24 hours 
in minimal media containing (Lane3) 1% starch (Lane 4) 1% maltose 
and (Lane 5) 1% glucose. Mycelium was removed and 1 ml of the culture 
was lyophilized after electrophoresis on a 10 % polyacrylamide gel the 
protein was stained with Coomassie Blue stain. (Lane 6) contains 25 µg 
yeast recombinant hIL6. The arrow indicates the position of the hIL6 
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Chapter 12 
General co lesions and recommendations for further work 
12.1 Conclusions 
The work performed during this study indicates that A. 
oryzae is a promising host organism for the heterologous production of 
mammalian proteins. A. oryzae has a number of transformation systems 
available including those based on the homologous niaD (this work, 
Chapter 3) and pyrG (de Ruiter-Jacobs et al. 1989) genes, both of these 
systems have positive selection methods for mutant selection. 
Additionally a number of heterologous transformation systems can be 
used efficiently, including those based on the A. nidulans argB and amdS 
genes and the E. coli gene encoding phleomycin resistance (this work, 
Chapter 5). 
Expression cassettes containing hIL6 cDNA linked to a 
heterologous gene have been introduced into A. oryzae and the levels of 
hIL6 secreted have been very favourable. These results indicate that A. 
oryzae is capable of processing and secreting the hIL6 protein. A. oryzae 
transformants produced approximately 1 mg hIL6 protein per litre of 
culture fluid in shake flask cultures. This yield is equivalent to hIL6 
levels obtained by our collaborating laboratory, in Belguim, when the 
same constructs were introduced into A. nidulans (Contreras et al. 1991). 
The expression cassettes utilized the A. nidulans glaA gene and the A. 
nidulans gpdA providing a system homologous to A. nidulans . As it is 
an industrial organism A. oryzae is a more efficient secretor than A. 
nidulans and it is considered that the levels of hIL6 produced by A. oryzae 
would increase if a homologous highly expressed gene was used. The 
236 
genes encoding the native a-amylase, glucoamylase and alkaline protease 
have been isolated (this work, Results-Part B and Chapter 9) and it is 
hoped that when constructs employing these genes are introduced into A. 
oryzae more hIL6 protein will be produced. 
The hIL6 protein has been produced in a number of other 
systems including S. cerevisiae (Guisez et al. 1990), E. coli (May et al. 1988, 
Brakenhoff et al. 1987, Yasueda et al. 1990, Gauldie et al. 1987, jambou et 
al. 1988) and mammalian cells (Ray et al. 1988, Shimizu et al. 1990). Often 
the yields of protein have not been included in these reports. Guisez et al. 
(1990) obtained 30 mg per litre from S. cervisiae and Yasueda et al (1990), 
600 mg per litre from E. coli. With the exception of S. cerevisiae none of 
these hosts have secreted the hIL6 protein necessitating expensive and 
time consuming purification procedures. The S. cerevisiae yield was 
obtained from cells grown in small scale fermenters on optimised media 
and its is felt that A. oryzae could perhaps match these production levels 
if grown under similar circumstances. The highest levels of hIL6 have 
been produced intracellularly from E. coli, these levels have enabled the 
commercial production of this protein by British Bio-technology Ltd. 
In addition to using homologous constructs it is considered 
that the production of hIL6 by A. oryzae could be increased by employing 
a variety of other methods. 
12.2 Improvement of protein yields 
Several methods have been used in attempts to increase 
heterologous protein production. For example, Berka and co-workers 
describe higher levels of chymosin from A. awamori when a mutant 
strain defective in aspartic protease was utilized (Berka et al. 1989), 
presumably this was a result of reduced degradation of the secreted 
237 
chymosin. An effective way of obtaining protease reduced mutants in A. 
oryzae has been described and using this method two mutants have been 
isolated and further characterized (this work, Chapter 9). The two 
mutants designated prtA and prtB were considered to be possible control 
mutants. The A. oryzae alkaline protease gene has been isolated and the 
active site has been disrupted (this work, Chapter 9). Additionally, other 
Aspergillus protease genes have been cloned, including the aspartic 
protease of A. awamori (Berka et al. 1990 ). Therefore, it may be possible to 
obtain more specific protease mutants by reverse genetics. Work done 
with A. nidulans suggests that extracellular proteases are not required for 
cell growth (Cohen 1973b). Therefore, it should be possible to produce 
further protease defective mutants in A. oryzae. It has been reported that 
the KEX-2 protease of yeast is responsible for the majority of the 
proteolysis of heterologous proteins in this organism (Tuite 1991). The 
KEX-2 protease is a membrane bound protease. It may therefore be worth 
investigating A. oryzae for similar proteases that are responsible for 
proteolysis of heterologous proteins. However, the KEX-2 protease in 
yeast is involved in signal sequence processing and additional problems 
may be encountered if the gene encoding this protease were mutagenised, 
such as incorrect processing of the N-termini of proteins or inhibition of 
secretion. 
It may be possible to increase the efficiency of transcription 
and translation of the heterologous gene in A. oryzae. As previously 
mentioned, there have been many reports of cDNA based transgenes not 
being expressed reliably in animals (Archibald et al. 1990, Brinster et al. 
1988). It is considered that the cDNAs are not transcribed as efficiently as 
genomic genes and produce transcripts that are unstable (J. Clark, AFRC, 
Edinburgh pers. comm. ). All the constructs used in this work employed 
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hIL6 cDNA, therefore, this may be affecting the expression of the gene in 
A. oryzae. There has been no reports, to my knowledge, of mammalian 
genomic genes being expressed in filamentous fungi. Although the fisson 
yeast Schizosaccharomyces pombe has been shown correctly excises a 
mammalian RNA transcript intervening sequence (Kaufer et al. 1985). It 
would be interesting to see if A. oryzae was capable of processing 
mammalian intron splicing signals and whether any increase in 
transcription or stability of transcripts occurred when a genomic gene was 
used. 
Mutagenising transformants and subsequent screening for 
higher heterologous protein producing mutants has been used to increase 
product yields in at least 2 cases. Ward and co-workers (1990) improved 
chymosin yields in A. nidulans from 14 µg per litre to 100 µg per litre and 
prochymosin levels in S. cerevisiae were increased by eight to ten fold, 
compared to the parent strain (Smith et al. 1985). In utilizing this system 
to attempt to increase prochymosin production, Smith and colleagues 
(1985) identified 'supersecreting' mutants in S. cerevisiae. 
Completmentation studies on these mutants revealed that mutations in 
at least four genes can lead to supersecreting phenotype, but mutations in 
two particular genes designated SSCI and SSC2 were the strongest (Smith 
et al. 1985). Further investigations of these mutants revealed that the 
supersecreting mutants did not in fact produce more prochymosin than 
the parent strains, but rather that the distribution of chymosin within the 
cell was altered (Smith and Gill 1985). The supersecreting mutants 
targeted less of the heterologous protein to the vacuole resulting in a net 
increase in the amount of prochymosin secreted. Studies on a 
hypercelluloytic and hypersecreting mutant of the filamentous fungi T. 
reesei, isolated on the basis of resistance to catabolite repression, revealed 
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the mutant strain to have 6-7 x more ER than the wild type strain (Ghosh 
et al. 1982). The ER had wider cisternae and the strain had ER associated 
saccules instead of the typical golgi body. The secretory process is being 
studied in yeast (Herman et al. 1991), E. coli (Bassford et al. 1991) and 
mammalian systems (Debey et al. 1975). The study of these and the 
secretory system of filamentous fungi may enable the design of 
heterologous expression cassettes to be improved and possibly facilitate 
the design of strains that are especially suited for heterologous expression 
(Bigelis and Das 1988). 
Catabolite repression refers to the repression of enzyme 
synthesis by glucose or other easily metabolized sugars and many 
enzymes, including a-amylase and glucoamylase, are subject to this. It is 
believed that some product of glucose metabolism rather than glucose 
itself is involved, because of the analogous effects of other easily 
metabolised sugars. The controlling metabolite has not been identified 
and it seems that the role of cAMP (Mahler et al 1981) similar to that 
found in catabolite repression in bacteria is not obvious in yeasts and 
filamentous fungi (Matsumoto et al. 1983, Gancedo and Gancedo 1986). 
More recent work has shown that carbon catabolite repression in S. 
cerevisiae depends on catalytic active hexokinase isoenzyme P11. It is 
believed that hexokinase PU acts as a 'recognition site' giving the 
triggering signal for glucose repression and there was evidence that two 
distinct domains occur on PU, one for regulation of glucose repression 
and the other for catalysing glucose phosphorylation (Entian et al. 1984). 
However, the molecular mechanism of the triggering system has still to 
be determined (Entian et al. 1984). Fiedurek and co-workers (1987) 
reported using mutagenesis of A. niger and selection on 2-deoxy-D- 
glucose (a toxic analogue of glucose) medium. They found 10 
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deoxyglucose resistant mutants which showed a range of increased 
glucoamylase production from a few percent to over 200 % of the parent 
strain. Partially constitutive production of some enzymes normally 
subject to glucose repression, including glucoamylase, has also been 
reported for deoxyglucose resistant mutants of N. crassa (Allen et al. 
1989). It may be possible to select for mutants of A. oryzae with reduced 
catabolite repression in this way. 
In the experiments presented here heterologous protein 
yield was as assessed from small shake flask cultures and no attempts 
were made to alter the growing conditions to increase yields. Established 
fermentation procedures employ optimised growth conditions and 
medium to obtain maximal yield. For example productivity of growth 
hormone release factor by S. cerevisiae can be increased ten fold if a 
continuous microbial fermenter with cell recycle is employed (Siegel and 
Brieley 1990). Owing to its long history of use, there is a wealth of 
information about fermentation conditions for maximal enzyme 
production from A. oryzae, for example Ueno et al. (1978). Additionally, 
A. oryzae can be grown using solid state culture as practiced widely in 
oriental fermentations. For example the Koji process yields high 
concentrations of A. oryzae proteolytic, amylolytic and macerating 
enzymes (Sugiyama 1984). 
Thus the production of heterologous proteins from A A. 
oryzae could be increased by employing a variety of traditional methods 
of strain improvement and fermentation design in conjunction with 
new techniques in molecular biology. As more is understood about the 
secretory process of eukaryotes, higher secreting strains may be genetically 
engineered. Thus A. oryzae could be an attractive host organism for the 
commercial production of mammalian proteins. 
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